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Preface 
 
The purpose of his work is to dissect the host factors involved in Mycobacterium 
tuberculosis infection. Mycobacterium tuberculosis is a facultative intracellular 
pathogen that subverts host pathways to establish its replication niche. Once the 
infection is established, the use of current anti-tuberculosis drugs have proven 
limited efficacy due to the long treatment time that led to low patient compliance and 
to M. tuberculosis drug resistance.  
Here we developed several methodologies, based in fluorescent proteins using 
fluorimetry to test the susceptibility of M. tuberculosis to host factors and new drugs 
during their intracellular life style within macrophages. These techniques enable and 
to study the effect of host vesicular traffic proteins and micro RNA 142-3-p during 
macrophage internalization and on macrophage intracellular survival. Additionally we 
studied and dissect the role of Rab GTPases in exosome secretion. 
The results of this thesis are published in international scientific journals with 
referees, in international chapter books, in patents and in scientific meetings 
proceedings. 
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Resumo 
 
A tuberculose (TB) é a manifestação patológica da infecção 
do Mycobacterium tuberculosis no seu hospedeiro: os humanos. Esta doença afecta 
os humanos há milénios e constitui ainda um problema de saúde pública a nível 
global. A reemergência da TB após decadas de declínio resulta sobretudo da co-
infecção com o vírus da imunodeficiência humana e do aparecimento de estirpes de 
M. tuberculosis resistentes aos antibióticos. 
O M. tuberculosis é um parasita intracelular facultativo, cujo principal nicho de 
sobrevivência são os macrófagos: as células do sistema imune cuja função é a 
destruição dos microrganismos. Após fagocitado pelo macrófago, o M. tuberculosis 
subverte o normal funcionamento do seu hospedeiro. Os fagossomas contendo o 
bacilo da tuberculose não maturam para fagolisossomas, não fundindo 
com endossomas tardios ou lisossomas, protegendo o bacilo dos factores 
microbicidas do macrófago. Apesar de o fagossoma estar bloqueado num estádio 
precoce da sua maturação este funde com outras vesículas do macrófago 
hospedeiro, fornecendo à micobactéria recursos para a sobrevivência e replicação.  
Em particular, multiplas publicações  sugerem que diferentes proteínas do 
hospedeiro reguladoras do tráfego vesicular ou do citoesqueleto da actina poderão 
desempenhar um papel relevante na sobrevivência deste patogénio. Contudo, os 
mecanismos através dos quais é estabelecida esta subversão não são conhecidos.  
O desenvolvimento de metodologias de larga escala para triagem no estudo dos 
factores do hospedeiro envolvidos na infecção de macrófagos, pelo M. tuberculosis, 
têm sido refreados pelas características únicas desta micobactéria. A única 
metodologia disponível para a quantificação de micobactérias intracelulares é a 
contagem de unidades formadoras de colónias (UFC), uma técnica laboriosa e 
dispendiosa. Nesta tese aproveitamos as características das proteínas fluorescentes 
para desenvolvermos metodologias para a quantificação da internalização e 
sobrevivência de micobactérias  em macrófagos e em culturas líquidas. O 
desenvolvimento dessas técnicas permitiu: 
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1) Desenvolver uma metodologia baseada nas propriedades das proteínas 
fluorescentes para a determinação da sobrevivência de M. tuberculosis 
intracelularmente em macrófagos infectados. 
2) Determinar o efeito de cerca de 120 genes humanos do tráfego vesicular 
na carga do M. tuberculosis em macrófagos humanos. 
3) Estudar o efeito dos genes validados no ponto 2) e do micro RNA 
mIR143-3p na internalização do M. tuberculosis por macrófagos humanos. 
4) Adicionalmente foi estudado o efeito do silenciamento de Rab GTPases 
na secreção de exosomas. 
 
De forma a desenvolver um método alternativo ao UFC compatível com a 
possibilidade de rastreamento em larga escala da sobrevivência de micobactérias 
aproveitamo-nos das características das proteínas fluorescentes com o objectivo de 
monitorizar a infecção de macrófagos pelo M. tuberculosis. Numa primeira fase 
culturas líquidas de M. tuberculosis expressando GFP foram sujeitos à acção 
microbicida de vários antibióticos e determinadas as suas concentrações mínimas 
inibitórias por fluorimetria. Posteriormente foram utilizados vários esteres derivados 
do ácido pirazinóico em M. tuberculosis expressando GFP por fluorimetria tendo-se 
quantificado a sua actividade biológica. Todos os compostos apresentaram uma 
maior actividade biológica que a pirazinamida ou o ácido pirazinóico. Compostos 
com maior comprimento da cadeia linear do álcool e maior lipofilia estão 
positivamente correlacionados com a actividade biológica. Apesar de adequado 
para a quantificação da inibição de crescimento de M. tuberculosis em culturas 
líquidas, a proteína GFP não se demonstrou propicia para a quantificação de 
micobactérias intracelulares. A quantificação por fluorimetria de M. tuberculosis 
intracelulares expressando a proteína fluorescente vermelha tdTomato, demonstrou-
se uma boa alternativa ao UFC. Adicionalmente, a quantificação da intensidade da 
fluorescência de macrófagos humanos THP-1 expressando GFP, permitiu 
quantificar tanto o número como a viabilidade dos macrófagos. 
O estabelecimento de uma metodologia de rastreamento em larga escala para a 
quantificação de M. tuberculosis intracelular, permitiu-nos proceder ao silenciamento 
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sistemático de cerca de 120 genes do tráfego vesicular humano e quantificar o seu 
efeito na carga de M. tuberculosis em macrófagos. Os candidatos obtidos no 
rastreamento foram posteriormente validados quanto à sua expressão genética. 
Identificámos 10 genes com efeito na carga intracelular de M. tuberculosis em 
macrófagos, em 2 genes, foi observado um aumento e em 8 genes, uma redução da 
carga de M. tuberculosis em macrófagos humanos. Os candidatos foram 
maioritariamente proteínas Rab, proteínas reguladoras e efectoras de Rab e 
proteínas do tráfego vesicular não classificadas. 
De forma a quantificar o contributo da internalização nos resultados observados no 
rastreamento dos 120 genes, desenvolvemos uma metodologia baseada em 
citometria de fluxo. Determinamos que, para micobactérias virulentas e avirulentas, 
a grande maioria dos genes testados são, provavelmente, reguladores positivos da 
internalização. Estas observações justificaram e confirmaram alguns dos resultados 
obtidos no rastreamento genómico e propõem um papel activo das micobactérias na 
modulação da sua internalização por macrófagos humanos.  
De forma a validar biologicamente alguns dos candidatos, estes foram silenciados 
novamente e foi quantificada a carga micobacteriana em macrófagos utilizando a 
metodologia convencional, as unidades formadoras de colónias. Com os resultados 
observados ficou demonstrado que a proteína Rab7a induz um aumento da carga 
macrofágica de M. tuberculosis. O silenciamento de Rab34 e Sintaxina 4 induz uma 
redução da carga de M. tuberculosis em macrófagos humanos sendo esta redução, 
possivelmente devida à redução da internalização nestas células. 
Os micro RNAs (miR), recentemente descritos, são uma nova classe de moléculas 
que controlam eventos pós-transcripcionais durante a expressão genética. Os miR 
ligam-se a regiões especificas do RNA mensageiro (RNAm) de uma proteína 
bloqueando a tradução proteica e/ou levando à degradação do RNAm. Os miRs 
controlam selectivamente a expressão de proteínas de diferentes vias metabólicas 
das células. Estudos feitos no nosso laboratório demonstraram que o miR-143-3p 
está sobre-expresso nos estádios iniciais da infecção de M. tuberculosis em 
macrófagos. O miR-143-3p liga-se ao mRNA do gene Wasl controlando a expressão 
da proteína N-Wasp, um transdutor de receptores membranares e do citoesqueleto 
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de actina. O silenciamento da N-Wasp reduz a internalização de M. tuberculosis 
pelos macrófagos. Estes resultados demonstram a regulação de N-Wasp pelo M. 
tuberculosis para controlar a sua internalização. 
Os exossomas são vesículas com um diâmetro de 30 a 100 nm que são secretadas 
por diversos tipos de células. Os exossomas desempenham  um papel importante 
na sinalização entre células e em macrófagos têm um papel de apresentação de 
antigénios. Os exossomas secretados por macrófagos infectados por M. 
tuberculosis são pró-inflamatórios in vitro e in vivo. No laboratório do Dr. Amigorena 
foi desenvolvida uma metodologia para quantificação de exossomas através de 
pérolas de latex conjugadas dom CD63 e a utilização de citometria de fluxo. Em 
colaboração com o Dr Ostrwsky, do laboratório do Dr Amigorena, Instituto Curie, 
Paris, França, efectuei um rastreio de larga escala para determinação dos genes do 
tráfego intracelular envolvidos na secreção de exossomas em células HeLa B6H4. 
Nesse estudo a proteína Rab27a e Rab27b foram envolvidas na secreção de 
exossomas em células humanas. Era nosso objectivo determinar se tal se verificava 
em macrófagos humanos, no contexto da infecção do M. tuberculosis, não foi 
possível por razões alheias à nossa vontade. 
Conjuntamente os dados apresentados nesta tese demonstram o efeito de factores 
específicos do hospedeiro que influenciam a sobrevivência e/ou internalização do M. 
tuberculosis por macrófagos, alguns deles aparentemente modulados pelo bacilo da 
tuberculose. Em particular, os dados sugerem que o M. tuberculosis desenvolveu 
um mecanismo específico de invasão dos macrófagos alveolares, provavelmente, 
para estabelecer o seu nicho replicativo sem activar em demasia o sistema imune 
do hospedeiro. Estes factores do hospedeiro, e em especial as proteínas que as 
codificam ou regulam são potenciais alvos para o desenvolvimento de drogas 
orientadas para a modulação do hospedeiro de forma a inibir ou controlar a infecção 
por M. tuberculosis. O desenvolvimento de novas drogas em formulações que 
inibam estirpes de M. tuberculosis resistentes é outra estratégia de erradicação 
deste patogénio nos humanos. 
Palavras-chave: Macrófago humano, Mycobacterium tuberculosis, tráfego 
vesicular, micro RNAs, exossomas, RNAi. 
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Abstract 
 
Tuberculosis is a pathological manifestation of the infection by Mycobacterium 
tuberculosis in humans. Facultative intracellular parasites, like M. tuberculosis, 
evolved mechanisms to subvert the proper functioning of their host cells to their 
benefit.  
In this thesis we token advantage of the characteristics of the fluorescent proteins to 
develop methodologies based on fluorimetry to quantify the macrophage 
internalization and the number of intracellular mycobacteria. The application of these 
techniques allowed: 1) to demonstrate that the GFP expressing mycobacteria may 
be used to test the effects of new drugs namely pyrazinoic acid esters against M. 
tuberculosis growth in liquid cultures. However GFP is not a good fluorophore to 
quantify intracellular mycobacteria. Instead we found tdTomato the election 
fluorophore to this purpose 2) To determine the effect of 120 genes in the host 
vesicular traffic during macrophage infection with M. tuberculosis. We identified 10 
genes, 8 lead to a reduction and 2 an increase of macrophage M. tuberculosis 
burden. 3) To demonstrate that a reduction in macrophage internalization was the 
cause for the reduction in intracellular M. tuberculosis observed in some of the genes 
identified in 2) and the modulation of internalization by the microRNA miR-142-3p. 
Additionally, we studied the effect of Rab GTPases silencing in exosome secretion. 
MicroRNAs (miR) are small non-coding RNA molecules that regulate gene 
expression. Previous studies in our laboratory shown that miR-142-3p was up-
regulated during early stages of M. tuberculosis macrophage infection. MiR142-3p 
binds to Wasl gene controlling the expression of N-wasp protein involved in signal 
transduction of membrane receptors and actin cytoskeleton. N-wasp silencing 
reduces M. tuberculosis internalization by macrophage. These studies demonstrate 
that M. tuberculosis regulates its internalization through N-Wasp.  
Taken together our results demonstrate the effect of specific host factors in the 
survival and/or internalization of M. tuberculosis by macrophages. Tuberculosis 
bacilli apparently modulate some of them. The development of new molecules in 
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formulations that inhibit resistant M. tuberculosis strains is another strategy for the 
eradication of this pathogen from humans. 
Keywords: Human macrophage, Mycobacterium tuberculosis, vesicular traffic, 
Micro RNAs, RNAi. 
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General Introduction 
 
Tuberculosis 
 
Tuberculosis (TB) afflicts human kind for millennia. It is thought that TB was 
originated in Africa and accompanied the “Out-of-Africa” migrations of modern 
humans approximately 40-70 thousand years ago1. Recently, a study from Turkey 
reported TB like lesions in 500000 years Homo erectus making this disease probably 
even older than modern humans2,3. 
The ancient known mention of TB was brought to us through Assyrian clay tablets 
from 600 BC4,5. During the industrial revolution in Europe the rapid demographic 
explosion of the urban populations together with poor life conditions were the major 
reasons for the high mortality due to TB. Significant scientific achievements for the 
elucidation of the pathogenesis of the disease where possible after the discovery of 
the etiologic agent in 1882 by Robert 6.    
During the second half of the XX century, with improving live conditions, sanitation 
and housing, diet and education, with the launch of sanatoria (where patients were 
isolated and exposed to the sun and circulating air) and a healthy diet, deaths from 
TB drastically decreased. Actually, the decline in TB incidence in Europe occurred 
even before the discovery of antibiotics, stressing the importance of living conditions 
and social factors in containing TB, and highlighting some of the difficulties that are 
still faced in low-income countries today7.  
Albert Calmette and his associate Camille Guérin developed the Bacille Calmette 
Guérin (BCG) vaccine, a live attenuated variant of Mycobacterium bovis, available 
since the early 19218. In the 1948 UNICEF started a massive BCG vaccination 
campaign the ﬁrst disease control program undertaken by an agency of the World 
Health Organization9. Despite this, the single available vaccine for TB prevention 
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their efficacy was proven to be limited over the years10. Although not being fully able 
to protect against the infection, the sickness in adults upon vaccination has less 
morbidity and it was demonstrated to be effective in preventing the meningitis forms 
in infants 11.   
The modern era for TB treatment born with the discovery of antituberculous  effect of 
antibiotics, such as streptomycin in 1948 and isoniazid in 1953 12,13. TB became a 
preventable and medically treatable disease and their incidence continued to drop in 
industrialized countries throughout the XX century14,15. This fact, led to TB being 
neglected by governments and public health agencies until the end of the 20th 
century7.  
However, the pandemic of AIDS with increased susceptibility to TB of 
immunodepressed HIV infected individuals, the increasing cases of multi drug 
resistant strains (MDR-TB) together with a vaccine that has proven unsuccessful, 
and with the increased mobilization of people due to globalization have put TB back 
on the agenda during the past twenty years16,17.  
With the dawn of the new millennia the prevalence of tuberculosis has been 
decreasing since 2005, while the incidence has decreased since 2002 and a 
reduction in mortality of 45% between 1990 and 201218. Nevertheless, TB still has a 
huge impact in public health worldwide, due to its high morbidity and mortality. It´s 
estimated that one third of the human population has been infected with M. 
tuberculosis, with about 5-10% (100-200 million) that will develop the disease. Co-
infection with HIV, malnutrition, diabetes or any immunosuppressive condition 
increases the probability for developing TB. In 2012, an estimated 8.6 million people 
developed TB and 1.3 million died from the disease (almost 150 people each hour), 
from which 320 thousand were HIV positive19.   
Public health and financial efforts including improved access to health care, better 
control of transmission and increased treatment efficacy are urgently needed. 
Indeed, new scientific knowledge about the basic mechanisms underlying TB and for 
the elucidation of the host-M. tuberculosis interactions, are mandatory in order to find 
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new targets to develop alternative strategies for improved vaccines or new drugs that 
tackle the emergence of antibiotic resistance7,20. 
 
Mycobacterium tuberculosis 
 
TB is caused by bacteria belonging to the Mycobacterium tuberculosis species 
complex: MTC (M. tuberculosis, Mycobacterium canettii, Mycobacterium africanum, 
Mycobacterium microti, M. bovis, Mycobacterium caprae and Mycobacterium 
pinnipedii, Mycobacterium mungi, Dassie bacillus and Mycobacterium orygis 21–23. 
Although these species have 99.9% similarity at the nucleotide level and identical 
16S rRNA sequences, they differ widely in terms of their host tropisms, phenotypes 
and pathogenicity 24. From these species, M. tuberculosis, M. africanum, M. bovis 
and M. canettii are important human pathogens and M. microti has been reported to 
infect immunocompromised human patients21.  
M. tuberculosis is a rod-shaped, slow-growing and obligate aerobe bacterium, which 
the only known natural host is the human species25,26. This aerobic facultative 
intracellular pathogen has characteristic features that include its slow growth, the 
capability to enter and exit into dormancy, and a special metabolism adapted to 
intracellular survival, together with a robust genetic homogeneity 27. Another 
remarkable characteristic of this pathogen is the ability to switch metabolic pathways 
after detection of specific environment 28.  The tubercle bacilli is fitted out  with a 
protein secretion system that can deliver virulent effectors to host cells 29.  
The etiologic agent of human tuberculosis has a cell wall characterized by a very 
complex thick cell wall (Figure 1.1) that shares characteristics of both gram positive 
and negative bacteria30. Composed partly by mycolic acids, renders this pathogen 
with intrinsic resistance to some antibiotics being also responsible for the acid-fast 
staining property used to identify mycobacteria, in Zhiel-Neelsen acid-fast stain 31. 
The cell wall long-chain mycolic acids are linked to arabinogalactan, which is 
attached to the peptidoglycan. In addition, the cell wall contains several lipoglycans 
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including lipoarabinomannan (LAM), its precursor’s lipomannan (LM), and 
phosphatidyl-myo-inositol mannosides (PIM). LAM acts as a virulence effector of M. 
tuberculosis, contributing to the inhibition of macrophage functions important for 
killing the pathogen by inhibiting phagosomal maturation and interfering with cell 
signalling and shifting the cytokine response from pro- to anti-inflammatory 32–34. 
Virulent, slow-growing mycobacteria like M. tuberculosis harbour mannose-capped 
LAM (ManLAM) in their cell wall the type of capping is important for virulence 34. The 
cell wall of virulent mycobacteria also contains a 19-kDa lipoprotein of unknown 
function which has been implicated in virulence through a role in host cell death and 
manipulation of bactericidal mechanisms 35.  
 
 
Figure 1.1. Schematic representation of the complex Mycobacterium tuberculosis cell wall. 
Arabinogalactan is attached to the peptidoglycan. Mycolic acids and glycolipids extend through the 
cell wall
152
. 
 
The majority of the species that compose this genus are non-pathogenic 
environmental bacteria, such as Mycobacterium smegmatis, which presents 
similarities to saprophytic bacteria from the genus Streptomyces. The strain H37 is a 
laboratory variant that was isolated from a 19-year old pulmonary TB patient in 1905, 
and later dissociated into a virulent strain (H37Rv) and an avirulent strain (H37Ra), 
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based on virulence in guinea pigs36. Although both strains can be cultured in suitable 
medium in the laboratory, only the H37Rv strain is capable of replication inside within 
human macrophages37. It has recently been described how H37Rv and H37Ra differ 
genetically and phenotypically, and the major difference lies in a mutation in the 
phoP gene, which is necessary for adaptation to the intracellular environment and 
PE/PPE/PE-PGRS genes involved in diverse functions such as virulence, fibronectin 
binding, and cell surface antigenic variations to evade the immune system38. 
 
From infection to disease  
 
The infection by M. tuberculosis follows a sequence of events relatively well known 
(Figure 1.2). M. tuberculosis is transmitted by aerosol route from infected individuals 
with TB. Once inhaled the bacilli containing aerosols reach the lungs, cross the 
mucosal barrier and encounters the alveolar macrophages39. After macrophage 
phagocytosis, the infected host cells secrets cytokines that induce a local 
inflammatory response leading to the recruitment of mononuclear cells from the 
blood stream40. The recruited cells get organized in a structure aiming to contain the 
infection called granuloma, a defining pathologic feature of M. tuberculosis 
infection
40,41
.  
The granuloma is a structure composed by a mass of various cell types around the 
infected alveolar macrophages, consisting of other macrophages, monocytes, 
neutrophils, giant cells, foamy macrophages, and epithelioid macrophages 
40,42,43
. 
While their function remains not completely understood, it is clear that constrains 
further propagation of the bacilli to the rest of the lung, arresting viable mycobacteria 
within this reservoir for a long period of time. This phase of the primo-infection 
usually is asymptomatic or confused with a simple cold but rarely will develop TB. 
However, instead of a full clearance of the bacilli most individuals may progress to a 
latent tuberculosis infection (LTB). It is estimated that only 5-10% of LTB will develop 
the disease in their lifetime. Factors that may contribute to this re-activation of the 
dormant bacilli are accompanied by a weakness of the immune system such as 
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consequence of malnutrition, ageing, immunosuppressant therapy or HIV co-
infection. Under this situation, the granuloma centre becomes necrotic, undergoes 
caseation, resulting in the destruction of the surrounding host tissue. This leads to 
the rupture of the granuloma and to the release of infectious bacilli into the airways 
leading to exhalation of infected aerosols and perpetuation if the infection
40,42,43
.   
 
 
Figure 1.2. Mycobacterium tuberculosis life cycle. Resident alveolar macrophages phagocytose 
inhaled bacteria. This leads to a pro-inflammatory response and recruitment of cells of the innate and 
adaptive immune systems, and the formation of a granuloma. The bacilli can be contained within the 
structure for long periods of time, but if immune control fails, the bacilli will commence replication, and 
a necrotic granuloma core develops. The granuloma then ruptures and M. tuberculosis is spilled into 
the airways 
40
. 
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TB Chemotherapy and resistance 
 
The current treatment regimen for TB includes a combination of four first line 
antibiotics, recommended by the WHO, composed of rifampicin, isoniazid, 
ethambutol and pyrazinamide along 2 months, followed by rifampicin and isoniazid 
for 4 months44. Chemotherapy is administered through directly observed treatment 
and short-course drug therapy (DOTS) programs, where patients are observed when 
they take their medication to ensure compliance, as non-compliance is a major 
contributor to the development of antibiotic resistance45,46. 
In 2012 the WHO estimated the 3,6% of new diagnosed TB cases and 20% of TB 
previously treated were multi-drug resistant M. tuberculosis TB (MDR-TB). Multi-
drug-resistant tuberculosis is defined as M. tuberculosis that is resistant to at least 
INH and  RMP, the two most powerful first-line treatment anti-TB drugs47. In 2012 it 
was estimated half million people with MDR-TB and 170 thousand resulted deaths. 
From these 9,6% were extensively drug-resistant TB cases, with bacteria resistance 
in addition to INH and  RMP to quinolones and at least one injectable second line 
antibiotic (i.e. kanamycin, capreomycin, or amikacin) 48.  
Resistant TB cases do not respond to conventional short-course antibiotic regimens 
and the treatment may be extended up to 2 years. The antibiotics used as alternative 
are less effective, more toxic to the patient and 50 to 100 times more expensive, 
having also poorer outcomes48.  
Some of the common causes of acquired drug resistance are prescription of 
inadequate treatment regimen, irregular drug supply, poor drug quality with low 
bioavailability, and poor compliance49,50. 
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Macrophage – M. tuberculosis interaction 
 
Macrophages are professional phagocytes relevant for the innate and adaptive 
immune responses. Resident macrophages are terminally differentiated in the body, 
e.g. alveolar macrophages are stationed in the lungs, Kupffer cells in the liver and 
microglia in the nervous system. The precursors of macrophages, the monocytes, 
circulate in the blood stream and are recruited into sites of infection or tissue 
damage upon cytokine challenge. The adhesion to specific extracellular matrix 
induces their differentiation to macrophages, cells with increased phagocytic 
capacity, different morphology and adhesive properties51.   
During infection, macrophages are one of the first line of defence, able to internalize 
and destroy pathogens, through a mechanism called phagocytosis52. Phagocytosis is 
an innate defence mechanism that removes foreign particles such as infecting 
bacteria and clear debris and death cells from among others, airways. The process 
initiates with adhesion to specific surface membrane receptors and engulfment of the 
bacterium by a plasma membrane-derived intracellular vacuole termed a 
phagosome. This is followed by a series of membrane fusion and fission events that 
massively reorganizes both the composition of phagosomal membranes and the 
phagosomal contents, a process known as phagosome maturation52. The pathway 
ends with the formation of the phagolysosome, a compartment competent to kill 
intracellular bacterium through their low pH, hydrolytic enzymes and the oxidative 
burst 53. Bacterial protein and lipid debris became sources of antigens for  antigen-
specific T cells presentation,  bridging innate to adaptive immune responses51. The 
resulted activated macrophages upon inflammatory or microbial stimulation acquire 
the antimicrobial properties necessary for elimination of the invader. However 
pathogens such as M. tuberculosis, have evolved means to circumvent most 
macrophage microbicidal responses 52,54,55.  
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Detection and internalization of M. tuberculosis by macrophages  
M. tuberculosis is recognized by a set of macrophage surface receptors, thereby 
initiating specific signalling pathways and modulating several immunobiological 
processes during and after internalization56,57. The uptake of M. tuberculosis bacilli 
by macrophages involves the recognition of some bacterial components pathogen 
associated molecular patterns (PAMPs) through several of macrophage pattern 
recognition receptors (PRR) toll like receptors (TLR)58 ,scavenger receptors, lectin 
receptors and other immune receptors including complement receptors (CR)59, 
mannose receptors (MR)60, receptors for the constant region of immunoglobulin G 
(FcγR), and, glycoproteins61. The type of receptors used for detection and/or 
internalization of  M. tuberculosis might affect the fate of the bacteria: for instance 
internalization via CR or MR reduces pro-inflammation and macrophage activation57 
allowing a silence invasion of host cells. In opposition the engagement of FcγR leads 
to phagolysosomal maturation of M. tuberculosis containing vesicles and therefore 
may be an advantage for the host62. 
 
Manipulation of host vesicular traffic pathways  
Upon internalization by macrophages, the newly formed phagosome containing M. 
tuberculosis redirects the host vesicular traffic pathways. M. tuberculosis´s virulence 
factors interfere with host phagolysosome biogenesis, by promoting homotypic 
fusion of early endosomes to provide nutrients to sustain replication63. Pioneering 
studies by Hart and Armstrong showed that phagosomes containing virulent M. 
tuberculosis do not fuse with lysosomes64,65. Several other studies shown that 
virulent mycobacteria containing phagosomes shared characteristics with early 
phagosomes, with a low acidified lumen (pH≈6) due to absence of V-ATPase66. 
Another important aspect of the mycobacterial phagosome is that the vacuole seems 
to retain access to markers derived from plasma membrane67–69, allowing acquisition 
of nutrients, such as iron70.  
As described for other intracellular pathogens, M. tuberculosis secretes virulence 
factors redirects the host vesicular  traffic through selective exclusion or retention of 
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Rab GTPases and SNARE proteins a major group of proteins responsible for 
coordination of vesicle traffic and fusion 71–73. 
Rabs and SNAREs proteins 
 
Rab proteins are a large family of monomeric GTPases with more than 70 members 
already identified in the human genome.  These proteins help to define the organelle 
identity consequence of their distinct intracellular localization 74,75. Nevertheless, 
different Rabs are able to bond the same membrane organelle forming distinct 
membrane microdomains bearing different functions 75,76.   
Another typical feature of these family of proteins is the molecular switches 
alternating between two conformational states: the GTP-bound “active” form and the 
GDP-bound “inactive” form 74,77,78 (Figure 1.3). The spatial and temporal recruitment 
of GDP-GTP exchange factors (GEFs) and GTPase activating proteins (GAPs) is 
responsible for the correct transitions between Rabs in organelle membranes. 
Briefly, the soluble inactive GDP-bound Rab is a substrate for GDP dissociation 
inhibitor (GDI). At the acceptor membrane, the complex interacts with GDI 
dissociation factor (GDF), which removes GDI from the complex, allowing the 
insertion of the Rab in the membrane. At this stage, GEF acts on the membrane-
inserted Rab to convert it to a GTP-bound active state, which in turn interacts with 
specific effectors, such as phosphatidylinositol kinases and phosphatases75,77,79,80. 
Through their effectors, Rabs mediate many key steps of membrane trafficking, 
including cargo selection, vesicle budding and transport, membrane tethering and 
fusion (Figure 1.3).  
Several components of the fusion machinery participate in this process, including N-
ethylmaleimide-sensitive factors (NSFs), NSF attachment proteins (SNAPs) and 
SNAREs (soluble NSF attachment receptor) 81–83. The pairing of an organelle target 
SNARE with the vesicle SNARE originates a four-helix trans-SNARE bundle that 
pulls membranes together, allowing the fusion of lipid bilayers. Posterior to 
membrane fusion, the pair of SNAREs bound to the membrane is designated as cis-
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SNARE and is separated into t-SNARE and v-SNARE through the recognition of the 
cis-SNARE complex by α-SNAP and the action of the NSF ATPase that interacts 
with α-SNAP 81–83. Since SNAREs have some degree of promiscuity, Rab GTPases 
and their effectors also regulate docking and fusion specificity84. 
 
M. tuberculosis manipulation of host vesicular traffic 
Phagosomes undergo a series of fusion and fission events along the endocytic 
pathway termed phagosome maturation85 that results in the biogenesis of 
phagolysosomes85. After sealing, nascent phagosomes rapidly lose some of the 
cytosolic membrane components. Rab5 became associated with early phagosomes 
immediately after their formation. Active Rab5 recruits several effectors such as 
rabaptin 5 and rabex 5, promoting a loop with early endosome antigen1 (EEA1)86. 
EEA1 effector thereafter binds to Syntaxin (STX) 13 modulating, transiently the 
association and pore like fusion between phagosomes and vesicles on the same 
level of maturation: early endosomes87. At this stage early phagosomes possess a 
moderate pH and a poor hydrolytic lumen 52. It is though that phagosomes 
maturation requires Rab5 conversion to Rab7 on the membrane organelle88. 
Recruitment of Rab7 to phagosomes is not completely understood. During this 
phase active Rab5 binds to its effector Vps34, a Phosphoinositide 3 Kinase typeII 
(PI3K) inducing the production of Phosphoinositide 3-phosphate (PI(3)P) in the 
phagosomal membrane89. Importantly, Rab5 also prompts, indirectly, the recruitment 
and GTP-loading (activation) of Rab790. The newly acquired Rab7 proceeds to direct 
the centripetal displacement of phagosomes towards lysosomes through acquisition 
of RILP (Rab7 interacting lysosomal protein) which binds to dynein and promotes the 
interaction between phagosomes and lysosomes91. The SNARE STX7 is recruited to 
late endosomes/lysosomes92 and is associated with phagosomes. This protein is 
recruited to phagosomes later than STX13 and accumulates throughout maturation 
probably promoting fusion between late endosomes/lysosomes and the phagosome. 
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Figure 1.3. Distinct membrane trafficking steps that can be controlled by a Rab GTPase and its 
effectors (indicated in orange).a | An active GTP-bound Rab can activate a sorting adaptor to sort a 
receptor into a budding vesicle. b | Through recruitment of phosphoinositide (PI) kinases or 
phosphatases, the PI composition of a transport vesicle might be altered (the conversion of PI-x into 
PI-y) and thereby cause uncoating through the dissociation of PI-binding coat proteins. c | Rab 
GTPases can mediate vesicle transport along actin filaments or microtubules (collectively referred to 
as cytoskeletal tracts) by recruiting motor adaptors or by binding directly to motors (not shown). d | 
Rab GTPases can mediate vesicle tethering by recruiting rod-shaped tethering factors that interact 
with molecules in the acceptor membrane. Such factors might interact with SNAREs and their 
regulators to activate SNARE complex formation, which results in membrane fusion. e | Following 
membrane fusion and exocytosis, the Rab GTPase is converted to its inactive GDP-bound form 
through hydrolysis of GTP, which is stimulated by a GTPase-activating protein (GAP). Targeting of 
the Rab–GDP dissociation inhibitor (GDI) complex back to the donor membrane is mediated by 
interaction with a membrane-bound GDI displacement factor (GDF). Conversion of the GDP-bound 
Rab into the GTP-bound form is catalysed by a guanine nucleotide exchange factor (GEF)
75
. 
 
15 
The phagolysosome contains an arsenal of highly hydrolytic enzymes that works in 
an acidic environment (pH bellow 5,5) designed to effectively eliminate invading 
microbes. Activated macrophages in addition to M0 ones are reprogrammed to high 
killing via free radicals and less extend of hydrolysis, fundamental for antigen 
presentation to the adaptive immune cells93. Several other Rabs and SNAREs 
proteins have been associated with phagosomes71,85. 
M. tuberculosis has the ability to invade macrophages, survive and, even replicate in 
phagosomes that do not maturate to phagolysosomes94. For long  has been 
observed that M. tuberculosis block phagosome-lysosome fusion64. However, M. 
tuberculosis containing phagosome is a dynamic compartment: rather than static 
retaining the characteristics of an early phagosome.  It has a pH  of 6.3, mainly due 
to reduced recruitment of the V-ATPase and has access to transferrin95–97 thus 
indicating that they are competent to fuse with endosomes for nutrient acquisition. It 
also lacks mature lysosomal hydrolases 98 and, the interactions between the 
phagosome and the TGN are limited99. Increasing body of evidence suggests that M. 
tuberculosis is able to manipulate macrophage vesicular traffic pathways. First, 
studies on phagosomal blockade by M. tuberculosis containing phagosomes indicate 
that the process is arrested during Rab5-Rab7 conversion94. More recent studies 
shows the presence of Rab7 in mycobacterial phagosomes, indicating that M. 
tuberculosis-containing phagosomes has the  machinery for Rab7 and therefore the 
maturation block could occur subsequently to Rab7 acquisition or were influenced by 
other components 100. A more recent study by Seto and colleagues helped to clarify 
the previous results, by demonstrating that Rab7 is transiently recruited to and 
subsequently released from mycobacterial phagosomes101. This phenomenon 
contributes to maturation block, by limiting the recruitment of the cathepsin D 
protease and the Rab-interacting lysosomal protein (RILP), a Rab 7 effector, to 
phagosomes 101. Rab14 and Rab22a, were also demonstrated to be involved in the 
inhibition of M. tuberculosis phagosome maturation102,103. Recently Seto and 
colleagues made a comprehensive study on the localization and function of 42 Rab 
GTPases in both Staphylococcus aureus and M. tuberculosis during phagosome 
maturation progress104. The authors observed 22 Rab GTPases recruited to S. 
aureus phagosomes, and 17 of these showed different recruitment kinetics relatively 
to M. tuberculosis phagosomes. Similarly to Rab7, Rab34 is a late endosomal Rab 
16 
involved in the recruitment of cathepsin D to phagosomes and transiently associated 
with M. tuberculosis phagosomes. The authors suggest that modulation of the 
recruitment of these proteins to M. tuberculosis phagosome is involved in the arrest 
of phagosome maturation and inhibition of phagolysosome biogenesis. 
In addition to Rab GTPases, proteins of the fusion machinery were also suggested to 
be targets for mycobacterial manipulation. The v-SNARE cellubrevin, also known as 
VAMP3, is involved in endosomal recycling and endosomal interactions with post-
Golgi compartments, and is usually acquired in phagosomes. Fratti et al. appointed 
cellubrevin as a mycobacterial target due to the observation of a discrete 
degradation of this SNARE during mycobacterial infection 105. Other SNARE that 
appears to be a target of M. tuberculosis is Stx4, which is a recycling endosomal and 
plasma membrane t-SNARE106. It was observed that Stx4 is retained in phagosomes 
containing PIM-coated latex beads, whereas the accumulation of this SNARE is 
lower in phagosomes containing uncoated beads. Since PIM is a mycobacterial 
glycolipid that impregnates host cell endomembranes, these findings indicate that 
PIM contributes to the fusion of M. tuberculosis-containing phagosomes with 
endosomal compartments, by retention of Stx4 in the phagosomal membrane 63. 
Despite recent advances little is known about the M. tuberculosis mechanisms for 
retention or exclusion of this proteins or effect in M. tuberculosis replication or killing 
for these proteins. 
 
Mycobacterium tuberculosis virulence effectors modulate host vesicular traffic 
To successfully modulate host macrophage vesicular traffic M. tuberculosis relies on 
virulence effectors that specific alter proteins to inhibit phagolysosome biogenesis 
and direct transport to MCP for obtaining nutrients for replication73. LAM and 
particularly ManLAM was found to be a virulence effector by reducing acquisition of 
EEA1 and Stx6 to MCP altering calcium signalling and promoting trans-Golgi to 
phagosome maturation block 107. Another described virulence factors affecting 
vesicular traffic is an acid phosphatase termed SapM secreted within the 
macrophage 33. SapM hydrolyzes PI(3)p accumulated on phagosomal membranes, 
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eliminating the docking site of EEA1 involved in phagosome maturation33. The use of 
in vitro organellar preparations lead to the finding that phosphatidylinositol manoside 
(PIM) specifically promotes early endosomal fusion in a ATP-, cytosol- and NSF-
dependent manner with absolute requirement of Rabs63. PIM stimulates phagosome-
early endosome defining a novel route for MCP acquisition of nutrients. M. 
tuberculosis nucleoside diphosphate kinase (Ndk) exhibits GTPase activating protein 
(GAP) activity towards Rab5 and Rab7a blocking phagosome maturation through 
inhibition of recruitment of EEa1 and RILP effectors to Rab5 and Rab7a 
respectively108.  
Tyrosine phosphatases secreted by M. tuberculosis protein kinase G (PknG), is 
secreted into the cytosol of infected macrophages and prevents the intracellular 
destruction of mycobacteria by blocking phagosome-lysosome fusion109.  PtpA is 
secreted into the macrophage cytosol to inactivate the human VPS33B, a 
component of the Class C VPS complex that regulates endosomal membrane 
fusion109. VPS33B dephosphorylation by PtpA results in the inhibition of phagosome-
lysosome fusion. In addition to its phosphatase activity, PtpA is also capable of 
binding to subunit H of the macrophage V-ATPase complex, indicating that PtpA can 
directly disrupt phagosome acidification109.  
For the release of some virulence effector molecules that interfere with host 
responses, M. tuberculosis possesses a specialized protein secretion system, the 
so-called early secretory antigenic target system 1 (ESX-1). Esx-1, encoded by the 
RD1 (region of difference 1) genomic region represents a major virulence 
determinant 110. 
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M. tuberculosis induction of macrophage exosome secretion 
 
Exosomes are small (50-100 nm) vesicles secreted by a range of cell types including 
macrophages. Exosomes biogenesis occurs by the inward invagination and budding 
of the limiting membrane of endosomal compartments forming multivesicular bodies 
(MVB)111.  When MVB membranes fuse with the plasma membrane, exosomes are 
secreted to the extracellular space where they can interact with other cells112,113. 
Exosomes derived from antigen presenting cells are enriched in Major 
Histocompatibility Complex (MHC) class II, MHC class I and in co-stimulatory 
molecules, and are capable of efficiently inducing T cell responses both in vitro and 
in vivo when injected into mice114. Exosomes derived from cancer cells can 
participate both in the induction of anti-tumour immune responses, and in tumour-
induced immunosuppression in vivo, depending on the tumour model studied or the 
physiological state of the patient115. 
In addition, these vesicles have been implicated in the pathogenesis of several 
infectious diseases as those caused by virus, prion or bacteria infected cells 116,117. 
Particularly, recent studies report that exosomes produced by macrophages infected 
with different intracellular pathogens, are pro-inflammatory, which highlight a new 
role of these structures in innate immunity118. This is truth also for mycobacteria as 
several recent reports show that exosomes are secreted by macrophages infected 
with several mycobacteria species. Exosomes secreted by BCG infected 
macrophages administered intra-nasally into naïve mice they stimulated antigen-
specific CD4+ and CD8+ T cells119. Identification of exosomes secreted by 
macrophages infected with M. tuberculosis revelled 41 mycobacterial proteins some 
already described to have antigenic properties120. Yet, these exosomes, derived 
from M. tuberculosis H37Rv-infected macrophages, inhibited IFN-γ induced MHC 
class II and CD63 expression on mice bone marrow derived macrophages, 
suggesting that exosomes, as carriers of M. tuberculosis  PAMPs, may provide a 
mechanism by which M. tuberculosis may exert its suppression of a host immune 
response beyond the infected cell121.  
19 
Although exosomes from M. tuberculosis infected macrophages have a huge 
potential in vaccine and diagnosis development for TB, the intracellular membrane 
traffic mechanisms underlying exosome secretion are still not understood.  
 
Macrophage MicroRNAs as a target for M. tuberculosis host 
subversion 
 
MicroRNAs (miRs) are small non-coding, single-stranded RNA molecules, with 
approximately 22 nucleotides length. In the cytosol, miRs bind specifically to the 3’-
UTR regions of target mRNAs in a sequence-specific manner, causing translational 
repression or mRNA degradation, promoting a reduction in the protein translation 
and availability, which leads to the consequent repression of biological functions 122.  
miRs are important to control a wide-range of biological processes, including 
development, cellular differentiation, proliferation, apoptosis, metabolism, immune 
response and in response to bacterial infections 123–126.  Expression of several miRs 
were demonstrated to be to be altered during M. tuberculosis infection127.  On both 
murine and human derived macrophages an altered expression of miR-155, a miR 
associated with enhanced TNF-α biosynthesis, was observed 128,129. Curiously, an 
opposite pattern of expression was shown in in human macrophages M. tuberculosis 
infection relatively to murine macrophages. In the case of M. smegmatis infection of 
human macrophages the gene is up regulated128,129. This suggests dependence in 
the regulation of the miR155 of the host cells and virulence of mycobacteria. To the 
best of our knowledge these are the only studies that systematically screened the 
miR expression on macrophage M. tuberculosis infection. 
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M. tuberculosis control of macrophage cell death 
 
Infected cells can undergo a programmed death, dependent of apoptotic caspases, 
to deprive intracellular pathogens of their survival niche and to expose them to 
immune cell recruitment130. M. tuberculosis is able to manipulate the host 
macrophage cell death response to its own advantage. For a long time, there was a 
discrepancy in the results obtained concerning host macrophage death upon M. 
tuberculosis infection, as some studies have shown M. tuberculosis to be pro-
apoptotic 131–134, while others have shown the bacterium to induce an anti-apoptotic 
effect in macrophages 135,136. However, it is becoming clear that virulent M. 
tuberculosis is able to inhibit apoptosis initially upon infection, through several 
strategies, in order to retain its intracellular niche. M. tuberculosis protects cells 
against apoptosis via two key pathways: first, through induction of TLR-2–dependent 
activation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-
kB) cell survival pathway and second by enhancing the production of soluble TNF 
receptor 2 (sTNFR2), which neutralizes the pro-apoptotic activity of  tumour necrosis 
factor alpha (TNF-α) 137–139. Additionally, M. tuberculosis down regulation of host 
expression of the anti-apoptotic protein BCL-2 is also evident in M. tuberculosis-
infected macrophages, although the mechanism of this gene repression is not 
known. This is achieved in part by the product of the gene nuoG, as deletion of this 
gene from mycobacteria results in elevated levels of apoptosis 135,136. 
On the other hand, accumulating evidence shows that virulent M. tuberculosis 
induces necrosis of the infected macrophages upon infection. Necrosis particularly 
pyroptosis is a particular type of cell death which occurs in response to excessive 
stress, microbial invasion or tissue damage. 
Furthermore, recent work shows that M. tuberculosis is capable of inhibiting the 
production of the prostaglandin E2 (PGE2), which plays a role in preventing 
mitochondrial damage as well as repairing the plasma membrane. This leads to 
necrosis rather than apoptosis, a situation which favours the bacterium to escape the 
macrophage and survive 134,140. Additionally, M. tuberculosis H37Rv can prevent 
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completion of the apoptotic envelope by removing a domain from annexin-1, and this 
is also thought to play a role in inducing necrosis rather than the more hostile 
apoptotic event, allowing bacterial dissemination in the lung 141. Thus, induction of 
necrosis is an important step in the pathogenesis of TB, enabling rupture of the host 
cell and spread to other cells once the bacterial load is sufficiently high. 
 
M. tuberculosis clearance by autophagy 
 
Autophagy is another form of programmed cell death by a separate pathway in which 
the cell ingests and degrades its own components, and this mechanism has been 
implicated in the delivery of cellular material and intracellular bacteria to 
phagolysosomes142. Induction of this mechanism has been shown to play a role in M. 
tuberculosis clearance. M. tuberculosis is eliminated from infected macrophages by 
the induction of autophagy as a consequence of nutrient starvation, drug inducer or 
IFN 143,144. Autophagy also potentially controls the intracellular burdens of M. 
tuberculosis in macrophages145. Autophagy can be seen as an alternative induction 
of phagolysosome biogenesis and a tool for M. tuberculosis clearance. 
 
Development of fluorescent based methods for studying host-
mycobacteria interaction 
 
 The “gold” standard for quantification of intracellular mycobacteria, colony forming 
units (CFU), relies on plating serial dilutions of lysed infected cells in solid media 
culture plates146. This technique is laborious, expensive and time consuming. CFU 
counting of mycobacterial species with fastidious growth-rates is only possible after 
several weeks of incubation. This approach is not suitable for high throughput 
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screens and therefore is essential the development of faster and more suitable 
methods147. The discovery of the green fluorescent protein (GFP) in the 1960’s was 
the basis of a revolution in molecular and cell biology148, presently researchers have 
a broad spectrum of colours and applications149. Fluorescent proteins allow the 
motorization of the cellular growth with high spatial and temporal resolution by 
fluorimetric detection using fluorimeters. Several fluorescent reporters are nontoxic 
cytoplasmic proteins and are continuously synthesized, which minimizes the effect of 
fluorescence signal dilution during cell replication 150. These reporters don’t require 
addition of co-factors or sample lysis and allow multiple labelling of the biological 
sample151.  
 
Thesis Goals 
 
The overall objective of this thesis is to dissect the role of human vesicular traffic 
proteins, specifically Rab GTPases and SNARE proteins, in the survival/persistence 
of intracellular M. tuberculosis in an in vitro macrophage infection model. Vesicular 
traffic proteins, namely Rab GTPases and SNARE, coordinate vesicular traffic and 
membrane fusion75,82. Intracellular M. tuberculosis selectively excludes or retains 
specific vesicular traffic proteins in their phagosomes73,104. Our hypothesis was 
whether or not these vesicular traffic proteins have a role in the survival/persistence 
of intracellular M. tuberculosis. To achieve this goal we designed a high throughput 
screen based in a dual fluorescence method using two different fluorescent proteins 
as reporters of M. tuberculosis and of human macrophages for quantification 
intracellular mycobacteria. Additionally, we used RNA interference (RNAi) to 
knockdown host vesicular traffic genes. The genes whose knockdown reduced or 
increase the intracellular mycobacteria obtained from the genomic screen were 
phenotypically validated and gene knockdown confirmed by RT-PCR. In order to 
define if the different genes obtained from the genomic screen had a role in 
macrophage internalization of M. tuberculosis we optimized an internalization assay 
based on flow cytometry. We demonstrated that some genes whose knockdown led 
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to a reduction in intracellular M. tuberculosis in the genomic screen showed a 
reduction in mycobacteria internalization by human macrophages. 
Additionally, previous results of our laboratory indicate that miR-142-3p is induced 
upon macrophage infection by mycobacteria. A gain-of-function experiment by 
inducing an increase of miR-142-3p led to a reduction in N-Wasp protein and, 
consequently to a reduced internalization of mycobacteria by murine macrophages. 
Likewise, virulent M. tuberculosis induced miR-142-3p expression and decreased N-
Wasp in monocyte derived human primary macrophages (MDHM). In this study we 
show that miR-142-3p induction and consequent N-Wasp reduction of protein 
amount in MDHM is specifically induced by virulent M. tuberculosis but not by the 
non-pathogenic species M. smegmatis or by latex beads. To address whether or not 
reduction of N-Wasp by RNAi induced a decrease of M. tuberculosis internalization 
in monocyte derived human macrophages we used the optimized internalization 
assay. The presented results show a possible mechanism by which M. tuberculosis 
controls the rate of human macrophage internalization.  
Finally, in order to dissect the role of Rab GTPases in exosome secretion we carried 
out a medium throughput genomic screen using a semi quantitative technique for 
ovalbumin and exosome secretion and systematically silenced 59 Rab GTPases. 
With this approach we were able to identify four Rabs, including Rab27a and 
Rab27b, proteins specifically involved in exosome secretion but not in ovalbumin. 
We also aimed to apply this technology to dissect the vesicular traffic genes involved 
in exosome secretion in M. tuberculosis infected macrophages. However it was not 
logistically possible to achieve this objective.  
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Development of a dual fluorescence method for 
quantification of intracellular survival of mycobacteria 
within viable macrophages.  
 
Abstract 
Mycobacterium tuberculosis evolved strategies to invade, survive intracellularly and 
egress human macrophages. Effective and fast methods for evaluation of M. 
tuberculosis intracellular survival are important tools to decipher host factors required 
for effective bacteria killing and indeed for new antimicrobial drug screenings. 
Conventional colony forming units counting (CFU) for quantification of 
Mycobacterium tuberculosis internalized by macrophages, is a labour intensive 
method with long incubation requirements that can take up to several weeks. 
Alternative fast and save methods, urge to be developed especially to be applied for 
mycobacteria intracellular survival assessments required in high-throughput screens 
(HTS). Other methods such as luminescence are not well suited for HTS, using 
multiple 96 wells plates because they need a disruption of the infected macrophages 
for release the substrate for the assay. Here we took advantage of fluorescent 
reporter proteins to accurately evaluate the amounts of mycobacteria that were 
internalized by macrophages in cell cultures. We developed a dual fluorescent 
assay, a method based in the use of two different fluorescent proteins as reporters, 
one for macrophage viability and the other for intracellular survival of M. tuberculosis. 
The method is cost-effective, suitable for HTS and is an alternative to traditional 
methods for quantification of intracellular mycobacteria. The assessment and 
quantification of infected host cells may provide additional information on the toxicity 
effects of new drugs on host viability, and give insights on host factors that impair M. 
tuberculosis survival/persistence.  
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Introduction 
 
Tuberculosis (TB) is still a major global public health problem. The etiologic agent, 
M. tuberculosis, infects one third of the human population, especially in the poorest 
countries. The emergence of multi drug resistant strains has been reported all over 
the world. Additionally, co-infection with HIV represents the major risk factor for 
development of active TB 1.  All these factors account for the TB global emergence 
due to the high prevalence of this disease that kills 1,3 million people annually 2.  
M. tuberculosis can survive and even grow within macrophages, within phagosomes, 
a cellular compartment that provides camouflage from the immune system and limits 
the access and activity of some antibiotics. Actually, for any drug to reach the 
intracellular compartment containing the bacilli it will be needed their uptake either by 
membrane translocation or via endocytosis, depending on the physiochemical 
characteristics of the molecular structure. After reaching the same compartment of 
the bacteria, the lumen will need to have a proper pH or ionic content for drug activity 
or for preventing their extrusion through efflux pumps expressed by the host cell and 
the mycobacteria 3,4. Additionally, M. tuberculosis has been shown to shift their 
transcriptional gene profile after macrophage uptake which may alter their 
susceptibility to drugs 5. Therefore, the identification of new potential anti-tubercular 
drugs using in vitro systems in broth culture screens may prove to be ineffective 
when in vitro assays are performed in infected cell cultures 6. Furthermore some 
pathogens such as M. tuberculosis or some host proteins when silenced or 
overexpressed may induce host cell death or toxicity. Therefore novel screening 
methods for drugs or host factors that may be involved in the killing of mycobacteria 
should evaluate in parallel the amount of intracellular pathogens and the ratio of the 
host infected viable cells. 
The current CFU method for determination of the number of live intracellular 
bacteria, involves methodologies such harvesting bacilli and growing them for 
quantification on solid media and subsequent counting of colonies. The principle 
drawbacks of such method is that of being labour-intensive and expensive due to the 
long period of time needed for M. tuberculosis grow (generation time of 18 to 24 
hours), associated with the possibility of contamination. Furthermore, non-specific 
binding of M. tuberculosis to both plastic ware and macrophage membranes 
generates an added obstacle. The lack of a fast, sample friendly and reliable 
alternative technique for intracellular quantification of M. tuberculosis has been 
limitations when HTS are required for assess host factors affecting intracellular 
pathogen survival/persistence. 
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The identification of GFP from Aequorea or in other organisms together with the 
subsequent expansion in the identification of different fluorescent proteins (FP) 
through GFP mutagenesis led to a “revolution” in cell biology 7. The ability to monitor 
in real time, live cellular mechanisms without cell toxicity or the need of adding any 
cofactor make these proteins perfect reporters of cell and organism viability.  
In this study we developed a dual fluorescence assay by making use of the 
expression of two different fluorescent proteins one addressing mycobacteria and 
the other human macrophages. The dual fluorescence assay provides us means to 
quantify intracellular M. tuberculosis and, simultaneously, macrophage viability 
during infection for HTS.  During the development of this methodology we tested the 
biological effect of pyrazinoic acid esters in M. tuberculosis broth cultures and 
identified some pitfalls of this kind of approach. Effective methods for the evaluation 
of the survival/killing of intracellular pathogens in their intracellular niche will be 
important for future research of host-pathogen interactions and will enable the 
identification of both new drugs that can target M. tuberculosis or host factors to 
impair pathogen intracellular survival in a rapid cost-effective way. 
 
Results 
 
M. tuberculosis fluorescent intensity is correlated with the amount of 
mycobacteria  
The measurement of the optical density is commonly used to quantify the number of 
mycobacteria in a broth culture and is correlated with the number of viable 
mycobacteria 8. However this approach can lead to artifacts due to the clumpy 
nature of these bacteria.  In order to develop a fluorescence-based method to 
effectively test mycobacterial sensitivity to antibiotics we used the M. tuberculosis 
strain H37ra expressing GFP. Mycobacteria were incubated in broth cultures with 
serial two fold dilutions of three different antibiotics (amikacin, hygromycin B and 
kanamycin) and were quantified by measuring the fluorescence intensities (FI; 
excitation: 488nm; emission: 520nm; Gain: 150) in parallel to the optical density at 
600 nm (OD600). The samples were recorded during the following 7 days (Figure 
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2.1).  We observed an increase both on fluorescence intensity and on OD600 in the 
control samples. In all the antibiotics samples tested we detected inhibitory 
concentrations for bacterial growth with exception of hygromycin B. This result was 
already expected since pMN042, used in this strain for GFP expression, has a 
hygromycin B resistance gene. The minimum inhibitory concentration (MICs) for M. 
tuberculosis H37Ra GFP was determined considering the highest concentration that 
led to 90% of inhibition compared with the control both by FI and OD, after 7 days of 
incubation (Table 2.1). MIC values obtained by OD measurement were higher than 
those by FI in an order of 2-4 folds. The MIC for the amikacin by  FI measurements 
was similar to those reported in a similar study 9. Although expression of GFP by 
mycobacteria, measured by FI, had higher sensitivity for assessment of cell viability 
in latter time points and OD600 was more sensitive in low cell concentrations for 
readings below 0,1, still the methods present a strong correlation (r2=0,94, Pearson’s 
correlation; p<0,05) (Figure 2.2). These results indicate that, within a specific range, 
IF is a good alternative method to evaluate M. tuberculosis susceptibility to new anti-
tubercular drugs. 
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Figure 2.1.Growth kinetics of M. tuberculosis expressing GFP to serial two fold dilutions of 
three antibiotics.Growth kinetic curves were determined by fluorescence intensity (left) and Optical 
Density at 600nm (right), during 7 days. A) Amikacin B) Hygromycin B and C) Kanamycin. RFU 
express relative fluorescence units. Blank medium wells were used as a background subtraction for 
all sample test wells and bacterial control wells. 
 
Table 2.1. Minimum inhibitory concentrations (MIC) of 3 antibiotics against M. tuberculosis 
H37Ra expressing GFP determined by fluorescence intensity (FI) and OD600 after 7 days 
incubation. 
      
 
MIC (µg/ml) 
Antibiotic 
  RFU OD600 
   
Amikacin 6,25 25 
Hygromycin B >50 >50 
Kanamycin 5 10 
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Figure 2.2. Fluorescent Intensity is correlated with OD600 for quantification of M. tuberculosis 
H37Ra expressing GFP. Linear correlation between relative fluorescence unit (RFU) and optical 
density at 600 nm of M. tuberculosis expressing GFP. These two different methods were used to 
monitor bacterial growth in the presence of antibiotics. Data corresponds to the values obtained with 
all drugs used in the assay. (p< 0,05 by Pearson Product Moment Correlation). 
 
Testing the method for evaluating the anti-mycobacterial activity of new 
Pyrazinoic acid esters. 
 
To evaluate the relevance of GFP as a reporter for mycobacterial growth we tested 
the biological activity of new pyrazinoic acid esters in broth cultures. Pyrazinoic acid 
derivatives, such as esters, may be used to overcome M. tuberculosis resistance 
attributed to pncA gene mutations. The pncA gene encodes the pyrazinamidase 
essential for converting pyrazinamide (PZA) to its active form pyrazinoic acid (POA) 
10. Previous studies showed that long chain esters of POA have adequate plasma 
and rat liver homogenate stability and can easily be activated by esterases other 
than pyrazinamidase to liberate POA 11.  
In order to test the feasibility of the fluorescence intensity method to determine the 
antimicrobial effect of new drugs against mycobacteria expressing GFP we 
determined the MICs of twenty eight pyrazinoic acid ester derivatives (Supplemental 
information). For this purpose serial two-fold dilutions of each compound was used 
y = 87017x - 3551,5 
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with a load of 106 mycobacteria per ml and incubated for 5 days. The growth 
inhibition of each compound was assessed by measuring FI of the GFP emission by 
mycobacteria. All compounds were screened for growth inhibitory activity against a 
drug-susceptible strain the avirulent Mycobacterium tuberculosis H37Ra (Table 2.2).  
Our results show that all compounds possess higher activity against M. tuberculosis 
H37Ra than PZA or POA in the same experimental conditions. Compounds 3g, 4h 
and 4i are the most active, with MIC’s ranging between 0,085 and 0,095 nM. On the 
other hand, compounds 5a, 4a, 5d and 5c were the less active with MIC ranging 
from 1,1 to 1,9 nM.   
 
The Lateral chain length and lipophilicity of pyrazinoic acid derivatives affects their 
biological activity 
 
Overall, the lateral chain length of pyrazinoic acid derivatives was moderately 
correlated with the biological activity against M. tuberculosis (R2=0,558; Pearson 
correlation; p<0,05) (Figure 2.3). However, in the case of pyrazinoic acid derivatives 
from primary alcohols we observed a strong correlation between the length of the 
lateral chain with the biological activity (R2=0,761; Pearson correlation; p<0,05) 
(Figure 2.4). 
We observed the same trend of biological activity in lipophilicity of pyrazinoic acid 
derivatives tested, with and moderate correlation of all compounds (Figure 2.5; 
R2=0,551; Pearson correlation; p<0,05) and a strong correlation of lipophilicity of 
pyrazinoic acid derivates from primary alcohols and biological activity (Figure 2.6; 
R2=0,769; Pearson correlation; p<0,05). Association between lipophilicity and 
biological activity might be explained by a better diffusion of more lipophilic 
compounds through the lipidic mycobacterial cell wall barrier 12. 
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Table 2.2. Minimum Inhibitory Concentration for pyrazinoic acid derivatives against M. 
tuberculosis H37Ra. 
 
Compound R MIC (mM) pMIC
PZA NH2(*) 3,249 -0,512
POA H 3,223 -0,508
3a C5H11 0,515 0,288
3b C6H13 0,96 0,018
3c C7H15 0,45 0,347
3d C8H17 0,846 0,072
3e C9H19 0,2 0,7
3f C10H21 0,378 0,422
3g C11H23 0,09 1,047
4a CH(CH3)2 1,204 -0,08
4b CH(CH3)C2H5 0,555 0,256
4c CH(CH3)C5H11 0,45 0,347
4d CH(CH3)C6H13 0,423 0,373
4e CH(CH3)C6H13 0,847 0,072
4f CH(CH3)C6H13 0,424 0,373
4g CH(CH3)C7H15 0,2 0,7
4h CH(CH3)C8H17 0,095 1,024
4i CH(CH3)C10H21 0,085 1,068
5a C(CH3)3 1,11 -0,045
5b C(CH3)2C2H5 1,03 -0,013
5c C(CH3)2C3H7 1,921 -0,283
5d C(CH3)2C4H9 1,8 -0,255
5e C(CH3)2C5H11 0,846 0,072
6a CH2CH(CH3)2 0,555 0,256
6b CH2CH(CH3)C2H5 1,03 -0,013
6c C2H4C(CH3)2 0,515 0,288
6d C4H8Cl 0,93 0,031
6e C6H5 0,5 0,301
6f C6H11 0,485 0,314
6g (CH3)C6H10 0,908 0,041
(*) instead of OR
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Figure 2.3. Correlation between the number of carbons of the alkyl chain of pyrazinoic acid 
esters and biological activity in M. tuberculosis. (pMIC, biologic activity; R
2
=0,558; Pearson 
correlation; p<0,05). 
 
 
Figure 2.4. Correlation between the number of carbons of the of first order alkyl chain 
pyrazinoic acid esters and biological activity in M. tuberculosis.(pMIC, biological activity; 
R
2
=0,761; Pearson correlation; p<0,05). 
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Figure 2.5. Correlation between the lipophilicity of the first order alkyl chain of pyrazinoic acid 
esters and biological activity in M. tuberculosis. (pMIC, biological activity; log p, lipophilicity; 
R
2
=0,511; Pearson correlation; p<0,05). 
 
 
 
Figure 2.6. Correlation between the lipophilicity of the of pyrazinoic acid esters biological 
activity in M. tuberculosis. (pMIC, biological activity; log p, lipophilicity; R
2
=0,769; Pearson 
correlation; p<0,05). 
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Fluorescence intensity of tdTomato allows M. tuberculosis quantification in 
vitro 
 
Although the FI measurement of GFP expressing mycobacteria was useful for 
quantification of M. tuberculosis in vitro we were unable to use this fluorescent 
protein to quantify intracellular M. tuberculosis. This might be due to the interference 
of autofluorescence from the bacteria sample in the GFP emission channel 13. To 
overcome this problem we decided to use a red shifted fluorescent protein: tdTomato 
one of the brightest red fluorescent proteins available with a bright fluorescence in 
the red part of the light spectrum 14,15 using M. tuberculosis expressing tdTomato, 
and THP-1 cells expressing eGFP a brighter mutant of GFP 16.  
To test if fluorescence intensity of tdTomato could be used to quantify M. 
tuberculosis in our in vitro settings, two fold serial dilutions of a mycobacterium 
inoculum was measured by fluorimetry and the results were compared with the 
optical density at 600nm (OD600) method commonly used to quantify mycobacteria
8. 
The results show a strong statistical correlation (r2=0,99; p<0,05) between both 
methods suggesting a positive linear relationship between values in fluorescent 
intensities and the number of bacilli in the broth culture. This point for a great 
potential of fluorescent intensity for an accurate quantification of mycobacteria in 
broth cultures (Figure 2.7). The quantification of M. tuberculosis by means of 
tdTomato fluorescence intensity had already been address by others with similar 
results 15. 
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Figure 2.7. Quantification of M. tuberculosis H37Ra tdTomato by fluorescence (RFU) and 
optical density (OD600nm).  Data is represented as the mean of RFU (excitation 554, emission 586, 
gain 200) ± standard deviation of three replicates for each OD600nm value. Wells with tissue culture 
medium were used as blanks for RFU. The line represents a linear regression between RFU and 
OD600nm (r2=0.9986; p<0.05 by Pearson Correlation). 
 
Fluorescence intensity of eGFP allows THP-1 quantification in vitro 
 
To address if we could quantify the number of THP-1 cells using fluorescent 
intensity, we transduced THP-1 cells with the plasmid pLEGO-G2 for suitable 
expression of eGFP. Different numbers of cells were seeded and differentiated into 
macrophages using black 96 well plates. Following incubation with alamar blue 
reagent (resazurin), resazurin is commonly used to quantify viable cells, the results 
were compared with eGFP fluorescent intensities. 
As shown in the Figure 2.8, the eGFP intensity was strongly correlated with 
the THP-1 cell number (r2=0,98; p<0,05). Nevertheless, there was a reduced 
sensitivity, compared with alamar blue (r2=0,98; p<0,05), to a total amount of cells 
below 12x103 in 96 well plates.  
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Figure 2.8. The eGFP intensity is a good reporter of THP-1 viability. Different known number of 
eGFP expressing THP-1 cells were plated and differentiated with PMA in 96 well plate and quantified 
by a) alamar blue or b) eGFP fluorescence. Both variables were correlated c) (R
2
=93,8; Pearson 
correlation; p<0,05;n=3). 
 
Although less sensitive for very low cell numbers (12x103 cells) eGFP fluorescent 
intensities were strongly correlated to the alamar blue labelled ones (r2=0,93; 
p<0,05). The data on eGFP fluorescent intensity shows that this fluorescent reporter 
can be used to quantify THP-1 cell numbers above 12x103. A relation between GFP 
intensity and cell number has been already described in chinese hamster ovary 
(CHO) cells 17.  
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Intracellular M. tuberculosis and macrophage viability can be assessed by 
fluorescence intensity 
 
To address if the above results had any significance in the context of M. tuberculosis 
macrophage infection, we combined the eGFP expressing THP-1 cells with 
tdTomato expressing mycobacteria in our infection model. After 3 hour pulse, at 
define time-points after infection, both host cells and mycobacteria fluorescent 
intensities were recorded and cells were lysed and plated to quantify mycobacteria 
by CFU. The data presented in the Figure 2.9 shows the results from such 
experiments. 
 
Figure 2.9. Quantification of intracellular M. tuberculosis by colony forming units and 
Fluorescent intensity in THP-1 cells. a) Effect of different MOI in the kinetics of intracellular survival 
of M. tuberculosis by CFU and RFU. At a MOI 5 the M. tuberculosis burden significantly increased 
between day 1 and 5 post-infection C) Correlation between the average values of CFU and RFU for 
the different time-points post-infection. Values are in mean±SD (*p<0,05; t-test; n=3) MOI, multiplicity 
of infection. 
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The survival kinetics of the mycobacteria determined either by fluorescence 
intensities or CFU shows that the numbers of intracellular M. tuberculosis H37Rv are 
dependent of the initial MOI (Figure 2.9. a and b). In the condition of THP-1 infection 
with a MOI 5, an increase of fluorescent intensity and CFU over the 5 days of 
infection was observed, with significant differences between the day 1 and day 5 (t-
test: p<0,05). For a MOI 1 or 2,5 the intracellular M. tuberculosis load is maintained 
over the 5 days of infection. At lowest MOIs, THP-1 cells can restrict M. tuberculosis 
growth, with a concomitant rate of replication. The variability in fluorescence intensity 
of M. tuberculosis bacilli is greatly explained by the CFU (Figure 2.9 c) with a strong 
correlation between the two methodologies (r2=0,86; p<0,05).This positive linear 
relationship suggests that fluorescence intensity is dependent of intracellular M. 
tuberculosis expression of tdTomato is a phenotype of the number of viable bacilli 
within macrophages. 
Comparing the results obtained from FI and CFU on day 5 post-infection 
(Figure 2.10) the FI of tdTomato (Figure 2.10 a) shows enough sensitivity to detect 
differences between the different MOIs used and the non-infected samples (NI) 
similar to those obtained by CFU. 
 
 
Figure 2.10. Comparison between fluorimetry and CFU counting to quantify M. tuberculosis 
H37Rv in THP-1 cells.THP-1 macrophages were infected with M. tuberculosis H37Rv (tdTomato) at 
MOI 1, 2.5 and 5. a) RFU (excitation 554, emission 586, gain 200) at day 5 post-infection. b) CFU at 
day 5 post-infection. Data are represented as the mean ± standard deviation of three replicates 
(ANOVA; Holm-Sidak; p<0.05; n=3). *p<0.05 and ** p<0.001 comparatively to NI (non-infected cells).  
50 
The cell viability of the infected cells varies throughout infection and is dependent on 
the MOI used (Figure 2.11). Nevertheless, there is an increase in fluorescent 
intensity throughout the experiment time (Figure 2.11a). This may be attributed to 
artefacts that results from the accumulation of eGFP proteins in the cells or in 
opposition may reflect proliferation of THP-1 cells after phorbol esters (PMA) 
withdraw, this reagent was used for macrophage differentiation. THP-1 cell viability 
at a MOI 1 remained similar to those in the uninfected cells. However, this viability, 
decreased at higher MOIs, being around one third lower at MOI 5 when compared to 
of uninfected cells (Figure 2.11b). 
 
 
Figure 2.11. Macrophage viability of M. tuberculosis infected THP-1 cells by fluorescent 
intensity. Cells were infected at different multiplicities of infection (MOI) with M. tuberculosis and 
were monitored throughout the following five days post-infection. a) Raw RFU; b) Data normalized to 
non-infected samples (NI); data Values are in mean±SD; n=3. 
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Discussion 
 
Broth cultures of M. tuberculosis are commonly used for anti-tubercular drug 
screening. In this work we showed that fluorescence intensity of both GFP and 
tdTomato can be an alternative method to OD for quantification of mycobacterial 
growth inhibition (Figure 2.1 and Figure 2.7). In order to confirm this we tested the 
biological activity of 3 conventional antibiotics and new PZA derivatives, twenty eight 
pyrazinoic acid esters, as alternative anti-tubercular drugs. All pyrazinoic acid esters 
tested in this study were demonstrated to be more active against M. tuberculosis 
H37Ra than PZA or POA (Table 2.2). All together our results indicates that the in 
vitro system for quantifying fluorescent mycobacteria has good correlation with the 
conventional methods such the OD600 and the CFU and was demonstrated to be 
accurate for evaluation of the antimicrobial effect of new drugs. 
 A major drawback observed during development of the fluorimetric methodology 
was the impossibility to quantify the effect of pyrazinoic acid esters in intracellular M. 
tuberculosis using our human macrophage model. This may be due to the use of 
DMSO and/or to the characteristics of the compounds. Nevertheless, this 
methodology might be useful to identify host factors involved in M. tuberculosis 
macrophage intracellular survival. 
In this work we applied fluorescence based methodologies for quantification of 
intracellular M. tuberculosis that can be used as an alternative to traditional CFU. 
Fluorescence based methods for cell quantification and viability do not requires co-
factors as for luciferase assays, or dyes such as resazurin. Furthermore these 
methods implicate macrophage disruption for substrate quantification or as in the 
case of CFU, for intracellular bacteria release for plating in culture petri dishes. 
Moreover, most fluorescent proteins are small, and have low cell toxicity and are 
continuously synthesized, which minimizes the effect of fluorescence signal dilution 
during cell replication 18. A broad range of fluorescent proteins variants that span 
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nearly the entire visible spectrum, permits multi-reporter fluorescence 19. Additionally, 
this method can be applied for other intracellular pathogens and their host cells. 
Replication of M. tuberculosis within human macrophages ultimately causes cell 
death 20. We observed an increased macrophage cell death with an increase on the 
MOI used. Similar results on the effect of the initial inoculum in the infection kinetics 
and cell viability have been published in primary monocyte-derived human 
macrophages (MDHM) 20. Welin and co-workers reported that the replication 
restriction in low inoculation experiments did not led to acquisition of CD63, a maker 
for fusion of phagosomes with late endosomes and lysosomes but led to acidification 
and cathepsin D recruitment. In the same report the authors show that increasing M. 
tuberculosis load led to decreasing HMDM viability. 
Recently an HTS based microscopic phenotypic assay based on fluorescently 
labelled M. tuberculosis within fluorescently labelled macrophages has been 
published for drug and genomic screening 21. Our method outstands on the cost-
effectiveness of the detector instrument and using GFP expressing THP-1 cells, 
does not need time point labelling of cells.  Effective methods for the evaluation of 
intracellular pathogens in their physiological survival niches are important for future 
research on host-pathogen interactions and will enable screening of compounds, 
pathogen and host factors that may impair intracellular growth of pathogens in a 
cost-effective manner.  
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Material and Methods 
Pyrazinoic acid esters 
Compounds 
The pyrazinoic acid esters used in this study are listed in supplementary information 
(Table S2.1) and were synthetized in the Professor Luís Constantino’s laboratory, 
Faculty of Pharmacy, University of Lisbon, Portugal. 
 
Determination of compound lipophilicity 
Compound lipophilicity (log P) was determined by the logarithm of the partition 
coefficient, the ratio of concentrations of un-ionized compound in the two phases of 
water and octanol at equilibrium22. 
 
Determination of minimum inhibitory concentrations (MIC) 
 
Minimum inhibitory concentrations for the compounds tested were performed by 
using the broth micro- dilution method 23. Solutions of each compound were 
prepared by first dissolving in dimethyl sulfoxide (DMSO; Sigma-Aldrich) to a 
concentration of 400 µg /ml and then further diluting in the respective culture media. 
Serial two-fold dilutions were made in 96-well microplates with concentrations 
ranging from 400 µg/ml to 12,5 µg/ml for each compound. Each well was inoculated 
with bacterial suspension at a concentration of 106 CFU/ml. No inhibitory effects 
were observed in the presence of DMSO at the concentrations used (1.25%). 
Isoniazid (Sigma-Aldrich) was used as a reference drug. Mycobacterium tuberculosis 
H37Ra ATCC 25177 harbouring the pMN042 plasmid was incubated in microplates 
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in appropriate broth medium for 5 days. Following this period they were observed 
under a light microscope to determine the lowest concentration with no visible 
mycobacterial growth. The results were confirmed by measuring the optical density 
at 600 nm and fluorescence intensity (488nm excitation; 520nm emission; gain 200) 
in a Infinite M200 plate spectrophotometer (Tecan). Due to the inference in 
compound molecular weight values the MIC concentrations were determined by 
conversion to molarity.  
 
Bacteria strains maintenance  
 
The avirulent M. tuberculosis strain H37Ra (25177™, ATCC) and H37Ra harboring 
pMN437 plasmid for expression of eGFP2+ 24, was a kind gift of Dr Michael 
Niederweis of the Microbiology Department of the Alabama University, USA and the 
virulent M. tuberculosis strain H37Rv (25618™, ATCC) were maintained in 
Middlebrook’s 7H9 broth medium (Becton, Dickinson and Company) supplemented 
with 10% (v/v) OADC (Becton, Dickinson and Company), 0.5% (v/v) glycerol (Sigma-
Aldrich) and 0.05% (v/v) Tyloxapol (Sigma-Aldrich) at 37°C with stirring 
(mycobacterial medium). M. tuberculosis H37Ra and H37Rv strains harboring 
pAsta3 plasmid (Add gene ID: 24657) 15, for expression of codon optimized for 
expression of mycobacteria gene for tdTomato fluorescent protein under the control 
of the Psmyc promoter and hygromycin B resistance selector gene  were cultured in 
the same medium supplemented with 50 μg/ml hygromycin B (Sigma-Aldrich) for 
selection. All manipulations of M. tuberculosis were performed in a Biosafety Level 3 
environment. 
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Cell lines 
 
THP-1 cells (ATCC TIB-202)25 were grown in RPMI media 1640 (GIBCO) 
supplemented with 10% (v/v) Fetal Bovine Serum (GIBCO), 1% (v/v) Penicillin-
Streptomycin (GIBCO), 1% (v/v) Pyruvate (GIBCO), 1% (v/v) L-Glutamine (GIBCO), 
1% (v/v) Non-essential aminoacids (GIBCO), 1% (v/v) Hepes buffer (GIBCO). 
Human Embryonic Kidney 293T (HEK 293T) cells (ATCC CRL-11268) 26 were grown 
in Dulbecco’s modified Eagle’s medium (DMEM, GIBCO) supplemented with 10% 
(v/v) Fetal Bovine Serum (GIBCO), 1% (v/v) Penicillin-Streptomycin (GIBCO). Cells 
were kept at 37ºC under a 5% carbon dioxide (CO2) atmosphere. 
 
Mycobacterial electroporation and Generation of a tdTomato expressing 
H37Rv and H37Ra 
 
M. tuberculosis H37Ra and H37Rv electroporation was made using a method 
developed elsewhere 27. Briefly, mycobacteria were grown in mycobacterial medium 
at 37°C with stirring until 0,5≤OD600nm≥1. In order to obtain electrocompetent cells, 
bacterial suspension was incubated on ice for 90 minutes to improve the 
transformation efficiency and centrifuged at 3000xg for 10 minutes. The pellet was 
washed 3 times in ice-cold 10% glycerol, reducing to half of the washing volume 
each time. After these treatment electrocompetent mycobacteria was stored at -80°C 
in 20% glycerol until further use. 
A mixture containing electrocompetent mycobacteria and 1µg pAsta3 (Figure 2.12) 
plasmid DNA was left on ice for 10 minutes and transferred to a 0.2 cm electrode-
gap electroporation cuvette. The cuvette was placed subjected to one single pulse of 
1.8 kV, 25 µF, 200 Ω and then placed on ice for 10 minutes. The transformants were 
inoculated into mycobacterial medium and incubated at 37°C for 36 h. Mycobacterial 
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cells were harvested by centrifugation at 3000xg for 10 minutes and plated out 
suitable dilutions on mycobacterial solid medium containing Middlebrook’s 7H10 
agar (Becton, Dickinson and Company), 0,5% (v/v) glycerol and 10% (v/v) OADC. 
Mycobacterial red fluorescence was confirmed by fluorescence microscopy after 2 to 
3 weeks of incubation at 37°C. Red fluorescent positive colonies were inoculated in 
mycobacterial broth medium with 50 μg/ml hygromycin B and incubated with stirring 
at 37°C. The transformants were frozen in 20% glycerol at -80°C 15. 
 
 
Figure 2.12. pASTA3 plasmid map.pASTA3 plasmid is a vector suitable for mycobacterial 
expression of a mycobacterial codon-optimised tdTomato fluorescent protein in pSMT3-S. Psmyc, 
strong mycobacterial promoter; tdTomato, inserted gene that codifies tandem dimmer tomato, a red 
fluorescent protein; pAL5000, mycobacterial replicon; Hygromycin B, hygromycin B resistance gene 
for bacterial selection; Ecoli OriE: E. coli origin of replication.
15
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Generation and quantification of eGFP expressing THP-1 
 
Lentivirus Production 
For generation of a THP-1 expressing enhanced Green Fluorescent Protein (eGFP) 
we used the lentiviral plasmid the LEGO-vector LeGO-G2, derived from pLentiLox3.7 
developed at the MIT HIV-1, a kind gift from Dr. Kristoffer Riecken from the 
University of Hamburg, School of Medicine and University Hospital of Hamburg-
Eppendorf, Germany. This is a fourth generation lentiviral vector for suitable cell 
marking, with a blasticidin selection cassette. The eGFP transcription is regulated by 
SFFV promoter (Figure 2.13).  
 
Figure 2.13. Lentivirus Vector Gene Ontology LeGo-G2 detail.  LeGo-G2 is a lentiviral vector 
expressing enhanced green fluorescent protein (eGFP) as a single removable marker gene (using 
Loxp/Cre system) and a SFFV promoter to ensure sufficient detection. The plamid carries a 
Blasticidin selection gene. SIN-LTR, self-inactivating-long-terminal-repeat; RRE, rev-responsive 
element; cPPT, central polypurine tract; SFFV,  promoter of spleen focus-forming virus; wPRE, 
Woodchuck hepatitis virus post-transcriptional regulatory element.
28
 
 
Lentivirus were produced according Moura-Alves et al 29,30. Briefly, HEK 293T cells 
were seeded at a density of 2.2x105 cells/ml (100 µl per well in 96 well plates) in 
DMEM media without Penicillin-Streptomycin. After 24 hours incubation at cell 
culture normal conditions, cells were transfected with a mixture of the 3 plasmids, the 
packaging plasmid (100 ng of pCMV-dR8.91), the envelope plasmid (10 ng of VSV-
G/pMD2.G) and 100 ng of the pLeGo-G2 vector, using Fugene HD  transfection 
reagent (Promega) in Optimem medium (GIBCO). After 18 hours of incubation, 
media was replaced with 170 µl of high serum growth media (30% FBS (v/v) DMEM). 
Twenty-four hours after media replacement, viruses were harvested (150 µl) and 
fresh media (150 µl) was added to the cells. The second viral collection was 
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performed 24 hours later and harvested viruses were pooled with the previous day 
collection and stored at -80ºC. 
 
Lentiviral transduction of THP-1 cells 
Lentiviral transduction was performed according what is described by Pedro Moura-
Alves et al. 29  Briefly, 10 µl of lentivirus were plated per well in a round bottom 96 
well plate. THP-1 cells were resuspended in RPMI medium containing 8 ug/ml of 
Polybrene (Sigma-Aldrich) at a density of 1.25x106 cells/ml, and 40 µl were added on 
top of the virus containing wells. Plates were spun for 90 minutes at 900xg at 37ºC. 
After spinoculation, media was removed and replaced with 200 µl of fresh RPMI, and 
cells incubated at 37ºC under normal cell culture conditions. After 2 days, transduced 
cell selection was performed by replenish 200 µl of RPMI media containing 
Blasticidin (Sigma-Aldrich) to a final concentration of 25 ug/ml and selection pressure 
was maintained for 2 weeks. 
 
Infection procedures 
 
Mycobacterial preparation  
Prior to any experiment, infection or broth cultures, mycobacterial cultures at mid log 
grow phase were centrifuged at 3000xg, 37°C for 10 minutes, washed in Phosphate 
buffer saline (PBS) pH 7.4 (Gibco) and, in the case of infection experiments,  
resuspended in in RPMI media 1640 (Gibco) supplemented with 10% (v/v) Fetal 
Bovine Serum (Gibco), 1% (v/v) Pyruvate (Gibco), 1% (v/v) L-Glutamine (Gibco), 1% 
(v/v) Non-essential aminoacids (Gibco), 1% (v/v) Hepes buffer (Gibco). To obtain a 
single-bacillus suspension the medium with the bacilli was passed 20 times through 
a sterile syringe equipped with a 21 gauge needle, followed by 15 minutes of 
ultrasonic. The remaining bacterial clumps were eliminated by centrifugation at 
350xg for 1 minute and single-cell suspension was verified by light microscopy. 
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Mycobacterial infection of THP-1 macrophages 
All infection experiments were made with RPMI media without phenol or antibiotics. 
THP-1 cell densities were quantified using a Neubawer chamber. For infection 
experiments we added 7,5x104 THP-1 cells/well in a black polystyrene 96 wells plate 
(Corning) and incubated them with 20 nM of phorbol 12-myristate 13-acetate (PMA) 
(Sigma-Aldrich) RPMI media without phenol for 24 hours for differentiation into 
macrophages. After this period, cells were allowed to rest in PMA free media for 
another 24 hours.  
In the day of infection, the macrophage media was discarded and was added 100 µl 
of single bacilli suspensions. The macrophages were infected with H37Rv in at 
different multiplicities of infection (MOI), proportion of mycobacteria/macrophage.  
After a specific pulse period, the macrophages were washed with warm media. After 
washing, 200 µl/well of media containing 10 µg/ml of gentamicin was added, to kill 
extracellular bacteria. Cells we incubated for 24 hours and replenish with 200 µl/well 
of media containing no antibiotics. It have been reported that at this range of 
concentration gentamicin does not accumulate in THP-1 cells and any intracellular 
gentamicin is also rapidly inactivated 34,35. 
   
 
Data acquisition and analysis 
 
Quantification of intracellular M. tuberculosis by colony forming units 
After defined time points post-infection, infected macrophages were washed with 
PBS and incubated with 0,05% (v/v) solution of IGEPAL at normal cell incubation 
conditions, for 10 minutes. Serial 10 fold dilutions were made with sterile distilled 
water, and plated Middlebrook’s 7H10 solid medium (Becton, Dickinson and 
Company) supplemented with 10% (v/v) OADC (Becton, Dickinson and Company), 
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0.5% (v/v) glycerol (Sigma-Aldrich). Plates were incubated at 37°C for 3 weeks. 
Microcolonies were count with the help of an optical microscope. 
 
Quantification of eGFP expressing THP-1 
Quantification of eGFP expressing THP-1 cells was made using an Infinite M200 
spectrophotometer (Tecan). Different number of THP-1 cells were plated in a black 
polystyrene 96 wells plate and incubated with 20nM of phorbol 12-myristate 13-
acetate (Sigma-Aldrich) in RPMI media for 24 hours for differentiation into 
macrophages. After this period of differentiation, cells were allowed to rest in PMA 
free media for another 24 hours. After the resting period, cells fluorescence was 
measured at 488nm excitation and 520nm emission and a gain of 175. Cell media 
formulation is descried in cell lines maintenance; however we used phenol free and 
no antibiotics RPMI (Gibco). These settings were also use in the quantification of 
mycobacterium infected cells. Alternatively, after differentiation THP-1 cells number 
was also assessed by resazurin fluorescence intensity using alamarBlue (Molecular 
Probes) following the manufacturer’s instructions. Briefly, 10% (v/v) of alamarBlue 
reagent was added to each well and incubated for 4 h at normal cell conditions. 
Fluorescence was measure at and excitation of 570nm and emission of 595nm, and 
a gain of 100. 
 
 
Quantification of mycobacteria by fluorimetry 
Quantification of M. tuberculosis H37Ra and H37Rv, harbouring pASTA3 or 
pMN042, in broth cultures was made by spectrophotometry of absorption and 
fluorescence in an Infinite M200 spectrophotometer (Tecan). Optical density at 
600nm (OD600nm) was measured to determine mycobacterial concentration 
(OD600nm=0.1 is equivalent to 1x107 bacteria/ml) 33. For Minimum Inhibitory 
Concentration determination (MIC) experiments, 200µl of 0,01 OD600 of M. 
tuberculosis H37Ra or H37Rv bearing the pASTA3 plasmid in different compound 
concentration. Pyrazinoic acid esters were a kind gift of Professor Luis Constantino, 
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Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal. Hygromycin B (Gibco), 
Amykacin and Kanamycin (Sigma-Aldrich) were used has controls. After several 
days of incubation at 37°C fluorescent quantification of mycobacteria was made 
using spectrophotometer Infinite M200 (Tecan). Fluorescence was measured at an 
excitation of 554 nm, an emission of 586 nm and a gain of 150 for broth cultures. 
These settings were also used to quantify intracellular M. tuberculosis. 
 
Statistical treatment  
 
The software SigmaPlot 12.0 (Systat Software Inc.) was used for statistical analysis. 
Student's t-test was used for comparing two means multiple means comparison was 
made using one-way ANOVA. To make multiple comparisons versus control group 
was used the Holm-Sidak method. The differences were considered statistically 
significant when p<0.05. To determine the correlation between two variables a linear 
regression was used as well as a Pearson Product Moment Correlation. 
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Supplementary information 
Table S 2.1. Name, structure and code of the pyrazinoic acid esters used in this study. 
Compound Structure Code 
pentyl pyrazinoate 
 
3a 
hexyl pyrazinoate 
 
3b 
heptyl  pyrazinoate 
 
3c 
octyl pyrazinoate 
 
3d 
nonyl  pyrazinoate 
 
3e 
decyl  pyrazinoate 
 
3f 
undecyl  pyrazinoate 
 
3g 
isopropyl  pyrazinoate 
 
4a 
sec-butyl  pyrazinoate 
 
4b 
1-methyl hexyl  pyrazinoate 
 
4c 
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 Table S 2.1. (continued)   
1-methyl heptyl pyrazinoate 
 
4d 
R-(-)-1-methyl heptyl  
pyrazinoate 
 
4e 
S-(+)-1-methyl heptyl  
pyrazinoate 
 
4f 
1-methyl octyl  pyrazinoate 
 
4g 
1-methyl nonyl  pyrazinoate 
 
4h 
1-methyl undecyl  pyrazinoate 
 
4i 
tert-butyl pyrazinoate 
 
5a 
1,1-dimethylpropyl pyrazinoate 
 
5b 
1,1-dimethylbutyl pyrazinoate 
 
5c 
1,1-dimethylpentyl pyrazinoate 
 
5d 
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Table S 2.1. (continued) 
1,1-dimethylhexyl pyrazinoate 
 
5e 
iso-butyl pyrazinoate 
 
6a 
2-methylbutyl pyrazinoate 
 
6b 
isopentyl pyrazinoate 
 
6c 
4-chlorobutyl pyrazinoate 
 
6d 
phenyl  pyrazinoate 
 
6e 
cyclohexyl  pyrazinoate 
 
6f 
methylcyclohexyl  pyrazinoate 
 
6g 
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Vesicular traffic genes involved in Mycobacterium 
tuberculosis macrophage infection. 
 
Abstract 
 
Mycobacterium tuberculosis is a facultative intracellular pathogen that is able to 
survive within phagosomes, endosomal vesicles of human phagocytes such as 
macrophages. The success of M. tuberculosis relies on the subversion of the host 
vesicular traffic events in order to provide the access to nutrients and, in parallel to 
inhibit the delivery of microbicidal factors to the bacterial containing phagosome. Rab 
GTPases and SNAREs are proteins that coordinate the trafficking and fusion of 
cellular vesicles and these are potential targets to be manipulated by M. tuberculosis 
virulence factors. To decipher the role of individual Rabs and SNARES on the 
intracellular survival of M. tuberculosis we developed a high trough put assay based 
on a dual fluorescent reporter assay that enables the quantification of intracellular 
mycobacteria and the viability of the infected macrophages along the time.  
Using this approach we identified a total of 10 host genes that interfered with 
intracellular M. tuberculosis survival including seven Rab GTPases, two SNAREs 
and one Rab effector.  The silencing of Rab7 and Rab43 led to an increase in M. 
tuberculosis survival within macrophages while the knockdown of two SNAREs, 
MSD032 and Stx4, five Rabs (Rab27a, Rab31, Rab34, Rab39B and Rab8) and the 
Rab effector RABEP1 a resulted in a reduction of mycobacteria cellular burden. Our 
study highlights the potential impact host vesicular traffic in the survival/persistence 
of intracellular M. tuberculosis. 
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Introduction 
 
Phagocytosis is an evolutionary conserved mechanism that evolved from a 
nutritional function in primitive unicellular organisms. In higher organisms it occurs 
mainly in specialized cells, i.e. phagocytes and lies at the center of the immune 
response, providing an innate route for destruction of pathogens, antigen 
presentation and inflammation 1–3. Phagocytosis is a highly regulated and complex 
cellular mechanism in which pathogen detection triggers their internalization in a 
membrane bound vesicle: the phagosome. Newly formed phagosomes undergoes a 
maturation process leading to modification in membrane and lumen that lead to the 
formation of a highly microbicidal organelle: the phagolysosome 4. During this highly 
dynamic and complex process the phagosome interacts by a series of fission and 
fusion events with several organelles 5–7. At the end of this trafficking pathway 
phagosomes become competent to fuse with late endosomes and lysosomes, 
acquiring proteolytic and antimicrobial properties, a mechanism called 
phagolysosome biogenesis. 
Rab GTPases and SNARES are major players directing vesicle traffic and  fusion, 
that regulate phagosome formation, maturation and phagolysosome biogenesis 5. 
Upon microorganism attachment to macrophage membrane receptors, a cup 
formation is provided allowing the sealing, of the nascent phagosome that will 
consequently fuse with early endosomes 8 by a process modulated by Rab5 9.  The 
Rab5 effector, early endosome antigen 1 (EEA1) binds to Stx13 providing a bridge to 
early endosome fusion 10,11. Phagosomal bound Rab5 rapidly decreases with the 
concomitant enrichment of EEA1 allowing Rab7 to reach the maturating phagosome, 
a phenomena named phagosomal Rab conversion 12. Consequently Rab7 bound 
phagosomes associates with Stx7 promoting fusion with late endosomes and 
lysosomes 11. After acquisition of Rab7  the phagolysosome biogenesis is 
accelerated by recruitment of  Rab interacting lysosomal protein (RILP) to the 
phagosome 13.  
Mycobacterium tuberculosis is the causative agent of tuberculosis and its success 
relies, on its ability to avoid destruction by the immune system, surviving and 
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replicating mostly inside immune cells that are designed to destroy invading 
microorganisms: macrophages 14. Presently is though that virulent mycobacteria are 
able to modulate their internalization and arrest phagosome maturation, avoiding 
delivery of microbicidal effectors and therefore sustaining intracellular persistence 
and replication 15. Several Rab GTPases and SNAREs have been shown to be 
differentially recruited to M. tuberculosis containing phagosomes when compared to 
avirulent bacteria or latex beads-containing phagosomes 16,17. It was previously 
though that M. tuberculosis phagosome was blocked on the Rab5-Rab7 stage of 
phagosome maturation 18. However, recently it has been shown that Rab7 is initially 
associated with the M. tuberculosis phagosome but is subsequently released, 
limiting the recruitment of cathepsin D and RILP 19. Several other Rab GTPases 
namely Rab14 and Rab22a were also demonstrated to associate with M. 
tuberculosis containing phagosomes preventing phagosomal maturation 20,21. 
Recently, Setto et al. compared the recruitment of Rab GTPases to phagosomes 
containing mycobacteria to those containing Staphylococcus aureus 16 and observed 
that Rab proteins associated with M. tuberculosis and S. aureus were similar. 
However, with the exception of Rab22b and Rab43, those responsible for cathepsin 
D recruitment and phagosomal acidification were progressively excluded from M. 
tuberculosis phagosomes. The authors propose a model in which Rab GTPases 
regulates phagosome maturation and the recruitment of those proteins is modulated 
by M. tuberculosis during inhibition of phagolysosome biogenesis. 
Another work by Fratti et al. showed that BGC containing phagosomes retain Stx13 
and degrades VAMP3 during mycobacterial infection 17. In neutrophils Stx4 has been 
described to be retained together with Rab5 in M. tuberculosis phagosomes in order 
to maintain the maturation block 22. Indeed, in macrophages Stx4 is retained in 
phagosomes containing phosphatidylinositol mannoside (PIM)-coated latex beads, 
whereas a decreased accumulation of this SNARE is observed in phagosomes 
containing just uncoated inert beads. Since PIM is a mycobacterial glycolipid that 
diffuses and incorporates into host cell endomembranes, these findings indicate that 
PIM contributes to the fusion of M. tuberculosis-containing phagosomes with 
endosomal compartments, by retention of Stx4 in the phagosomal membrane 23.  
Although, several Rab GTPases and SNAREs have been associated differentially to 
the M. tuberculosis containing phagosomes their role on the pathogen survival has 
74 
not been yet demonstrated. Certainly for Rab22a, while a RNAi knockdown enhance 
maturation of M. tuberculosis containing phagosome through increase acquisition of 
Rab7, no significant effect on intracellular M. tuberculosis survival was observed 20. 
The standard method for quantification of intracellular M. tuberculosis involves 
laborious, time consuming and expensive quantification of colony forming units 
(CFU) and implicates de destruction of the sample (the infected host cells, in a tissue 
culture well plate) at a defined time point. The factors affecting accuracy of this 
method have been identified for more than one century 24. Specifically, CFU 
quantification of slow growing mycobacteria provides the additional challenge of an 
incubation of several weeks. The lack of a fast, sample friendly and reliable 
alternative technique for intracellular quantification of M tuberculosis halted higher 
throughput studies on factors affecting intracellular M. tuberculosis 
survival/persistence.  
 The identification of GFP from Aequorea and the subsequent expansion in the 
identification of different fluorescent proteins (FP) through GFP mutagenesis or in 
other organisms led to a “revolution” in cell biology 25. The ability to monitor live 
cellular mechanisms without cell toxicity or the need of adding any cofactor make 
these proteins perfect reporters of cell and organism viability.  
In this work we proposed to dissect the role of macrophages vesicular traffic 
proteins in M. tuberculosis infection. In order to achieve this we developed a dual 
fluorescent assay profiting from mycobacteria and human macrophages expressing 
two different fluorescent proteins (tdTomato and eGFP respectively). Likewise, the 
dual fluorescence assay provided means to quantify intracellular M. tuberculosis 
and, simultaneously, macrophage viability during infection along time and using the 
same sample.   
In order to identify macrophage vesicular traffic genes with a role in M. 
tuberculosis infection we performed a RNAi based screen. A lentiviral library shRNAs 
enriched in shRNAs targeting vesicular traffic genes were used to generate loss-of-
function phenotypes for those genes. We silenced the expression of around 120 
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vesicular traffic genes and quantified tdTomato and eGFP fluorescence after 5 days 
post infection.  
Our results show that vesicular traffic genes modulation affects M. 
tuberculosis survival/persistence and affects differently virulent and avirulent 
mycobacteria strains.  
 
Results 
 
Vesicular traffic genes affect intracellular M. tuberculosis macrophage load 
 
In an attempt to identify the vesicular traffic genes involved in M. tuberculosis 
macrophage infection, we have performed RNAi-based screen to systematically 
silence around 120 genes (listed at Table S3.1 on Supplementary Information) that 
have already been reported to be involved in intracellular vesicular traffic. This 
collection of genes was mainly constituted by Rab GTPases and SNAREs but 
included also some Rab effectors and other vesicular traffic genes. The screening 
outline is presented on Figure 3.1.  
THP1 human monocytic cells stably expressing eGFP were transduced with 
lentiviral vectors for expression of shRNA targeting a specific gene by RNAi and the 
positive clones were selected with puromycin. Next, we differentiated the transduced 
THP-1 cells to macrophages using phorbol 12-myristate 13-acetate (PMA). For 
infection of transduced macrophages a multiplicity of infection (MOI) of 1 was used 
(meaning 1 bacillus to 1 cell). Five days post-infection, the fluorescence intensities of 
both tdTomato, the intracellular M. tuberculosis reporter and, the eGFP, the 
macrophage viability reporter were recorded for each tested silenced gene of the 
THP-1 clone library. Samples with an eGFP fluorescent lower than half of the control 
samples were discarded from the analysis. In order to present the data of all screen, 
Z-scores calculation were made using the Equation 3.1. 
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Equation 3.1. Z-score calculation. Z-score was calculated by the difference of the mean of each 
shRNA targeting a genes (   (        )) and the mean of the control samples (   (      )) 
divided by the standard deviation of the control samples (      ). 
 
 
The results of the screening are shown in Figure 3.2. Genes were considered 
candidates as having an effect on intracellular M. tuberculosis if at least two shRNAs 
possessed a tdTomato fluorescence increase or decrease that was 2,5 standard 
deviations from the average of the control (scramble: SCR, a shRNA construct that 
does not targets any protein mRNA). After several rounds of validation we identified 
a total of 21 candidate genes with a reduction of the fluorescence observed for 18 
genes while an  increase was detected in 3 (Table 3.1).  
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Figure 3.1. Lentiviral production and RNAi based screening outline. Lentiviral library was kept in 
glycerol stocks at -80°C.  1. Bacterial stocks transformed with the pLKO.1 plasmids encoding the 
gene interference hairpins were incubated at 37°C and plasmid DNA was purified by a high through 
put plasmid purification protocol. 2. The 293t cells were transfected with a library generated of pLKO.1 
and the packaging plasmids, pCMV-dR8.91 (Delta 8.9) plasmid encoding gag, pol and rev genes and  
pCMV-VSV-G plasmid encoding envelope, to produce the lentiviral vectors. 3. Lentiviruses were used 
to transduce THP-1 cells as describe in methods. 4. After puromycin selection of the transduced cells, 
each 96 well plate was split and further incubated for 116 hrs. THP-1 cells were count by cytometry 
and 75x10
3
 per well were seeded in black 96 well plates. 5. Cells were differentiated with PMA and 
infected with tdTomato expressing H37Rv at a MOI of 1. Five days post-infection fluorescence 
intensities of either the cells (eGFP) or the mycobacteria (tdTomato) were recorded.  
78 
 
 
Figure 3.2. Identification of vesicular traffic genes with an effect on intracellular M. 
tuberculosis by RNAi screen. Around 120 vesicular traffic genes were targeted in THP-1 cells by 
lentiviral shRNA delivery. Five days post-infection intracellular M. tuberculosis expressing tdTomato 
fluorescence was measured (excitation: 554nm; emission: 586; gain: 200). In the y-axis the average 
fluorescence intensities of each shRNA sample were subtracted by the average of scramble control 
and divided by the standard deviation of the scramble. In the x-axis the control normalised 
fluorescence intensities of each shRNA. Highlighted in red the shRNAs with more than 2,5 standard 
deviations of the control. 
 
Validation of candidate genes obtained in the RNAi screen 
 
Following the RNAi-based screen, and in order to validate if the results observed 
were due to effective knockdown of a certain gene, the respective mRNA was 
quantified by qRT-PCR. The knock down efficiency was calculated comparing the 
expression level of a shRNA from a gene of interest with the level of expression of 
that gene in control cells. A candidate gene was considered validated if the average 
level of knock down was higher than 35%. In Figure 3.3 are represented the different 
values for tdTomato RFU and respective knockdown for the shRNAs validated by 
qRT-PCR. Table 3.2 summarizes the list of the validated candidates, their 
classification and function. 
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Table 3.1. List of candidate genes with potential effect on M. tuberculosis intracellular burden. 
Resistance genes are those whose silencing leads to an increase of fluorescence and therefore to 
bacilli survival, while the susceptibility genes have the opposite effect with an effect on bacilli killing.  
  
Susceptibility Genes Resistance Genes 
    
    
MDS032 RAB7A 
RAB3A RAB42 
RABGAP1 RAB43 
RAB7B   
RAB7L1   
RAB8A  
RAB11FIP3  
RAB24  
RAB27A  
RAB31  
RAB33A  
RAB34  
RAB39B  
RABEP1  
RABGGTA  
SNAP23  
STX4  
VAMP2  
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Figure 3.3. Knock down validation of vesicular traffic genes obtained from the shRNA screen. 
a) Relative fluorescence intensity determined on tdTomato infected and silenced THP1 cells, for the 
validated candidates. b) Relative gene expression of the knockdown efficiency for the candidate 
vesicular traffic genes determined by qRT-PCR. The gene expression relative levels for each 
candidate gene was normalised relatively to control cells. 
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Table 3.2. List of validated susceptibility and resistance genes that affect the intracellular M. 
tuberculosis burden and predicted cellular function. 
  
Susceptibility genes Classification – Function/Subcellular localization 
   
MDS032 SNARE - Golgi-ER transport 
26
  
RAB27A Rab GTPase – Lysosomes, Melanosome transport 
27
 
RAB31 
Rab GTPase – early endosomes, Cathepsin D 
recruitment to phagosomes 
16
 
RAB34 
Rab GTPase – Golgi, Cathepsin D recruitment to 
phagosomes 
16
 
RAB39B Rab GTPase – Golgi, unknown
28
. 
RAB8A Rab GTPase – Golgi, Phagosome, unknown function 
16
 
RABEP1 
Rab effector - Homotypic endosome fusion and 
trafficking of recycling endosomes
29
 
STX4 
SNARE - Plasma membrane,  t-SNARE that mediates 
docking of transport vesicles
30
 
   
Resistance Genes  
   
RAB7 
Rab GTPase – late endosomes/lysosomes, 
Phagosome recruitment of cathapsin D and 
phagosomal acidification. 
16
 
RAB43 
Rab GTPase – ER-Golgi Transport , Phagosome 
recruitment of cathepsin D.
16
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Biological characterization of vesicular traffic genes involved in M. 
tuberculosis infection 
 
To further biologically validate the susceptibility or resistance genes obtained from 
Table 3.2 with the effectiveness of gene silencing we did a comparison on the 
quantification of intracellular M. tuberculosis survival obtained by RFU with the 
results of the gene expression. In addition to validate the RFU results we performed 
in parallel the quantification of intracellular mycobacteria by CFU. Figure 3.4 
summarizes the results obtained from RFU and CFU quantification after infection of 
THP-1 cells that were knocked down for Rab7, Rab34, Stx4 and Rab14. The results 
indicate a similar trend between the RFU and the CFU and are supported by the 
mRNA expression of the selected genes. Also, the figure 3.4 shows the main 
phenotypes observed. For instance, Rab7 knockdown led to an increase in both 
tdTomato RFU and CFU as expected while in the case of Rab34 and Stx4 the RNA 
silencing led to a decrease in intracellular mycobacteria. Surprisingly the Rab14 
knockdown had no effect on the amount of intracellular M. tuberculosis.  
Since avirulent species and strains of M. tuberculosis complex are usually 
used in host-pathogen interactions studies, all over the world, we asked whether the 
knockdown of the validated genes (Figure 3.4) had similar effect on the strain M. 
tuberculosis H37Ra. The results of macrophage knockdown and posterior infection 
with M. tuberculosis H37Ra are summarized in figure 3.5. For both strains Rab7 
knockdown induced an increased survival a indicating a clear role in M. tuberculosis 
intracellular clearance. However for all remaining tested genes contradictory 
phenotypes were observed. This is the case of Rab34 knockdown were an increased 
survival of the avirulent strain is detected, in opposition to what is observed for M. 
tuberculosis H37Rv. The knockdown of Rab14 induces a reduction on the amounts 
of avirulent mycobacteria while no effect was found for virulent M. tuberculosis. 
Similarly, Stx4 knockdown reduced the survival of virulent mycobacteria while with 
the avirulent M. tuberculosis no differences to the control samples were shown.  
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Figure 3.4. Effect of vesicular traffic genes knockdown on intracellular M. tuberculosis H37Rv 
survival. M. tuberculosis macrophage burden was measure both by fluorescent intensity of M. 
tuberculosis reporter (tdTomato; black bars) and by CFU (grey bars). White bars represent the relative 
level of mRNA of the selected gene to the expression of those genes in control samples determined 
by qt-RT-PCR. a) Rab7; b) Rab34; c) Syntaxin4 and d) Rab14. Data is presented as the average+SD 
(n=4 for RFU and CFU; n=2 for mRNA; t-test; *p<0.05;**p≤0,01). e) and f) confirmation of protein 
knockdown for Rab14 and Rab34 by western blot. 
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Figure 3.5. Effect of vesicular traffic genes knockdown on intracellular avirulent M. 
tuberculosis H37Ra survival. Black bars represent the CFU normalized to 100% on control samples 
and grey bars represents the percentage of CFU relatively to control on infected macrophages 
silenced with two distinct hairpins shRNAs of the same gene, for respectively. a) Rab7;b) Rab34; c) 
Syntaxin4 and d) Rab14.Data is presented as the average+SD (n=4 for RFU and CFU; n=2 for 
mRNA; t-test; *p<0.05;**p≤0,01). 
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Discussion 
 
By RNA silencing of approximately around 120 macrophage genes related with 
vesicular traffic and membrane fusion and using a dual fluorescent assay set up in 
our laboratory on M. tuberculosis infected host cells we were able to identify a total 
of 10 genes that affected M. tuberculosis macrophage infection. Of all 8 candidate 
genes led to reduction (susceptible genes) and 2 candidate genes lead to an 
increase (resistance genes) in M. tuberculosis burden within human macrophages.  
Among the susceptible genes found was Rab8a meaning that the silencing of this 
GTPase increase mycobacteria killing within macrophages. Rab8a has been found 
to be associated to phagosomes in proteomic studies 31–33. Indeed, in a previous 
study by Seto and colleagues, Rab8 was demonstrated to be transiently associated 
with mycobacteria containing phagosomes (MCP) as well in S. aureus containing 
phagosomes during  the first hour of 16. Furthermore these authors showed that the 
expression of dominant negative proteins had no effect in both latex bead 
phagosomes (LBP) acidification or on cathepsin D recruitment. These results are in 
accordance with ours pointing for an effect on phagosome maturation and therefore 
bacteria intracellular killing drive by Rab8a. 
Stx4 another identified susceptible gene target was described in literature as being 
involved in glucose-activated exocytosis of insulin, by interaction with actin in 
pancreatic beta cell line MIN6 34. 
Fratti and co-workers showed that MCP retains Stx4 and that  Phosphatidylinositol 
Mannoside (PIM) from M. tuberculosis coated latex beads induce Stx4 accumulation 
in latex bead phagosomes 22,35 suggesting a role in phagolysosome blockade. 
However since in most studies they usually uses BCG or H37Ra instead of the 
virulent M. tuberculosis H37Rv, it is not surprisingly that they results show the same 
tendency than ours using H37Ra but not the H37Rv strain. 
Rab27a has been found associated with MCP at later stages of infection 16. 
Nevertheless, this protein has been reported to negatively modulate complement 
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receptor mediated phagocytosis of c3bi-zymosam particles in human macrophages 
36 suggesting a role in the phase of bacteria internalization within macrophages. 
Rab27a knockdown induced a shorter coronin1A association to phagosomes and an 
increase in phagocytic uptake of zymosam particles. The authors describe for the 
first time that coronin1A is an effector of Rab27a. An association between CoroninA1 
and MCP maturation block has been recently described 37. Coronin1A knockdown 
results in activation of the p38 MAPK pathway, autophagosome formation around 
MCP and lead to reduce M. tuberculosis survival. We hypothesise that in Rab27a 
knockdown may be reducing coronin1A association to MCP.   
Rab34 was described has being transcriptionally dependent of the transcription 
factor NF-қB during lysosomal mediated killing of avirulent mycobacteria by 
macrophages, predicting a role of this Rab GTPase in phagosomal maturation 38. 
Moreover, Rab34 has shown to have a role in cathepsin D recruitment to 
phagosomes 16. Recently, this Rab GTPase has been reported to mediate 
phagolysosome fusion by a cargo size dependent mechanism independent of Rab7 
39. Overexpression of Rab34 led to a decrease in BCG survival concomitantly RNAi 
interference led to increased survival 39. However, our results show consistently that 
Rab34 silencing decreased macrophage intracellular M. tuberculosis burden (Figure 
3.4). Still, we did observe, an increase in intracellular survival in H37Ra avirulent 
mycobacteria in Rab34 silenced THP-1 cells (Figure 3.5). We conclude that Rab34 
mediated killing of mycobacteria might be specific for avirulent mycobacteria and that 
virulent M. tuberculosis is able to block that mechanism. 
Rab31 also known as Rab22b has been firstly describe to had a role in trans-Golgi 
network (TGN) 40. Recently, Rab31 was observed in M. tuberculosis containing 
phagosomes early in macrophage infection and is excluded after 60 minutes 16. On 
the other hand, this GTPase was implicated in phagosome maturation by recruitment 
of cathepsin D to latex bead phagosomes 16. Our results indicate that that Rab31 
knockdown reduces the numbers of intracellular M. tuberculosis. We speculate that 
the reduction in cathepsin D recruitment and therefore the vesicle traffic from trans 
Golgi to late endosomes is not enough to sustain significant replication in our 
persistence macrophage infection model. 
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D12, the mouse homolog of MDS032, is a SNARE from the endoplasmic reticulum 
(ER) 26. D12 formed a tight complex with stx18) as well as Sec22b and bound to 
SNAPα, indicating that D12 is a SNARE protein 41. This complex has been 
associated with ER membrane involvement of phagocytosis 26. Analyses of deletion 
mutants using the opsonized zymosan assay and immunoprecipitation showed that 
this inhibition is mediated by the interaction with stx18 and/or D12 26. We do not 
know if this has a parallel to human macrophages. Although we observe that 
MDS032 knockdown intracellular M. tuberculosis it would be very interesting to 
determine if this gene is involved in macrophage internalization of this pathogen. The 
involvement of ER in M. tuberculosis infection could give the pathogen means to 
control antigen presentation. 
Rab39B has 74% similarity to Rab39A and has been isolated in human foetal brain 
42. Mutations of this gene are associated with mental retardation associated with 
autism, epilepsy, and macrocephaly 28. This protein has been localized in the TGN 
and associated with vesicles from the recycling pathway in mouse hippocampal 
neurons 28. The silencing of this protein led to a reduction in M. tuberculosis burden 
within macrophages and this may be due to internalization defects related to 
recruiting recycling endosomes. Our results with Rab39B are the first to identify and 
associate such effects as susceptible gene target during M. tuberculosis infection. 
Definitely, knockdown of Rab7 was sufficient to increase intracellular M. tuberculosis 
and thus this protein can be classified has a resistance gene responsible for 
clearance of this pathogenic bacteria. Rab7 is a key regulatory protein for proper 
aggregation and fusion of late endocytic structures in the perinuclear region and 
consequently for the biogenesis and maintenance of the lysosomal compartment 43. 
In phagosomes of mammalian cells the recruitment and activation of Rab7 alone is 
insufficient to induce fusion of phagosomes with late endosomes and lysosomes 44.  
Active Rab7 recruits its effector protein RILP (Rab-interacting lysosomal protein) that 
binds to dynein-dynactin motors and promotes the interaction of Rab7 bearing 
phagosomes to lysosomes 45. Curiously, Rab7 is recruited to MCP without RILP 
association and released afterwards. The same is truth for autophagossomes, Rab7 
is also involved in autophagosome maturation and content destruction. M. 
tuberculosis is eliminated from infected macrophages by the induction of autophagy 
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as a consequence of nutrient starvation, drug inducer or interferon gamma (IFN-γ) 46. 
Autophagy potentially controls the intracellular burdens of M. tuberculosis in 
macrophages 47. All together these and ours results indicate a crucial role of Rab7 
for mycobacteria killing. Likewise the control of this GTPase may provide a 
therapeutic target for M. tuberculosis clearance by macrophages. 
Rab43 was shown in our results to be another resistance gene target as their 
silencing induced an increase in intracellular M. tuberculosis. Previous studies 
associate Rab 43 with the ER and the Golgi 48. This protein was indeed found to be 
associated with latex beads phagosomes upon macrophage activation by IFN-γ 33. 
During infection Rab43 is present in M. tuberculosis phagosomes and retained 
throughout infection, this GTPase is involved in cathepsin D recruitment to latex 
bead phagosomes this protein 16. The results suggest that while this protein is 
associated with recruitment of material associated with phagosome maturation, is 
not excluded from the M. tuberculosis phagosome and its knockdown is associated 
with a reduction in intracellular pathogen survival/persistence. 
Finally, Rab5 was previously described to be retained in M. tuberculosis containing 
phagosomes 22,49–51. Recently Seto et al. observed that this protein exists in 80% of 
M. tuberculosis containing phagosomes 16. Curiously, Rab5a was found to be the 
only isoform transcriptionally up-regulated in response to treatment with cytokines 
such as interleukin-4 or IFN-γ in macrophages 52. Another up-regulated isoform of 
Rab5, the Rab5b was identified during Raw264.7 macrophages infection with 
virulent M. tuberculosis 53. Rab5c was found to co localize with mycobacterial 
phagosomes in HeLa cells. We speculate that Rab5 isoforms may cooperate in their 
functions on the endocytic pathway and that the knockdown of one isoform may be 
complemented by the other. Nevertheless, RABEP1 encodes the protein Rabaptin-5 
a Rab5 effector involved in endocytic membrane fusion and homotypic endosome 
fusion 54,55. One peculiar characteristic of Rabaptin-5 is to be an effector of both 
Rab5 and Rab4, linking endosome fusion and recycling 29. Rabaptin-5 silencing by 
RNAi caused enlarged endosomes and delayed recycling of transferrin in 
knockdown HeLa cells 56. However we don’t know if there is a similar mechanism in 
phagosomes from professional phagocytes. Both latex beads and phagosomes 
containing BCG do not seems to possess a detectable Rabaptin-5 57. Our results 
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show that RABEP1 is a susceptible gene target which silencing leads to a decrease 
on mycobacteria burden. The mechanism remains however to decipher. 
Seto et al. observed that some Rab GTPases that were not recruited to phagosomes 
containing a virulent M. tuberculosis strain were actively associated with 
phagosomes containing the avirulent M. tuberculosis strain H37Ra or M. bovis BCG. 
In parallel these authors show that the recruitment of Rab GTPases implicated in the 
regulation of phagosome maturation is modulated in a virulence dependent manner. 
In this work we have found differences in the effect of the knockdown of selected 
vesicular traffic genes in avirulent and virulent M. tuberculosis. The use of clinical 
strains like CDC 1551 a recent clinical isolate 58 might help to determine the clinical 
relevance of the genes identified here. Most studies on vesicular traffic genes were 
made in avirulent mycobacteria and consequently the results obtained don´t have 
always significance in the virulent M. tuberculosis context. Nevertheless, these 
studies help us to identify the relevance of vesicular traffic genes in macrophage 
phagocytosis and to highlight the possible vesicular traffic factors exploited by M. 
tuberculosis and intracellular pathogens in general during infection.  
The maintenance of M. tuberculosis´ replication niche within macrophages is highly 
complex and dynamic. In order to undoubtedly identify the host factors involved in M. 
tuberculosis infection is important to use methods capable of intracellular pathogen 
quantification. In this work we show that our dual fluorescent reporter assay could be 
used to perform a high content screen and process hundreds of samples per 
experiment. This technique can be applied to other mutant M. tuberculosis and other 
intracellular pathogens, using other groups of host targets, or virtually to test the 
effect of drugs.  
Although, several vesicular traffic genes have been found to be differentially 
recruited/excluded from the M. tuberculosis containing phagosomes 16,18  the impact 
of those genes in the survival or persistence have not been elucidated. Here we 
showed that a group of vesicular traffic genes have an effect on the survival of 
intracellular mycobacteria. Nevertheless, the mechanisms associated with some of 
those phenotypes are still to be elucidated. 
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Material and Methods 
 
Mycobacteria cultures 
 
Mycobacterium tuberculosis strains H37Rv and H37Ra were cultured in 7H9 medium 
supplemented with 10% oleic acid albumin dextrose catalase and 0.05% tyloxapol. 
All manipulations of M. tuberculosis were performed in a Biosafety Level 3 
environment. 
Each of these species of mycobacteria harbours a plasmid constitutively expressing 
Green Fluorescent Protein (GFP) and a hygromycin resistance as a selection 
marker. The culture medium contained 50 µg/ml hygromycin B (Sigma-Aldrich) in 
order to maintain selective pressure on the plasmid carriers.  
All cultures were kept at 37°C and were subcultured until achieving exponential 
phase before being used on experiments: 7-10 days beforehand for M. tuberculosis. 
 
Cell lines 
 
The human monocyte cell line THP-1 (ATCC TIB-202) was cultured in RPMI 1640 
medium supplemented with 10% (v/v) FBS, 1% (v/v) glutamine, 1% (v/v) penicillin-
streptomycin, 1% (v/v) HEPES buffer, 1% (v/v) sodium pyruvate and 1% (v/v) non-
essential amino acids. 
The HEK 293T cell line (ATCC CRL-11268) was used to amplify the viral constructs 
of the lentiviral knockdown libraries. They were maintained in DMEM supplemented 
with 10% (v/v) foetal bovine serum and 1% (v/v) antibiotic – penicillin-streptomycin. 
Cell lines were maintain at 37°C in an atmosphere containing 5% carbon dioxide. 
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hairpin-pLKO.1 Plasmid preparation 
 
Plasmids were prepared according to TRC proceedings listed at 
(https://www.broadinstitute.org/genome_bio/trc/publicProtocols.html). 96 deep well 
sterile growth plates (Corning) were pre-filled with 1.2 ml of Terrific Broth (TB, 
Invitrogen) media containing 100 µg/ml carbenicillin (Sigma-Aldrich). The hairpin-
pLKO.1 containing bacterial glycerol stocks were inoculated on the TB pre-filled 96 
deep well plates and grown for at least 16 hours at 37ºC under agitation, 300 rpm. 
After incubation, plates were centrifuged for at 1500xg for 8 minutes at 4ºC, and 
supernatants discarded. Bacterial cell pellets were ressuspended in 200 µl of RNase 
A containing Ressuspension Buffer (50 mM Tris-HCl, 10 mM EDTA pH 8.0 and 0.1 
mg/ml RNase A) and further lysed in 210 µl fresh Alkaline Protease containing lysis 
buffer (200 mM NaOH, 1% (w/v) SDS and 25 units/ml of Alkaline Protease) for 4 
minutes at room temperature. Bacterial cell lysates were neutralized by adding 300 
µl Neutralization buffer (3.75 M Guanidinium Hydrochloride, 0.9 M KOAc and 1.4 M 
HOAc, pH4.35). After 30 minutes at 4ºC, centrifugation at 3000xg, lysates were 
transferred to a clarification filter plate (Whatman) and centrifuged at 3000xg for 
additional 5 minutes at 4ºC. Clarified lysates were then incubated at 70ºC for 30 
minutes. After incubation, lysates were transferred to a pDNA binding plate 
(Whatman), centrifuged at 1800xg for 2 minutes at 4ºC and supernatants were 
discarded. Two washes were performed by centrifuging the pDNA binding plates at 
1800xg for 2 minutes at 4ºC in the presence of 600 µl of Wash buffer (480 ml of 
100% ethanol added to a 120 ml of a solution containing 15 mM NaCl, 40 mM Tris-
HCl and 25 mM Tris, pH 6.65). Plasmid DNA was eluted from the pDNA binding 
plates by centrifuging at 1800xg for 5 minutes at 4ºC after an incubation of 10 
minutes with 140 µl of Elution buffer (10 mM Tris-HCl, pH 8.0). Plasmid DNA 
concentration was assayed by spectrophotometry in a Tecan Infinite 200 equipment 
using Quant-iT PicoGreen dsDNA reagent (Invitrogen) following manufacturer’s 
protocol, and further stored at -80ºC. 
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Lentivirus production 
 
Lentiviruses were produced according to TRC lentiviral proceedings present at the 
RNAi Consortium website 
(https://www.broadinstitute.org/genome_bio/trc/publicProtocols.html). Briefly, HEK  
293T cells were seeded at a density of 2.2x105 cells/ml (100 µl per well in 96 well 
plates) in DMEM media without Penicillin-Streptomycin. After 24 hours incubation at 
cell culture normal conditions, cells were transfected with a mixture of the 3 
plasmids, the packaging plasmid (100 ng of pCMV-dR8.91), the envelope plasmid 
(10 ng of VSV-G/pMD2.G) and 100 ng of the shRNA containing pLKO.1-puro vector 
(Figure 3.6), using Fugene HD transfection reagent (Promega) in Optimem medium 
(GIBCO), following TRC transfection proceedings. After 18 hours of incubation, 
media was replaced with 170 µl of high serum growth media (30% FBS (v/v) DMEM). 
Twenty-four hours after media replacement, viruses were harvested (150 µl) and 
fresh media (150 µl) was added to the cells. The second viral collection was 
performed 24 hours later and harvested viruses were pooled with the previous day 
collection and stored at -80ºC.  
 
Lentiviral transduction 
 
Lentiviral transduction was performed according what is described at the RNAi 
Consortium website 
(https://www.broadinstitute.org/genome_bio/trc/publicProtocols.html). Briefly, 10 µl of 
viruses were plated per well in a 96 well plate. THP-1 cells were ressuspended in 
RPMI medium containing 8 µg/ml of Polybrene (Sigma-Aldrich) at a density of 
1.25x106 cells/ml, and 40 ul were added on top of the virus containing wells. Plates 
were spun for 90 minutes at 900xg at 37ºC. After spinoculation, media was removed 
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and replaced with 200 µl of fresh THP-1 media, and cells incubated at 37ºC under 
normal cell culture conditions. After 2 days, transduced cell selection was performed 
by adding 50 µl of THP-1 media containing puromycin (Calbiochem) to a final 
concentration of 5 ug/ml. Cells were kept under puromycin selection for 3 days and 
then were ready to be used in further assays.  
 
Infection procedures 
 
Mycobacterial preparation  
Prior to any experiment, infection or broth cultures, mycobacterial cultures at mid log 
grow phase were centrifuged at 3000xg, 37°C for 10 minutes, washed in Phosphate 
buffer saline (PBS) pH 7.4 (Gibco) and, in the case of infection experiments,  
resuspended in in RPMI media 1640 (Gibco) supplemented with 10% (v/v) Foetal 
Bovine Serum (Gibco), 1% (v/v) Pyruvate (Gibco), 1% (v/v) L-Glutamine (Gibco), 1% 
(v/v) Non-essential aminoacids (Gibco), 1% (v/v) Hepes buffer (Gibco). To obtain a 
single-bacillus suspension the medium with the bacilli was passed 20 times through 
a sterile syringe equipped with a 21 gauge needle, followed by 15 minutes of 
ultrasonic. The remaining bacterial clumps were eliminated by centrifugation at 
350xg for 1 minute and single-cell suspension was verified by light microscopy. 
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Figure 3.6. Vector map for the pLKO.1 lentiviral vector. The self-inactivating lentiviral vector 
backbone contains elements for efficient viral packaging and shRNA expression. These include Ψ, 
the lentiviral packaging site; RRE, the Rev-responsive element; cPPT, central polypurine tract. RSV 5′ 
LTR is a hybrid of the Rous Sarcoma virus promoter and the HIV 5′ LTR. SIN 3′ LTR is the HIV 3′ LTR 
with a self-inactivating U3 deletion. Expression of the shRNA is driven by the human U6 promoter 
(hU6). The lentiviral vector also contains the mammalian selection marker puromycin resistance gene 
(PAC) under the control of the PGK promoter as a mammalian selection marker. pUCori is the 
bacterial origin of replication of the plasmid, F1 ori is the single-stranded phage F1 origin of 
replication, and AmpR is the ampicillin resistance gene. 
 
Mycobacterial infection of THP-1 macrophages 
All infection experiments were made with RPMI media without phenol or antibiotics. 
THP-1 cell densities were quantified using Milipore EasyCyte H6 Guava flow 
cytometer, using its proprietary InCyte software. 7,5x104 THP-1 cells/well seeded in 
a black polystyrene 96 well plates (Corning) and incubated with 20 nM of phorbol 12-
myristate 13-acetate (PMA) (Sigma-Aldrich) RPMI media without phenol for 24 hours 
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for differentiation into macrophages. After this period, cells were allowed to rest in 
PMA free media for another 24 hours.  
In the day of infection, the cell media was discarded and was added 100 µl of single 
bacilli suspensions. The macrophages were infected with H37Rv in at a multiplicity of 
infection (MOI) of 1, proportion of mycobacteria/macrophage.  After a specific pulse 
period, macrophages were washed with warm media. After washing, 200 µl/well of 
media containing 10 µg/ml of gentamycin was added, to kill extracellular bacteria. 
Cells were incubated for 24 hours and replenish with 200 ml/well of media containing 
no antibiotics. It have been reported that at this range of concentration gentamycin 
does not accumulate in THP-1 cells and any intracellular gentamicin is also rapidly 
inactivated 59,60.  Cell media was replaced every 48 hours. 
 
 
Data acquisition and analysis 
 
Quantification of mycobacteria expressing tdTomato and THP-1 expressing eGFP 
Quantification of intracellular H37Rv, expressing tdTomato and THP-1 expressing 
eGFP was made by spectrophotometry of fluorescence in Tecan’s M200 
spectrophotometer. THP-1 macrophages fluorescence was measured at 488nm 
excitation and 520nm emission and a gain of 175, and intracellular H37Rv at an 
excitation of 554nm, an emission of 586nm and a gain of 200. 
 
Quantification of intracellular M. tuberculosis by colony forming units 
Five days post-infection, infected macrophages were washed with PBS and 
incubated with 0,05% (v/v) solution of IGEPAL (Sigma-Aldrich) at normal cell 
incubation conditions, for 10 minutes. Serial 10 fold dilutions were made with sterile 
distilled water, and plated Middlebrook’s 7H10 solid medium (Becton, Dickinson and 
Company) supplemented with 10% (v/v) OADC (Becton, Dickinson and Company), 
0.5% (v/v) glycerol (Sigma-Aldrich). Plates were incubated at 37°C for 3 weeks. 
Micro colonies were count with the help of an optical microscope. 
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Quantitative RT-PCR 
 
Total RNA was extracted using TRIzol reagent (Invitrogen) and final RNA quality and 
concentration determined by spectrophotometry using Nanodrop 2000c equipment 
(Thermo Scientific). Complementary DNA (cDNA) synthesis was carried out using 
1ug of total RNA and Superscript II Reverse Transcriptase (Invitrogen) according to 
manufacturer’s directions. Quantitative RT-PCR (qRT-PCR) was performed in the 
presence of Power SYBR green PCR Master Mix (Applied Biosystems) and the 
amplification protocol was performed on a 7300 Real-Time PCR System (Applied 
Biosystems). All samples were normalized against the expression of the 
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the 
relative expression of each gene was calculated using Pfaffl’s method 61. Primers are 
listed in supplementary information section (Table S3.2). 
 
Western-blot 
 
Transduced cells were denatured at 95°C for 5 minutes in the presence of Laemmli 
buffer (BioRad), before loaded 20 μl on 12% Sodium Dodecyl Sulphate 
polyacrilamide gels. Electrophoresis was performed at 200 V for 1 hour. Proteins 
were transferred onto nitrocellulose membranes with an electrical intensity of 30 V 
overnight in a cold room. At the following day, membranes were blocked for 1 hour at 
room temperature. The blocking buffer contains Tris-buffered saline plus 0.05% (v/v) 
Tween 20 (TBS-T) and 5% (w/v) Bovine Serum Albumin (BSA) in order to avoid 
unspecific binding of the detection antibody. Following that, membranes were 
incubated with primary antibodies (Table 3.3) diluted in TBS-T plus 1% (w/v) BSA for 
2 hours at room temperature. After 3 washes in TBS-T, membranes were probed 
with horseradish peroxidase (HRP)-conjugated secondary antibodies (Table 3.3) for 
1 hour at room temperature. After 3 washes in TBS-T, membranes were stained for 
5 minutes with the chemiluminescent reagent, Luminata Crescendo Western HRP 
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Substrate (Millipore). Chemiluminescence was detected and captured with 
ChemiDoc XRS+ system (Bio-Rad).  
 
Table 3.3. List of Antibodies used to perform WB, dilutions and incubation times. 
            
Antibodies Reference Company Dilution Incubation 
        Time  Temperature 
      
Rab14 sc-271401 Santa Cruz Biotecnology 1:300 2 hours RT 
Rab 34 ab73383 Abcam 1:1000 2 hours RT 
Beta-tubulin ab20775 Abcam 1:4000 2 hours RT 
anti-mouse 172-1011 Bio-Rad 1:4000 1 hour RT 
anti-rabbit 170-6515 Bio-Rad 1:4000 1 hour RT 
            
      
 
Statistical treatment  
 
The software SigmaPlot 12.0 (Systat Software Inc.) was used for statistical analysis. 
One tail Student's t-test was used for comparing two means and ANOVA more than 
two means. Statistical significance was assumed when P < 0.05 or P<0,01. 
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Supplementary Information 
 
Table S3.1. List of vesicular traffic genes targeted to knockdown by shRNA. 
Gene Name NM_ID Gene Name NM_ID 
BET1 NM_005868 RAB33B NM_031296 
BET1L NM_016526 RAB34 NM_031934 
BNIP1 NM_001205 RAB35 NM_006861 
EPIM NM_001980 RAB36 NM_004914 
GOSR1 NM_004871 RAB36 NM_004914 
GOSR2 NM_004287 RAB37 NM_175738 
MDS032 NM_018467 RAB37 NM_175738 
RAB10 NM_016131 RAB38 NM_022337 
RAB11A NM_004663 RAB39 NM_017516 
RAB11B NM_004218 RAB39B NM_171998 
RAB11FIP1 NM_025151 RAB3A NM_002866 
RAB11FIP2 NM_014904 RAB3A NM_002866 
RAB11FIP3 NM_014700 RAB3B NM_002867 
RAB11FIP4 NM_032932 RAB3C NM_138453 
RAB11FIP5 NM_015470 RAB3C NM_138453 
RAB13 NM_002870 RAB3GAP2 NM_012414 
RAB14 NM_016322 RAB3IL1 NM_013401 
RAB15 NM_198686 RAB3IP NM_022456 
RAB17 NM_022449 RAB40B NM_006822 
RAB18 NM_021252 RAB40B NM_006822 
RAB19B XM_376681 RAB40C NM_021168 
RAB1A NM_004161 RAB41 NM_001032726 
RAB1B NM_030981 RAB42 NM_152304 
RAB2 NM_002865 RAB43 NM_198490 
RAB20 NM_017817 RAB4B NM_016154 
RAB21 NM_014999 RAB5A NM_004162 
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Table S3.1. (Continued) 
Gene Name NM_ID Gene Name NM_ID 
RAB22A NM_020673 RAB5A NM_004162 
RAB23 NM_016277 RAB5B NM_002868 
RAB24 NM_130781 RAB5B NM_002868 
RAB25 NM_020387 RAB5C NM_004583 
RAB26 NM_014353 RAB6A NM_002869 
RAB27A NM_004580 RAB6B NM_016577 
RAB27B NM_004163 RAB6C NM_032144 
RAB28 NM_004249 RAB7 NM_004637 
RAB2B NM_032846 RAB7B NM_177403 
RAB30 NM_014488 RAB7B NM_177403 
RAB31 NM_006868 RAB7L1 NM_003929 
RAB32 NM_006834 RAB8A NM_005370 
RAB33A NM_004794 RAB9A NM_004251 
RAB9B NM_016370 SNAP29 NM_004782 
RABEP1 NM_004703 STX11 NM_003764 
RABEP2 NM_024816 STX12 NM_177424 
RABEPK NM_005833 STX17 NM_017919 
RABGAP1 NM_012197 STX18 NM_016930 
RABGAP1L NM_014857 STX1A NM_004603 
RABGEF1 NM_014504 STX3A NM_004177 
RABGGTA NM_004581 STX4A NM_004604 
RABGGTB NM_004582 STX5A NM_003164 
RABIF NM_002871 STX6 NM_005819 
RABL2A NM_007082 STX7 NM_003569 
RABL2B NM_001003789 STX8 NM_004853 
RABL3 NM_173825 SYBL1 NM_005638 
RABL4 NM_006860 VAMP2 NM_014232 
RABL5 NM_022777 VAMP3 NM_004781 
SEC22B NM_004892 VAMP4 NM_003762 
SEC22L2 NM_012430 VAMP5 NM_006634 
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Table S3.1. (Continued) 
Gene Name NM_ID Gene Name NM_ID 
SEC22L3 NM_004206 VTI1A NM_145206 
SNAP23 NM_003825 VTI1B NM_006370 
SNAP25 NM_003081 YKT6 NM_006555 
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Table S 3.2. List of primers used in qRT-PCR. 
Gene Name Primer Sequence 
      
GAPDH HGAPDH-L AAGGTGAAGGTCGGAGTCAA 
  HGAPDH-R  AATGAAGGGGTCATTGATGG 
MDS032 MDS032-L CCACAAAGACGGTGCATCT  
  MDS032-R TCCTTACGTCCATCTCAGGC  
RAB11FIP3 RAB11FIP3-L GTTTGCTACGGTCTACGGGG  
  RAB11FIP3-R GGCTGTGATCCCTTGGTAGA  
RAB27A RAB27A-L ACAAGCGGTTCTCTACCCTG  
  RAB27A-R CCCTACACCAGAGTCTCCCA  
RAB31 RAB31-L AGGATGCTGCTGAGCCC  
  RAB31-R ACGATGCTTGATTTCCCAAC  
RAB33A RAB33A-L AGGGAGAAGACCGTGGAAAT  
  RAB33A-R TTGCGGTAGTAATGCTCGAC  
RAB34 RAB34-L GCACAAAGACTTCCACCCC 
  RAB34-R CCCACCACAATGATCTTGGA 
RAB3A RAB3A-L GACCATCTATCGCAACGACA  
  RAB37-R CATAGCGCCCCGGTAGTAT  
RAB39B RAB39B-L GGAGATCGAGCCAGGAAAAC  
  RAB39B-R AGTTCCTGTAGTAGGCGCGA  
RAB42 RAB42-L CGTGGAGACCTCGGTTAAAA  
  RAB42-R TCTAGCTTGATGTCCCCCTG  
RAB43 RAB43-L ACCATGAAGACGCTGGAGAT  
  RAB43-R CTGCGGTAGTAGCTCTGGGT  
RAB7B RAB7B-L GATGCAGCCATCGGAGCCCTTGT 
  RAB7B-R GGCCAGCATCCTCTCCAAGATTATC 
RAB7A RAB7A-L CCGTTTAGTCTCCTCCTCGG  
  RAB7A-R CCTTCAGCAACACTTTCTTCCT  
RAB8A RAB8A-L GACGCCTTCAACTCCACTTT  
  RAB8A-R ACCGGCTGTGTCCCATATCT  
RABEP1 RABEP1-L GGCTTCCCAGCCTGACG  
  RABEP1-R TGTTCAAGCTGCTGTTGTGC  
RABGGTA RABGGTA-L AGATGGAGTATGCCGAGGTG  
  RABGGTA-R CAAGTCAAGATGGGTGACCA  
SNAP23 SNAP23-L GTTGGGGTGTCCGAGTTG  
  SNAP23-R TCTGGTGAGCTCTCTGTTGAA  
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Table S 3.2. (Continued) 
Gene Name Primer Sequence 
      
STX4 STX4-L ATAGAGCCCCAGAAGGAGGA  
  STX4-R TTGATGAGCTCCACGAATTG  
VAMP2 VAMP2-L GCGCAAATACTGGTGGAAAA  
  VAMP2-R CTCCTCGGGGATTTAAGAGC  
RABGAP1 RABGAP1-L GCGCAAATACTGGTGGAAAA  
  RABGAP1-R TCTTCGAGGAGAAGTCTGGC 
RAB24 RAB24-L AAGGTGATGTCGGTCGGA 
  RAB24-R CTTGGCACCCCGATAGTAGA 
RAB7L1 RAB42-L CAGGACAGCTTCAGCAAACA 
  RAB42-R TGAAGCCGCACTATCTCGTA   
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Host factors involved in Mycobacterium tuberculosis 
internalization within macrophages 
 
Abstract 
 
An assay based on ﬂow cytometry was developed to assess and quantify 
mycobacteria macrophage phagocytosis in vitro. Different origin species of 
macrophage cell cultures were used and infected with several GFP expressing 
strains and species of virulent and avirulent mycobacteria. Additionally, we 
knockdown distinct vesicular traffic genes selected from a genomic screen as 
potential candidates with a role in M. tuberculosis macrophage infection. Our results 
indicate that the rate of internalization is dependent on the species/strain doubling 
time and on the virulence, being the virulent M. tuberculosis H37Rv the strain with 
the lowest internalization rate of all tested. Additionally, we show that mycobacteria 
uptake occurs very fast within the first half hour of infection. Furthermore here we 
demonstrate that the method is feasible as allowed to identify several vesicular traffic 
genes demonstrated previously with a role in M. tuberculosis macrophage infection 
as positive regulators of mycobacteria internalization by host cells. 
 
Introduction 
 
Phagocytosis of invading microorganisms by macrophages is a multi-step 
process that involves detection, uptake, destruction and presentation of antigens to 
adaptive immune system1. Macrophage entry is the first critical step in M. 
tuberculosis infection. The process involves the interaction between pathogens´ 
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ligands and macrophage surface receptors. To survive inside macrophages the 
bacilli evolved strategies for engaging specific receptors to gain entrance without 
triggering immune activation and degradation inside the macrophage 2. M. 
tuberculosis is able to engage several macrophage receptors probably due to the 
complex structure of its cell wall 3. Although, various macrophage receptors already 
described, such as complement receptors, mannose receptor, lung surfactant protein 
receptors, CD14, scavenger receptors, Toll like receptors and Fc receptors, their 
contribution in the intracellular fate and survival of M. tuberculosis is still far from 
being understood 4,5. However, virulent M. tuberculosis macrophage uptake through 
Fcγ receptor-mediated phagocytosis leads to fusion of mycobacteria containing 
phagosomes with lysosomes 4. 
After pathogen detection, internalization and phagosome biogenesis induces 
an increase of macrophage membrane area to compensate the gradual apposition of 
plasma membrane onto invading microorganisms 6. Rather than originating only from 
plasma membrane, the excess of membrane for phagosome biogenesis is obtained 
from different macrophage organelles by a process called focal exocytosis 7. Rab 
GTPases and SNARE proteins have been implicated with the recruiting of 
membrane to the nascent phagosome 8. Indeed, it was shown that the SNARE 
Vamp3 and Rab11 were involved in early and recycling endosomes and Vamp7 in 
late endosome recruitment to the phagocytic cup 7,9. In addition to organelles related 
to the endosome/lysosome pathway, the endoplasmic reticulum (ER) has also been 
implicated in phagosome formation. ER-derived membrane has been observed in 
the bottom of forming phagosomes, and some ER-resident SNAREs were detected 
in a proteomics analysis of isolated phagosomes (Gagnon et al., 2002; Desjardins, 
2003). Recently, a proteomic study by Campbell-Valois identified the plasma 
membrane, endosomes/lysosomes, Golgi, ER and mitochondria as contributors to 
the phagosome membrane and also identified several Rab GTPases and  SNARE 
proteins from those organelles associated with nascent phagosomes 10. Most data 
on membrane recruitment during phagocytic uptake comes from Fcγ receptor-
mediated phagocytosis studies 11. However it is expected that different phagocytic 
receptors and other factors may influence the machinery engaged for engulfment 11.  
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The vesicular traffic proteins involved in the uptake of M. tuberculosis are still 
to be deciphered. Here we took advantage of the powerful potential of fluorescence-
activated cell sorting (FACS) flow cytometry to develop and optimize a macrophage 
internalization assay for mycobacteria. This approach provided us tools for further 
biologically characterise the role of several vesicular traffic gene, after siRNA 
knockdown of macrophages, in mycobacteria internalization. Our data shows that 
mycobacteria/macrophage internalization rates are dependent on of the cell line 
used and on the virulence of mycobacteria. Virulent M. tuberculosis is internalized at 
lower rates by macrophages when comparing to the avirulent counterparts fast 
growing M. smegmatis and slow growing M. bovis BCG. Additionally, we identified 
six vesicular traffic genes, Rab27a, Rab39b, RABEP1 and Stx4, whose knockdown 
reduced macrophage internalization of virulent M tuberculosis. Two other additional 
genes identified Rab27a and Stx4 were shown to possess a reduced internalization 
effect on knocked-down macrophages infected with the avirulent M. smegmatis.  
 
Results 
 
Quantification of Mycobacteria Internalization by FACS 
 
In order to establish a method based on flow cytometry to assess the rate of 
mycobacteria internalization by macrophages we first used Mycobacterium 
smegmatis expressing GFP to infect phorbol-esters PMA diferentiated THP-1 cells at 
different multiplicities of infection (MOI). After a 3 hours pulse the percentage of GFP 
positive THP-1 cells were quantified by flow cytometry (Figure 4.1). Gated Forward 
Scatter (FSC) and Side Scatter (SSC) were measured from infected cells samples 
(Figure 4.1a and 4.1d). The gated population was used to establish a SSC /FL1 ratio 
allowing to distinguish between THP-1 cells that internalized GFP expressing 
bacteria (GFP positive) (Figure 4.1e) from uninfected control cells (Figure 4.1b). By 
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transforming the FL1 data in histograms one can compare the distribution of 
fluorescent intensity in the GFP positive population (Figure 4.1c). We observed an 
increased THP-1 fluorescence intensity concomitant with an increase on the MOI. 
Treatment of THP-1 with 1ug/ml of cytochalasin  D, an inhibitor of actin 
polymerization and therefore on macrophage internalization 12, for 15 minutes before 
and during the pulse time, significantly reduced the internalization o GFP 
mycobacteria in 4 fold change (ANOVA; p<0,001; n=3). 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Flow cytometry analysis of mycobacteria infected THP-1 cells. (a and c) macrophage 
sample acquired in the Forward Scater (FSC) and Side Scater (SSC), respectively. (b) The cell 
population can be subsequently gated and a precise quantification of the macrophages that do not 
contain GFP-bacteria and (d) those who contain GFP-bacteria, at a MOI of 20. e) Different amounts of 
bacteria are distinguishable as a function of the fluorescence intensity. GFP-positive cells show higher 
intensity as the MOI increases from 5 (blue), to10 (green) and to 20 (red). f) Internalization of 
mycobacteria is inhibited by cytochalasin D (A-NOVA;n=3; *p=0,001; ** p<0,001). 
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These results suggest that increments in GFP positive cells associated with 
increasing amounts of mycobacteria per macrophage were due to an increase in 
mycobacteria uptake. To confirm that mycobacteria were internalized by 
macrophages and not just adherent outside of the membrane we quantified the 
extracellular mycobacteria directly after the uptake phase (Figure 4.2a), while others 
were subjected to every step of the post-infection protocol treatment (Figure 4.2b). 
From a random sampling, we calculated the percentage of macrophages with 
adjacent extracellular mycobacteria (Figure 4.2c). The treated samples with a 
protocol described in methods of washing were completely clear of adherent 
mycobacteria, while 58% of the macrophages in the non-treated samples were not.  
 
 
Figure 4.2. Fluorescence microscopy images of macrophage samples infected with 
Mycobacterium smegmatis. J774 cells were infected at a MOI 100 and analysed 1 hour post 
infection. In a) the sample was stained with ethidium bromide and immediately observed under a 
fluorescence microscope. In b) the sample was stained and subjected to the entirety of the post-
infection protocol c) Bar plot representing the quantification of adherent extracellular mycobacteria in 
the original samples from where images a and b were taken. Images captured with a Zeiss Axioskop 
40 microscope and its software AxioVision 4 using a FITC filter. 
 
Rates of internalization 
 
Figure 4.3 presents representative histograms of uninfected and infected THP-1 
macrophages with a MOI of 1 bacterium per macrophage for 4 hours. In order to 
optimize the macrophage internalization assay for bacteria we further tested the 
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influence of macrophage species or of mycobacteria and the minimum time required 
and multiplicity of infection (MOI) on uptake rate. Figure 4.4 shows the internalization 
profiles on J774 mouse macrophages.  A marked difference between multiplicities of 
infection is observed, as they maintain some graphical distance, with no overlap. 
When using a MOI of 100 almost all macrophages were infected by mycobacteria, 
which is not surprisingly if we consider such a high bacterial burden. Considering the 
avirulent M. smegmatis is not only internalized faster, but also to a greater extent, 
reaching a higher percentage of infected macrophages than the other mycobacteria 
(although these differences were non-significant by the Holm-Sidak pairwise 
comparison, p>0.05). M. tuberculosis appears to be internalized at a lower rate than 
the other mycobacteria during the first hour of contact with macrophages, which is 
particularly evident in the curve corresponding to a MOI of 1, hardly reaching 20% at 
the end point. 
 
 
Figure 4.3. Example populations of uninfected and infected macrophages, as obtained by flow 
cytometry and represented in histograms. Left: Uninfected control sample of THP-1 macrophages. 
Right: Sample of THP-1 macrophages infected with Mycobacterium smegmatis for 4 hours with a 
multiplicity of infection of 1. X axis represents intensity of green fluorescence in a logarithmic scale. Y 
axis represents number of events. The two samples are taken from the same experiment. With flow 
cytometry software we calculated the percentage of total events that are in each population. 
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Figure 4.4. Internalization by J774 mouse macrophages of different mycobacteria. a) M. 
smegmatis; b) M. bovis BCG; c) M. tuberculosis. Each data point includes the average and standard 
deviation of three replicate experiments. 
 
In Figure 4.5 we can observe the internalization profiles on THP-1 human 
macrophages. Figure 4.5a confirms that M. smegmatis is slightly more internalized 
than its other counterparts contrary to M. tuberculosis that shows a tendency for a 
slower internalization rate especially at a MOI of 1 or 10, as indicated by a less steep 
curve. Nonetheless, there is substantial difference in the kinetics of internalization of 
M. tuberculosis compared to other mycobacteria at the early stages. Global 
differences were evaluated using the Holm-Sidak method, indicating that the 
differences between M. tuberculosis and other mycobacteria were significant 
(p<0.05). The apparent decline on the 4 hour mark of MOI 100 in Figure 4.5.c is 
buffered by the standard deviation and is not likely to represent a real decrease in 
internalization.  
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Figure 4.5. Internalization by THP-1 macrophages of different mycobacteria. a) M. smegmatis; b) 
M. bovis BCG; c) M. tuberculosis. Each data point includes the average and standard deviation of 
three replicate experiments. 
 
In human monocyte-derived macrophages (HMDM), represented in Figure 4.6, the 
results shows a reach to the plateau earlier on, as we can see a shorter difference 
between the time points of 1 hour and 4 hours, which is more evident in the case of 
M. tuberculosis. 
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Figure 4.6. Internalization by human monocyte-derived macrophages of different 
mycobacteria. a) M. smegmatis; b) M. bovis BCG; c) M. tuberculosis. Each data point includes the 
average and standard deviation of three replicate experiments. 
 
Figure 4.7 represents the results from the previous experiments but with a different 
graphical arrangement in order to allow a clear analyse of the difference in the 
uptake rate of the different macrophage species. The results show that human 
monocyte-derived possess the greatest phagocytic efficiency, largely exceeding its 
counterparts in the first hour (significant for HMDM versus J774, p<0.05), although 
all reach the peak activity before the fourth hour. No significant differences were 
observed between J774 and THP-1 cells in these measurements. A relevant 
observation is that M. tuberculosis is shown to be internalized to a lesser extent, 
although it was present in the same concentrations as the other mycobacteria at the 
time of infection (significant, p<0.05). Simultaneously there is an inverse correlation 
between virulence and percentage of internalization; we observe the latter is greater 
with M. smegmatis, lower with BCG and the lowest with M. tuberculosis, a pattern 
easily observed in HMDM.  
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Figure 4.7. Internalization efficiency of different macrophages, sorted by species of 
mycobacteria. Only the MOI of 10 is represented. 
 
Vesicular traffic genes are positive regulators of mycobacteria internalization 
 
In order to validate the internalization method set up we further  determined 
the role of host vesicular trafficking factors during macrophage internalization of 
avirulent (M. smegmatis) and virulent (M. tuberculosis). For this purpose we used 
mycobacteria expressing GFP to infect THP-1 cells at a MOI 10  after one hour of 
pulse and measure the percentage of GFP positive THP-1 cells by flow cytometry. 
Figure 4.8 displays the overall results for internalization of mycobacteria in THP-1 
cells knockdown for the candidate genes validated in the genomic screen. Overall 
most of the knockdowns led to a reduction in the internalization of both mycobacteria 
species indicating that these proteins are likely positive regulators of internalization. 
The pattern was rather similar between the two species of mycobacteria, despite the 
difference in baseline internalization rates between them. The reduction, was 
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however, slightly higher in M. tuberculosis compared to M. smegmatis. The 
internalization rate reduction was almost twofold more substantial with virulent M. 
tuberculosis (23%) than with the avirulent M. smegmatis (12%).  
The selection of host factors with an effect on internalization  was based on 
the criteria that two or more hairpins silencing each protein had to cause a difference 
in internalization of at least 2.5 times the standard deviation of the controls and the 
the hairpins of the same gene have the same tendency (incresing or decreasing 
macrophage uptake). We found seven macrophages candidate genes for 
internalization of M. tuberculosis and 4 candidate genes for M. smegmatis (Figure 
4.9). 
It is not surprising to realize that proteins mostly associated with vesicular 
traffic and phagosome maturation exert influence on internalization, which is a 
vesicular and membrane process 13. The fact that the silencing of these proteins 
significantly decreased the efficiency of internalization suggests that some cross-
regulation must exist between the chronologically separate systems of internalization 
and phagosome maturation. 
 
Figure 4.8. Overview of the internalization assay performed on candidate vesicular traffic 
proteins. The different gene interference hairpins are sorted in the vertical axis for the two strains. 
The horizontal axis expresses normalize internalization to the control (internalization / control). M.tb: 
Mycobacterium tuberculosis; Msmeg:Mycobacterium smegmatis 
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Figure 4.9. Candidate genes with a role in internalization in two species of mycobacteria. a) 
Mycobacterium tuberculosis and b) Mycobacterium smegmatis. Different gray tones represent 
different gene interference hairpins. 
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Discussion 
 
In the present work flow cytometry was successfully used to assess of mycobacteria 
uptake by macrophages. The results shown here indicate that internalization of 
mycobacteria by macrophages is dependent on the multiplicity of infection, on the 
macrophage type and on mycobacteria species.  Indeed we show that mycobacteria 
uptake by macrophages is a fast phenomenon, as we observed that the majority of 
mycobacteria are internalized in the first 30 minutes after contact with the 
macrophages. HMDM were more competent to internalize mycobacteria than THP-1 
or J774 macrophages.  
The decreasing order of internalization among the tested mycobacterial species 
is coherent with the growth rate of each one. Faster-growing mycobacteria were 
internalized at a higher rate and to a higher extent, and the reverse is also true 
(Figure 4.7). This leads us to raise the supposition that bacterial growth occurred 
during the experiment, affecting the results. This hypothesis can be dismissed for M. 
bovis BCG and M. tuberculosis, for which the doubling time greatly exceeds the 4-
hour maximum duration of the experiment. M. smegmatis, on the other hand, has a 
doubling time of approximately 3 hours and could present a liability to the robustness 
of the method, given that the infection takes place at 37°C. However, when we 
consider that the bacteria were taken from a culture in exponential phase, thoroughly 
washed and individualized, significantly diluted and ressuspended in a non-optimal 
medium, exponential bacterial growth is not expected to take place in these 
conditions. 
The observed relationship between growth rate and internalization are also 
correlated when analysing virulence. Indeed, M. tuberculosis, M. bovis BCG and M. 
smegmatis are in a decreasing scale of virulence inversely proportional to the scale 
observed in internalization (Figure 4.7). It seems that M. tuberculosis may be 
internalized by a different route of M. smegmatis or M. bovis BCG, or actively inhibits 
its internalization. Previous work by Stockes and co-workers demonstrated that 
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glycan-rich outer layer of M. tuberculosis is antiphagocytic controlling and limiting the 
interaction of the bacterium with macrophages 14. 
The knockdown of several candidate vesicular traffic genes involved in M. 
tuberculosis macrophage infection interfere with macrophage uptake of M. 
smegmatis and M. tuberculosis. In this situation we could observe the same 
tendency of a lower uptake of M. tuberculosis. Based on our criteria we selected four 
candidate genes that have a potential effect on M. smegmatis macrophage uptake 
and seven for M. tuberculosis. For all at least two hairpins induced a reduction in the 
percentage of macrophages infected with M. tuberculosis, suggesting that these 
proteins might be positive regulators of macrophage uptake. Curiously the proteins 
whose knockdown led to a reduction in M. tuberculosis macrophage internalization 
also lead to reduced intracellular M. tuberculosis burden.  
Nevertheless, the involvement of MDS032 in M. tuberculosis uptake is an attractive 
candidate in M. tuberculosis macrophage interaction. D12, the mouse homolog of 
MDS032, is a SNARE from the ER 15. D12 formed a tight complex with Stx 18 as 
well as Sec22b and bound to SNAPα, indicating that D12 is a SNARE protein 16. 
This complex has been associated with ER involvement of phagocytosis 15. Analyses 
of deletion mutants using the opsonized zymosan assay and immunoprecipitation 
showed that this inhibition is mediated by the interaction with Stx 18 and/or D12 15. 
We do not know if this has a parallel to human macrophages. Although we observe 
that MDS032 knockdown reduces mycobacteria internalization, we didn’t observe 
influence of Sec22b in M. tuberculosis infection in the genomic screen from the 
previous chapter. Additionally, the involvement of the ER in early time points of M. 
tuberculosis infection could provide a route of pathogen subversion of macrophage 
antigen presentation 17. 
Stx4 is a SNARE present in the cellular membrane of macrophages and is 
recruited to the nascent phagocytic cup to mediate the membrane fusion events 
involved in exocytosis necessary for the extra membrane needed for particle uptake 
18. Additionally, Stx4 and Rab27a have been implicated in phagocytosis by 
macrophages 19,20.  
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Rab27a was reported to regulate macrophage uptake in complement 
mediated phagocytosis by prolongation of phagosome F-actin coating by GTP 
Rab27a and recruitment of Coronin 1A by the GDP form 20. We observed a reduction 
in mycobacteria uptake in Rab27a knockdown human macrophages. The 
association between Coronin 1A and M. tuberculosis survival 21 makes this 
candidate worth of study.  
Since the first studies on flow cytometry for quantification of mycobacteria 
uptake by host cells to the best of our knowledge this is the first to compare in vitro 
different strains and macrophage types. This technique can also be adapted for in 
vivo studies using knockout mice for study of host genes in alveolar macrophage 
phagocytosis 22. 
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Materials and Methods 
 
Mycobacteria cultures 
Mycobacterium tuberculosis strain H37Rv and Mycobacterium bovis BCG were 
cultured in 7H9 medium supplemented with 10% oleic acid albumin dextrose 
catalase and 0.05% tyloxapol. All manipulations of M. tuberculosis were performed in 
a Biosafety Level 3 environment. 
Mycobacterium smegmatis (mc2 155) was grown in liquid culture medium containing 
4,7g/l Middlebrook 7H9 broth and 5g/l Nutrient broth (Difco), supplemented with 
0.05% tyloxapol and 0.5% glucose.  
Each of these species of mycobacteria harbors a plasmid constitutively expressing 
Green Fluorescent Protein (GFP) and a hygromicin resistance as a selection marker. 
The culture medium contained 50 µg/ml hygromycin B (Sigma-Aldrich) in order to 
maintain selective pressure on the plasmid carriers.  
All cultures were kept at 37°C and were subcultured until achieving exponential 
phase before being used on experiments: 7-10 days beforehand for M. tuberculosis 
and M. bovis BCG, but only overnight for the fast-growing M. smegmatis. 
 
Cell cultures 
The murine macrophage cell line J774A.1 (ATCC TIB-67TM), referred to as ‘J774’, 
was cultured in Dulbecco’s Modified Eagle Medium (DMEM, Gibco) supplemented 
with 10% (v/v) fetal bovine serum (FBS), 1% (v/v) glutamine and 1% antibiotic – 
penicillin-streptomycin (v/v).  
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The human monocyte cell line THP-1 (ATCC TIB-202) was cultured in RPMI 1640 
RPMI media 1640 (Gibco) supplemented with 10% (v/v) Foetal Bovine Serum 
(Gibco), 1% (v/v) Pyruvate (Gibco), 1% (v/v) L-Glutamine (Gibco), 1% (v/v) Non-
essential aminoacids (Gibco), 1% (v/v) Hepes buffer (Gibco).. 
The formulations described above are also referred to as ‘complete’ DMEM or RPMI 
media. If antibiotic is not included, they are referred to as ‘infection’ media. 
Primary human monocyte-derived macrophages were obtained from blood from 
donors. Monocytes were first isolated according to the protocol from Miltenyi Biotec, 
using the MidiMACS kit and LS columns. For the differentiation of monocytes into 
macrophages, 300,000 cells were seeded on a 24-well plate with 300 µl RPMI 
medium per well and allowed to adhere to the plate bottom. After 2 hours, 300 µl of 
RPMI with 20% (v/v) FBS, 2% (v/v) penicillin-streptomycin, 2% (v/v) sodium 
pyruvate, 2% (v/v) β-mercaptoethanol and 0.6 µl of macrophage colony stimulating 
factor (M-CSF 1000x) for a final concentration of 20 ng/ml in each well. After 
approximately 72 hours 600 µl of complete RPMI containing 20 ng/ml M-CSF were 
added. At the seventh day the macrophages were collected via resuspension with a 
trypsin-EDTA solution and were ready to be plated for the infection experiments. 
The HEK 293T cell line (ATCC CRL-11268) was used to amplify the viral constructs 
of the lentiviral knockdown libraries. They were maintained in DMEM supplemented 
with 10% (v/v) fetal bovine serum and 1% (v/v) antibiotic – penicillin-streptomycin.  
All of the above were cultivated at 37°C in an atmosphere containing 5% carbon 
dioxide. 
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Infection protocol 
 
Preparation of macrophages 
Cells were seeded onto 24 or 12-well plates (approximately 500,000 cells per well) 
with the appropriate culture medium (complete DMEM or RPMI). THP-1 cells were 
plated for 24 hours in contact with 20 nM phorbol 12-myristate 13-acetate (PMA, 
Sigma-Aldrich), which differentiates the monocytes into macrophages, followed by 
24 hours of resting in complete culture medium without PMA. J774 macrophages 
were plated 24 hours in advance at half the desired concentration, so that they would 
multiply to the intended final concentration on the day of the experiment.  
 
Preparation of bacteria 
Disassembly of bacterial aggregates is necessary as large clumps may have a 
strong influence on phagocytosis. The steps involved are: washing with Phosphate 
Buffered Saline (PBS) at 1x concentration; resuspension in infection medium (DMEM 
or RPMI medium according to the cells to be infected); passaging several times with 
a 5ml syringe and a 21 gauge needle; a 5-minute ultrasound bath followed by a short 
centrifugation at a low force: 1 minute, 300xg to pellet any remaining aggregates. 
After the last centrifugation, only the supernatant was collected. 
By reading the optical density at 600 nanometers, bacterial suspensions were 
adjusted for concentrations corresponding to multiplicities of infection (MOI) of 1, 10 
and 100 bacteria per macrophage. This calculation was based on the standard 
relationship between optical density (OD) and concentration of bacteria (OD 0.1 <=> 
1*107 bacteria/ml) 
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Infection 
The contact between macrophages and bacteria was initiated by removing the cell 
culture medium and replacing it with the bacterial suspension in infection medium. 
To achieve the three different lengths of infection, the samples were infected at 
different times, so that afterwards they could all be stopped and processed at the 
same time. Considering the stopping time of the infection as the “time point –zero”, 
samples were infected at –4 hours, –1 hour and –30 minutes. Between 
manipulations, samples were incubated at 37°C in an atmosphere containing 5% 
CO2. 
 
Processing samples after infection 
While remaining adhered to the plate, the cells were washed three times with warm 
PBS, thus removing the mycobacteria. Cells were then dislodged using 400 µl 
trypsin with a 5-minute incubation at 37°C. Afterwards the cells were resuspended in 
1 ml of infection (antibiotic-free) DMEM or RPMI medium to neutralize the proteolytic 
action of trypsin. This was followed by centrifugation for 10 minutes at 450xg. 
Fixation was then performed with 4% paraformaldehyde, for 30 minutes at room 
temperature, and the samples were then finally washed and resuspended twice in 
PBS with 1% fetal bovine serum and kept at 4°C until they were used for flow 
cytometry. 
 
Alternate protocol for screening of knockdown cells 
The experiments regarding protein knockdown were restricted to the time point of 1 
hour and the MOI of 10 mycobacteria per macrophage. This was necessary to 
accommodate the large number of samples – 181. The values were chosen because 
they present a more moderate burden on the macrophages and at the same time 
allow for more expressive differences across all cell types. 
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The experimental handling itself differs from the previous sections in that it was 
performed on 96-well microplates in proportionally smaller volumes. The infection 
and post-infection protocols were otherwise identical to those described before. 
 
Confirming the absence of extracellular bacteria 
Extracellular bacteria adherent to the macrophage, but not internalized, can 
compromise the readings of flow cytometry. To determine whether the post-infection 
protocol was effective in separating bacteria from the macrophages, a parallel 
experiment was conducted. Wild-type J774 macrophages were first plated in two 
different conditions: either onto glass coverslips placed on the plate wells (group A) 
or onto the plate wells’ bottom (group B). Both samples were infected with M. 
smegmatis with a MOI of 100 for 1 hour. Group B was subjected to the entire post-
infection protocol, while group A was not. All samples were stained with 25 µg/ml of 
ethidium bromide at the end of the infection. Extracellular mycobacteria stained red, 
while internalized mycobacteria emitted only green fluorescence from GFP. 
Samples were placed on microscope slides and observed under a Zeiss Axioskop 40 
fluorescence microscope (Göttingen, Germany) using a FITC filter. Besides 
qualitative observations of the relative abundance of red mycobacteria around the 
macrophages, quantification was also made: from a random sampling, we 
determined the percentage of macrophages with neighboring red mycobacteria. 
 
Production of Lentiviral particles 
Lentivirus vector library was obtained from the RNAi Consortium in partnership with 
Professor Luís Moita from the Institute of Molecular Medicine (Lisbon, Portugal), 
contained hits from a previous screen performed in our laboratory, whereby 
knockdowns of several membrane-associated proteins were shown to affect 
intracellular survival of mycobacteria in macrophages (see previous chapter).  
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Lentiviruses were contained in 96-well microplates with plKO.1 plasmids which 
coded for a different short specific RNA hairpin, lentiviral proteins and the resistance 
to puromycin as a selection marker. Each hairpin has a specific target on the host’s 
messenger RNA. 
The plasmids contained in the library were transfected into Escherichia.coli via 
electroporation. After overnight growth at 37°C with mixing (220 revolutions per 
minute), the DNA was extracted, in plasmid form, from the bacteria, using a PureLink 
Quick Plasmid Miniprep Kit and its respective protocol (Invitrogen). 
The DNA was then quantified using picoGreen, a fluorescent nucleic acid stain, and 
its corresponding protocol (Life Technologies). The plasmids were co-transfected 
onto HEK 293T cells together with additional lentiviral proteins. These provide the 
necessary materials for the assembly of mature viral particles. The HEK 293T cells 
then began producing these particles containing the desired DNA construct, whilst 
being selected for transfection via the addition of 5 µg/ml puromycin to the growth 
medium. 
After 24 hours, the virus particles were passage into DMEM containing 30% fetal 
bovine serum and collected 24 hours later. These virus particles were used to infect 
wild-type THP-1 monocytes, on a 96-well microplate. The monocytes were 
maintained in culture medium with 5 µg/ml puromycin and passaged or split into new 
microplates to obtain larger numbers of cells with a stable knockout. 
Before infection, THP-1 cells were counted, normalized and plated on a fresh 96-well 
microplate at a concentration of 375 000 cells/ml. 
The negative controls for the protein knockdowns were infected with viruses that 
contained an RNA hairpin with no target in the human genome, meaning that it 
would not bind to any messenger RNA of the host cell nor silence protein production. 
These hairpins contain a scrambled sequence and are called shScramble. 
130 
Quantification of internalization by flow cytometry 
Samples were read on a Milipore EasyCyte H6 Guava flow cytometer, using its 
proprietary InCyte software, as well as the freeware Flowing Software (Turku Centre 
for Biotechnology, Finland). Fluorescence was measured using the excitation and 
emission wavelengths of 488 and 525 nanometers with a 75 miliwatt blue laser. The 
macrophage population was gated based on forward and side scatter values, in such 
a way that extracellular bacteria and debris were excluded from the event count. 
5000 events from inside that gate were acquired with an average rate of 260 events 
per second.  
The mycobacteria constitutively expressed Green Fluorescent Protein, while the 
macrophages did not, and so internalization was measured by quantifying the 
percentage of total macrophages that emitted intense green fluorescence. 
Uninfected macrophage samples were used as negative controls to calibrate the 
readings of green fluorescence intensity for each experiment. 
Using the values from different time points, the kinetics of internalization were 
determined and plotted using a custom function in R software. Data points were 
connected to create a growth-like profile for the internalization rates, which include 
the average values as well as the standard deviation for each data point. All 
experiments were performed in triplicate. 
 
Statistical treatment 
The software SigmaPlot 12.0 (Systat Software Inc.) was used for statistical analysis. 
Three-way ANOVAs were performed to evaluate the global differences in 
internalization between different macrophages and different bacteria by taking into 
account the variables of time and MOI. Pairwise differences between types of 
macrophages and types of mycobacteria were evaluated using the Holm-Sidak 
method. Differences were considered significant for p<0.05. 
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Labelling hits in the knockdown screen 
To evaluate whether the effect of knocking down the selected proteins was relevant 
for internalization, a criterion had to be fulfilled: two or more hairpins silencing each 
protein had to cause a difference in internalization of at least 2.5 times the standard 
deviation of the controls.  
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Micro RNA mir-142-3p is modulated by Mycobacterium 
tuberculosis and its partner, N-WASP, is involved in the 
internalization of the bacilli. 
 
Abstract 
 
Micro RNAs (miRs) are involved in the post-transcriptional repression of the target 
protein mRNAs. Recently our laboratory has shown that miR-142-3p is induced upon 
macrophage infection by mycobacteria. A gain-of-function by increase the amount of 
miR-142-3p led to a reduction in N-Wasp protein and, consequently to a reduced 
internalization of mycobacteria by murine macrophages. Likewise, virulent 
Mycobacterium tuberculosis induced miR-142-3p expression and decreased N-Wasp 
in monocyte derived human macrophages (MDHM). In this study we show that miR-
142-3p induction and consequent N-Wasp reduction of protein amount in MDHM is 
specifically induced by virulent M. tuberculosis but not by the non-pathogenic 
species Mycobacterium smegmatis or by latex beads. Furthermore, reduction of N-
Wasp by RNAi induced a decrease of M. tuberculosis internalization in MDHM.  
 
Introduction 
 
Tuberculosis (TB) is still a global public health problem being responsible for more 
than 1,3 million deaths every year. The success of Mycobacterium tuberculosis (M. 
tuberculosis), the etiologic agent of TB, relies on the capacity to replicate within host 
cells responsible for clearance of invading organisms: the macrophage. In order to 
establish its intracellular niche M. tuberculosis subverts macrophage’s microbicidal 
factors by modulating its route of internalization, inhibiting the phagolysosome 
formation while keeping the macrophage from displaying a proper inflammatory 
response1.  
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A central feature to M. tuberculosis strategy is the manipulation of actin's fate within 
macrophage such that it favours bacterial survival. M. tuberculosis is able to disrupt 
the  macrophage actin network2. Actin polymerization has been observed in 
phagosomes containing latex beads or mycobacteria and facilitates maturing 
phagosomes with lysosomes leading to the killing of mycobacteria 3–5. Several 
signalling lipids, cAMP, extracellular ATP and the P2X7 receptor, were shown to be 
involved in actin assembly and the killing/survival of pathogenic mycobacteria6–10. In 
addition, actin assembly is involved in the pro-inflammatory response. Disruption of 
actin cytoskeleton leads to NF-kB translocation, a transcription factor involved in the 
pro-inflammatory response 11. Moreover, some lipid effectors that regulate actin 
assembly also control NF-κB12. Actin may also be involved in cytokine secretion 
once been observed that TNFα containing vesicles are delivered to the actin-rich 
phagocytic cup before secretion13. 
MicroRNAs (miRs) are post-transcriptional factors, with 20-22 nucleotides, that 
regulate translation of the mRNA of determined proteins. After being released to the 
cytoplasm, these molecules can bind to complementary proteins mRNA inducing 
their silencing by inhibiting ribosomal translation or by mRNA destruction, reducing 
protein genetic expression and thereby their function. A growing body of evidence 
suggest a broad involvement of miRs in M. tuberculosis infection and highlighted 
their potential in diagnosis, treatment and understanding TB14–16. 
In order to identify potential miRs involved in mycobacteria infection, our laboratory 
performed a global transcriptomic analysis to assess the modulation of miRs upon 
M. smegmatis infection of the murine macrophage cell line, J774A.1. This approach 
identified miR-142-3p as a potential candidate being modulated during M. smegmatis 
infection. Expression of miR-142-3p was up regulated in murine macrophages upon 
mycobacteria infection. Moreover, it was found that N-Wasp mRNA, was targeted by 
miR-142-3p leading to a decrease in N-Wasp protein in macrophage s. N-Wasp is 
involved in signal transduction from receptors on the cell surface, leading to the 
promotion of F-actin polymerization, via the Arp2/3 complex and is involved in 
macrophage phagocytosis 17. In this work we further analyse the expression of miR-
142-3p and N-Wasp regulation by M. tuberculosis in monocyte derived human 
macrophages (MDHM). Our results confirms that in MDHM as well in the murine 
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model, a decrease in N-Wasp modulated by miR-142-3p leads to a specific reduction 
in M. tuberculosis internalization. However, in MDHM both miR-142-3p induction and 
internalization reduction were specifically induced by pathogenic M. tuberculosis but 
not by avirulent mycobacteria or latex beads.   
 
Results 
 
M. tuberculosis modulates miR-142-3p expression levels in human 
macrophages 
 
Human macrophages were exposed to latex beads as an inert stimulus, since they 
can be internalized by these cells without subverting the phagocytic pathway. In 
parallel and addiction they were challenged with either M. smegmatis or M. 
tuberculosis. The miR-142-3p expression was quantified by qPCR analysis in all 
conditions tested. Our results indicate that while M. tuberculosis infection of human 
macrophages specifically induces the expression of miR-142-3p in the first hour of 
infection, the challenge with M. smegmatis or with latex beads failed to do so (Figure 
5.1a). 
Our results show that pathogenic M. tuberculosis modulation of miR-142-3p in 
human macrophages modulates its internalization when compared to latex beads or 
avirulent M. smegmatis. MiR-142-3p is highly conserved across species18. Our 
findings in the murine model suggest that M. tuberculosis induces the timely 
expression of miR-142-3p in order to down-modulate the function of N-Wasp protein, 
and therefore, modulate the uptake by phagocytic cells. Given the M. tuberculosis is 
the etiological agent of TB in humans, and that human macrophages are the main 
reservoir for this intracellular pathogen, here we used primary human monocyte-
derived macrophages in order to investigate whether the expression of miR-142-3p 
leads to a subsequent reduction of N-Wasp and alter the rates of phagocytosis. 
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a) 
b) 
Next, we measured whether the difference in miR-142-3p expression obtained from 
the challenge with each mycobacterial species at 1 hpi is sustained throughout 
infection. Indeed, we observed that it became more pronounced at 4 hpi, with an 
eventual decline at 24 hpi, but remaining always above the expression level of non-
infected cells (Figure 5.1b).  
 
Figure 5.1. Relative expression of miR-142-3p in MDHM. a) Under M. smegmatis, M. tuberculosis 
or latex beads, exposure (1 h) of macrophages, as measured by qPCR analysis. b) Relative 
expression of miR-142-3p in human macrophages infected with M.smegmatis or M. tuberculosis as 
the indicated time points, as measured by EXIQON (DK) microRNA qPCR services. The data are 
representative of two independent experiments done in triplicates ± SD (*P = 0.05; ***P = 0.01). 
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M. tuberculosis modulates N-Wasp expression levels in human macrophages 
 
Coincidently, the protein levels of N-Wasp were slightly, but significantly reduced 
(~20%) at both 1 and 4 h upon M. tuberculosis infection, while remaining unaffected 
by the challenge with M. smegmatis or exposure to latex beads (Figure 5.2). These 
results, along with previous findings in the mouse model, prompted us to examine 
whether the decrease in N-Wasp expression had any functional consequence for the 
phagocytosis process of M. tuberculosis. N-Wasp is involved in transduction of 
signals from receptors on the cell surface to the actin cytoskeleton and is involved in 
macrophage phagocytosis. In order to identify the potential role of N-Wasp we 
hypothesised whether N-Wasp was involved in the internalization of M. tuberculosis 
by MDHM. 
 
 
Figure 5.2. N-WASP is downregulated in M. tuberculosis infected primary human 
macrophages. Relative protein levels by western blot analysis. N-Wasp levels relative to β-Tubulin 
either at 1 h post-infection with 20% reduction (a) or 4 h post-infection with 40% reduction (b). A 
representative blot (c and d) from three independent experiments is shown with densitometry 
quantiﬁcation for each time point; data are represented as the mean fold change per sample ± SD (*P 
= 0.05). 
 
a) b) 
c) d) 
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Figure 5.3. N-Wasp knockdown reduces M. tuberculosis internalization in human primary 
macrophages.siRNA-mediated inactivation of N-Wasp (WASL) was performed as described in 
materials and methods. Transfection of the siRNA SMARTpool targeting N-Wasp (si-WASL) resulted 
in an average of about 54% reduction of the protein level relative to that of the transfection with a non-
targeting control siRNA pool (si-CTL; a). A representative western blot analysis (b) illustrates the gene 
inactivation obtained from four independent experiments (c); data are represented as the mean fold 
change relative to control sample (set arbitrarily at 1) ± SD (**P ≤ 0.01). phagocytosis of H37Rv-
eGFP by human macrophages either inactivated for N-Wasp (si-WASL, gray) or transfected with the 
non-targeting siRNA pool (si-CLT, black), was analysed either by ﬂow cytometry (histogram) analysis 
at MOI 10 (c), or by CFU (inlet) assay at MOI 0.1, after 4 h of infection (d). Red indicates the 
ﬂuorescence background of non-infected macrophages. The median ﬂuorescence intensities (MFI) 
are as follow: 36 (non-infected), 117 (si-WASL) and 189 (si-CTL). Right: H37Rv-eGFP proliferation as 
measured by CFU analysis for different time points (days) for the same cellular conditions and donor 
as described for left panel. The data are representative of two independent experiments done in 
triplicates ± SD (*P = 0.05; **P = 0.01). 
 
 
a
)
b
)
c
)
d
)
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To accomplish this, we used a siRNA-based protocol that we have adapted and 
improved to effectively inactivate the gene expression in MDHM19. Using this 
protocol, we obtained a significant reduction (on average ~54%) of N-Wasp protein 
levels in human macrophages (Figure 5.3 a and b). This partial reduction of N-Wasp 
protein resulted in a decrease of M. tuberculosis uptake as measured either by flow 
cytometry (Figure 5.3b), or by CFU assays at 4 hpi (Figure 5.3c,); this pattern 
continued over a time course of 1 week (Figure 30d). Altogether, these results 
suggest that the modulation of N-Wasp function via miR-142-3p might contribute to 
the phagocytosis process of M. tuberculosis in human cells. 
 
Discussion 
 
The regulation of N-Wasp activity is important for host-pathogen interactions, since 
this protein is known to be involved in actin dynamics required during the invasion of 
host cells by several pathogens. For instance, salmonella induces actin assembly via 
N-Wasp and therefore bacteria uptake by non-professional phagocytes through a 
type III secretion system 20. Additional examples include the actin filament assembly 
and regulation associated with the establishment of actin pedestals during 
enteropathogenic E. coli EPEC 21 and Vaccinia virus invasion 22, and the actin tail-
propulsion based invasion of host cells by shigella 23 and listeria 24. More relevant for 
our study, actin tail based movement dependent on N-Wasp during mycobacteria 
infection was also described for Mycobacterium marinum, a close relative of M. 
tuberculosis 25,26. Finally, knock-out of N-Wasp was associated with a defective 
immune response to M. bovis BCG 27. Our findings strongly suggest that effective 
modulation of N-Wasp activity via miR-142-3p can influence the rate of bacterial 
intake by macrophages, and to our knowledge, this is the first description of a 
microbial strategy employing the use of miRs to regulate actin-mediated events that 
potentially leads to phagolysosome biogenesis. The central role of N-Wasp in this 
process is indeed supported by the case of Yersinia pseudotuberculosis, which 
modulates the activity of N-Wasp to control its internalization in host cells 28. 
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The present study proposes a novel but general strategy in the context of 
mycobacteria infection is the role of miRs in modulating mycobacterial uptake by 
phagocytic cells, revealed by the partial and temporal inhibition of N-Wasp activity 
via miR-142-3p. Collectively, throughout this project we demonstrated that: (1) 
mycobacteria infection of macrophages results in a short-lived induction of miR-142-
3p, and in the case of M. tuberculosis, accompanied by a partial decrease of N-
Wasp protein levels (2) N-Wasp mRNA (Wasl) is a direct target for miR-142-3p, (3) 
miR-142-3p leads to a significant decrease of intracellular mycobacteria intake by 
macrophages, and (4) the siRNA-mediated inactivation of N-Wasp in human M s 
affects the initial rate of phagocytosis of M. tuberculosis.  
Moreover, recent reports show a broader implication of miR-142-3p in mycobacterial 
infection. Xu and co-workers shown that during infection of murine macrophage by 
Bacillus Calmette-Guérin (BCG), miR-142-3p is also down regulated. They 
demonstrate that miR-142-3p post-transcriptionally down-regulation of IRAK-1 
protein expression. This reduction leads to a decrease in pro-inflammatory mediators 
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), tumour 
necrosis factor alpha (TNF-α) and interleukin (IL)-6 in macrophages. These findings 
show the ability of mycobacteria in the reduction of macrophage pro-inflammatory 
response through miR-142-3p 29. Furthermore, TB patients with active disease show 
a decrease expression of miR-142-3p in CD4+ cells as well as in blood cells of 
children with both active and latent TB infection, which may represent that M. 
tuberculosis miR-142-3p subversion to be systematic in TB and not just in the 
macrophage. The decreased expression of miR-142-3p in latent TB infection 
highlights this miR as a potential candidate for diagnose latent TB. 
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Material and Methods 
 
Cell preparation, cell lines and bacterial culture conditions 
 
The human monocyte derived macrophages were obtained from healthy blood 
donors (Instituto Português do Sangue, Lisbon, Portugal), and differentiated 
following a previously published procedure30. A protocol of collaboration was 
established between Drs. Anes and Castro (the head of the Portuguese Institute for 
Blood in 2007), in order to have access to buffy coats from blood donors for scientific 
research. Alternatively, monocytes were obtained from healthy blood donors 
Etablissement Français du Sang (EFS) in Toulouse, France. Written informed 
consents were obtained from the donors under EFS contract 
n°21/PVNT/TOU/IPBS01/2009-0052. Following articles L1243-4 and R1243-61 of 
the French Public Health Code, the contract was approved by the French Ministry of 
Science and Technology (agreement nuAC 2009-921). The monocytes were 
differentiated into M s following a previously published protocol 31. 
The strain Mycobacterium smegmatis mc2155, containing a p19 (long lived) EGFP 
plasmid was kindly provided by Dr. Douglas Young (London School of Hygiene and 
Tropical Medicine, London, UK), and the green fluorescent protein (GFP)-expressing 
strain of M. tuberculosis (H37Rv-pEGFP) plasmid was a kind gift from G. R. Stewart 
(University of Surrey, United Kingdom). Msmeg was grown in medium containing 
Middlebrook's 7H9 broth Medium (Difco, USA), Nutrient broth (Difco, USA) 
supplemented with 0.5% glucose and 0.05% Tween 80 at 37°C on a shaker at 200 
r.p.m.3. Bacteria were sub-cultured every day in fresh medium before use. M. 
tuberculosis H37Rv was grown in Middlebrook's 7H9 medium (Difco) and 
supplemented with 10% OADC Enrichment (Oleic acid; Albumin Factor V, Bovine; 
Dextrose; Catalase Powder; Sodium Chloride) (Difco, USA) 3. All manipulations of M. 
tuberculosis were performed in a Biosafety Level 3 environment. 
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MicroRNA expression 
 
Total RNA was isolated using TRIzol reagent (Invitrogen, Paisley, Scotland) 
according to the manufacturer's instructions. RNA quality was controlled using the 
RNA 6000 Pico LabChip kit (Agilent, Waldbronn, Germany) and quantified with a 
NanoDrop ND-1000 Spectrophotometer (Nanodrop Technologies, Wilmington, DE, 
USA). Microarray results were submitted to GEO repository with the GEO accession 
number GSE23429. 
 
RT-qPCR 
 
Messenger RNA relative quantification started with 1 μg of total RNA that was used 
for random hexamer primed cDNA synthesis (SuperscriptTM II reverse transcriptase, 
Invitrogen) according to the manufacturer protocol. Amplification was detected using 
SYBR Green PCR master mix (Applied Biosystems) and different sets of primers 
(MWG) at a final concentration of 0.5 μM. The PCR settings used: 1 cycle of 95°C for 
10 min, followed by 40 cycles of 95°C for 15 s, 60°C for 30 s, and 72°C for 30 s. The 
mRNA expression profiles were normalized with respect to GAPDH (Glyceraldehyde 
3-phosphate dehydrogenase). The qPCR was performed using an ABI 7500 Real 
Time PCR System (Applied Biosystems) and data was collected at the amplification 
step and analysed with SDS v1.2. Software. Fold increase of each gene was 
calculated using the −2−ΔΔCt method. 
The specific relattive quantification of miR-142-3p in total RNA samples was based 
on TaqMan MicroRNA Assays from Applied Biosystems (ABI) in our laboratory or by 
final report analysis provided by EXIQON (DK) microRNA qPCR services. Briefly, 10 
ng of total RNA were used for cDNA synthesis, according to the manufacturer 
protocol. The qPCR was run with the following steps: 1 cycle of 95°C for 10 min, 
followed by 40 cycles of 95°C for 15 s, and 60°C for 15 s, without dissociation stage. 
The miR expression profiles were normalized either to reference gene U6 (snRNA) 
or to the average obtained between miR-23a, miR-23b, and miR-24, whose 
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expression levels are suitable under the experimental conditions applied in this 
study. The mean and standard deviation over all the median normalized intensity 
data obtained from the microarray was calculated. The data was filtered so that the 
mean expression of the median normalized intensity value is high (higher than 10), 
and that the standard deviation is low (15 % of the mean). 
 
Western blot 
 
Cells plated in 24-well plates, under different conditions, were washed twice with 
PBS, and harvested in 250 μl of ice-cold, non-denaturating lysis buffer (TRIS 50 mM, 
NaCl 150 mM, Triton 1%, EDTA 1 mM, Protease Inhibitor Cocktail Tablets from 
Roche, Mannheim, Germany). Lysates were collected after 30 min of incubation and 
spun down for 5 min at 12000 ×g, to remove debris of broken cells. The supernatant 
was collected and the protein concentration was measured using Bradford method. 
Approximately 20 μg of protein extracts were subjected to electrophoresis in 10% 
SDS-PAGE gels, transferred to a nitrocellulose membrane and blocked with 0.1% 
Tween20, 5% of low fat milk Tris Buffered Saline (TBS). For the confirmation of 
siRNA-mediated inactivation of N-Wasp, total protein lysates were extracted in the 
same manner as above. Proteins were separated with 4–12% Bis-Tris Gel 
(Invitrogen), transferred onto nitrocellulose membranes and incubated with anti-N-
WASP (H100, Santa Cruz Biotechnology, 1/200), anti-actin (A5060, Sigma-Aldrich, 
1/10000) overnight at 4°C. All membranes were washed and incubated with 
secondary HRP-conjugated antibodies. The bands were visualized with a 
chemiluminiscence reagent (Amersham Biosciences, UK) and quantified using 
Adobe Photoshop CS3 software. 
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SiRNA-mediated gene silencing 
 
Human M s were transfected with the siRNA (final concentration of 133 nM) using 
the Hiperfect transfection reagent according to the protocol we have developed and 
optimized19. This siRNA targeted the following human genes (all SMARTpool from 
Dharmacon): WASL and a non-targeting/scramble. This protocol resulted in a 
transfection efficiency of nearly 100% and a survival rate ranging no less than 85%, 
as determined by flow cytometry of cell transfected with siGLO RISC-free siRNA 
(Dharmacon) and the Anexin-V kit (Miltenyi Biotec). Upon 6 h of transfection with 
these siRNAs, the reaction was stop by adding medium with the presence of MCSF 
(10 ng/ml) (Miltenyi Biotec). After 96 h, MDMs were used for experiments. The gene 
silencing effect lasted up to 7 days with no significant toxicity to MDMs. Functional 
gene silencing was verified by western blot analysis as described above. 
 
Statistical analysis 
 
Data are presented as mean either ± SD or ± SEM of at least three independent 
experiments; p-values (Student's T-Test) are relative to the control. Statistical 
significance was assumed when P < 0.05. 
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The role of Rab GTPases in exosome secretion 
 
Abstract 
 
Exosomes are secreted membrane vesicles that share structural and biochemical 
characteristics with intraluminal vesicles of multivesicular endosomes (MVEs). 
Exosomes are secreted by several cell types and could be involved in intercellular 
communication and in the pathogenesis of infectious and degenerative diseases. 
The molecular mechanisms of exosome biogenesis and secretion are, however, 
poorly understood. Using a genomic screen RNA interference screen, we identified 5 
small GTPases of the Rab family that promote exosome secretion in HeLa cells, 
including Rab27a and Rab27b. 
 
Introduction 
 
Exosome are small membrane vesicles (50-100nm) secreted by most types of cells1. 
Although, exosomes display a common protein composition, mostly including 
proteins from the endocytic system, the plasma membrane and cytosol, specific cells 
have a specific set of proteins2.  
Exosomes are secreted by most cell types and have been implicated in cell-to-cell 
communication3 . They have been implicated in important immune responses4. For 
example, exosomes secreted by antigen presenting cells bears MHC class I and II, 
which can be directly recognized by activated CD4+ and CD8+ T cells. Exosomes 
from mice or cultured macrophages infected with mycobacteria contain several host 
proteins and pathogen antigens that induce a pro-inflammatory response in naïve 
macrophages and activate antigen-specific CD4+ and CD8+ T Cells in vitro and in 
vivo5–7. 
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Evidence collected during the last 20 years suggests that in most cell types, 
exosomes correspond to secreted intraluminal vesicles (ILVs) of MVEs8. ILVs are 
formed by inward budding of the limiting membrane of MVEs into the lumen of these 
endosomes9. The observation by electron microscopy (EM) of fusion profiles 
between MVEs and the plasma membrane, with the consequent release of ILVs as 
exosomes, has been to date the strongest evidence of the endosomal origin of 
exosomes10–12. Nevertheless, in some cell types, such as T-lymphocytes, exosomes 
bud at the plasma-membrane from endosome-like domains13. Therefore, 
identification of the molecular machinery responsible for the control of the 
intracellular trafficking of MVEs and their fusion with the plasma membrane is of 
crucial importance for understanding key aspects of exosome secretion. 
Since members of the Rab family of GTPases functionally participate in different 
steps of intracellular membrane trafficking, both along the endocytic and the 
secretory pathways, we analysed here the roles that the different Rab proteins could 
specifically play in exosome production or secretion, using the human HeLa cell line. 
To this end, a shRNA-based screen targeting human Rabs was performed. We 
observed that knocking-down five Rab proteins (Rab2b, Rab9a, Rab5a, Rab27a and 
Rab27b) inhibited exosome secretion without major modifications in the secretion of 
soluble proteins through the regular secretory pathway. 
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Results 
 
Semiquantitative detection of exosomes in cell culture supernatants 
 
To allow large-scale screening of molecules specifically involved in exosome 
secretion, we developed a quantitative FACS-based assay allowing simultaneous 
detection of exosomes and of proteins secreted through the classical secretory 
pathway, in small volumes of cell culture supernatants. The HeLa B6H4 tumour cell 
line, which stably expresses the transactivator CIITA (which drives expression of all 
genes of the MHC class II family, including HLA-DR) and a secreted form of chicken 
ovalbumin (OVA), was used for this assay. These cells secrete soluble OVA through 
the classical secretory pathway, and HLA-DR-positive exosomes: these two 
molecules can thus be used as reporters of alterations of either type of secretion. 
Briefly, exosomes present in cleared cell culture supernatants were captured onto 
latex beads coated with antibodies to CD63, a tetraspanin strongly enriched in late 
endosomes and exosomes. Exosome-bearing beads were analysed by FACS after 
staining with either anti-HLA-DR and anti-CD81 fluorescent antibodies (CD81 is 
another tetraspanin abundant on exosomes)11,14, or Annexin V (which binds to the 
phosphatidyl-serine (PS) present at the surface of exosomes)15(Figure 6.1A). 
Membrane vesicles with a diameter ranging from 50 to 100 nm and with the typical 
cup-shaped morphology of exosomes were detected by electron microscopy (EM) on 
the surface of the beads (Figure 6.1B). As expected, exosome detection was 
dependent on the number of exosome-secreting cells present in the wells (Figure 
6.1C, D), with a threshold of sensitivity of 75,000 cells/well. To assess the specificity 
of this assay for exosomes, as opposed to other secreted membrane vesicles 
originating from the plasma membrane, supernatants from apoptotic cells (which are 
known to secrete abundant apoptotic blebs) were tested. The FACS signals obtained 
with these supernatants were significantly lower than those obtained using 
supernatants from living cells (Figure 6.1E). We conclude that this assay allows the 
specific detection of a population of CD63/HLA-DR/PS-positive membrane vesicles 
produced by living cells, corresponding to exosomes. 
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Figure 6.1. 
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Figure 6.1. Semi-quantitative detection of exosomes in cell culture supernatants. (continued). 
(A) Schematic drawing of the technical approach used to selectively capture and stain exosomes 
present in cell culture supernatants by using anti-CD63-coated beads and FACS detection. (B) EM 
image of exosomes present on the surface of anti-CD63-coated beads after incubation with 
supernatant from B6H4 cells. (C) Representative flow cytometry dot-plots showing HLA-DR/CD81 
(top) and Annexin V (bottom) stainings of exosomes captured by beads incubated with supernatants 
from increasing numbers of cultured cells. Percent of positive beads are indicated inside the positive 
region. (D) Dose-response curve of HLADR/CD81 (left) and Annexin V (right) staining of exosomes 
captured by beads incubated with 66 different supernatants. (E) Specific detection of exosomes 
secreted by live cells, as compared to membranes secreted by apoptotic cells. A total of 50,000 cells 
either UVirradiated or untreated were seeded in a 96-wells plate. After 12h incubation, exosome 
depleted-medium was added and 24h later supernatants were incubated with anti-CD63-coated 
beads and analysed by FACS. 
 
 
Soluble OVA in cell culture supernatants was detected using beads coated with anti-
OVA antibodies and subsequently stained with a secondary anti-OVA fluorescent 
antibody (data not shown). This methodology allowed the quantitative detection of 
OVA, with a sensitivity of 30,000 cells/well. The detection of OVA in the supernatants 
of cells in which apoptosis was induced by UV-irradiation was significantly lower, as 
compared to live cells. Altogether, these assays allow the simultaneous 
quantification of both exosomes and OVA in very small volumes of culture 
supernatants collected from 96-well plates. 
 
Role played by members of the Rab GTPase family in exosome secretion 
 
In order to identify proteins involved in exosome secretion, a lentiviral shRNA library 
targeting 59 members of the Rab GTPase family was screened using the 
methodology described above as readout. Variability of the signals for exosome and 
OVA secretion obtained in control cells expressing a scrambled shRNA were below 
20%, as shown in Figure 6.2A. Candidate genes that induced a significant 
modification in the secretion of exosomes but not in the secretion of OVA were 
selected if at least two different shRNAs (out of the three to five that target each 
individual gene) induced a similar phenotype. 
Some examples of Rab proteins that were not considered as hits in the screen 
because did not fulfil the selection criteria are shown in Figure 6.2B. For instance, 
silencing of a Rab associated with the secretory pathway, Rab6a (Golgi) inhibited the 
secretion of OVA but did not affect exosome secretion. In contrast, inhibition of two 
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endocytic Rabs, Rab7 (late endosome) or Rab11a (recycling endosome), modified 
neither exosome nor OVA secretion significantly. Following the primary screen, 
19Rab proteins that modified exosome production were selected. These candidates 
were re-evaluated in a second round of the screen performed in independent 
triplicate plates. The Rab proteins that yielded consistent results between replicates 
and between the two independent screens were chosen for a final confirmation step.  
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Figure 6.2. Modulation of exosome and OVA secretion by members of the Rab family. 
(continued). (A) Exosome secretion measured as HLA-DR/CD81 staining (Exo, black bars) and OVA 
secretion (white bars) by cells transduced with a control shRNA. Mean±sd of 3 experiments (in each 
experiment, 100% = mean of 3 independent control wells). (B) Exosome and OVA secretion and 
specific mRNA levels of cells transduced with different shRNAs (each bar represents a different 
shRNA) targeting Rab proteins that were not selected as hits in the screen, either because neither 
exosome nor OVA secretion were modified (Rab7, Rab11a) or because only OVA secretion was 
inhibited (Rab6a). Pooled results from duplicate plates in one experiment are shown. (C) Exosome 
and OVA secretion, and specific mRNA levels in cells transduced with shRNAs targeting Rab family 
members that were selected as candidate hits because at least 2 shRNAs significantly affected 
exosome without affecting OVA secretion. Pooled results from duplicate experiments (2-3 plates / 
experiment) are shown. (D) Exosome secretion by control and by either Rab27a or Rab27b-KD cells 
was also evaluated by detection of exposed PS with Annexin V. Arrows indicate the shRNAs that 
were chosen for further characterization. Stars indicate statistically significant differences with control. 
 
Discussion 
 
Two major results are presented here. First, we have set up an assay allowing 
medium-scale screens of the molecular machinery specifically involved in exosome 
secretion. Second, using this assay, we identified a few Rab family members, 
including Rab27a and Rab27b that play a role in exosome secretion.  
Several other Rabs, in addition to Rab27, were identified in this study as being 
potentially involved in exosome secretion. Most of them are known to participate in 
trafficking in the endocytic pathway 19,20, thus supporting the endosomal origin of 
exosomes: Rab9 associates with late endosomes and orchestrates retrograde 
trafficking to the TGN, Rab5 functions at the level of early endosomes. Finally, Rab2 
is generally described in association with the intermediate compartment between 
endoplasmic reticulum and Golgi apparatus, but in phylogenetic trees, it is closer to 
Rab4, Rab11 and Rab1417, i.e. Rabs associated with the endocytic pathway. On the 
other hand, other Rabs associated with the endocytic system, such as Rab7 or 
Rab11, did not modify exosome secretion in HeLa cells. These observations suggest 
that a specific subset of the endocytic system participates in the generation of 
exosomes. 
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Material and Methods 
 
Cells and reagents 
HeLa-CIITA cells49 were stably transfected with pcDNA3 encoding the OVA cDNA 
fused to the signal peptide of lactadherin21, and a subclone named HeLa B6H4 was 
selected. These cells were cultured in DMEM containing 4.5 g glucose/l (Invitrogen, 
Paisley, Scotland) supplemented with 10% fetal calf serum (Abcys), 2 mM glutamine, 
penicillin/streptomycin (100 IU/ml and 100 μg/ml, respectively), 300 μg/ml 
hygromycin B (Calbiochem, La Jolla, CA) and 500 μg/ml of geneticin (Gibco-
Invitrogen). For exosome production, cells were cultured in “exosome-depleted 
medium”, i.e. complete medium depleted of FCS-derived exosomes by overnight 
centrifugation at 100,000 g22. Lentiviruses expressing shRNA specific for the 
choosen genes were obtained from the RNAi consortium (TRC) and produced as 
previously described23. Antibodies: for FACS analysis : mouse anti-human CD63 
(FC-5.01, Zymed) and goat anti- OVA (ICN) for coupling to aldehyde sulfate latex 4 
μm beads (Invitrogen), PE-conjugated mouse anti- HLA-DR (L243, BD), anti-CD81 
(BD), rabbit anti-OVA (Sigma-Aldrich) coupled to FITC according to manufacturer 
instruction (Pierce), mouse anti-CD63 followed by Alexa488-coupled goat anti-
mouse (Molecular Probes). 
 
Immunoadsorbtion and detection of exosomes by FACS 
Anti-human CD63 or anti-OVA antibodies were coupled to 4 μm beads following the 
manufacturer instructions. Briefly, 35 μg of antibody were coupled to 1x108 beads in 
MES buffer overnight at room temperature. Remaining free activated groups were 
blocked with PBS-4% BSA (30 min RT) and beads were stored in PBS with 0.1 % 
glycine and 0.1% sodium azide. 
Cell culture supernatants were cleared from cell debris by successive centrifugations 
at 1,200 rpm for 5 min and 4,000 rpm for 20 min. Hundred μl of cleared supernatants 
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were incubated with 20,000 anti-CD63 and 20,000 anti-OVA coupled beads 
overnight at room temperature (with shaking at 6,500 rpm). Beads were washed 
twice in PBS 2% BSA and incubated with PE-conjugated anti HLA-DR and anti-
CD81 and FITC-coupled anti-OVA (all at 1:100 dilution) for 30 min on ice. Beads 
were washed twice in annexin V buffer (BD Biosciences) and incubated with APC-
conjugated annexin V (1/10) for 10 minutes. Stained beads were acquired on a 
FACSCalibur (BD Biosciences) and data were analysed with FlowJo software (Tree 
Star, Ashland, OR). Threshold of negative staining was obtained with beads 
incubated with unconditioned medium, and for each culture condition, arbitrary units 
(A.U.) of exosome or OVA secretion were calculated as % of positive beads x MFI of 
positive beads. 
 
Lentiviral infection and screening procedure 
HeLa B6H4 cells were plated in 96 well round-bottom plates at 2,500 cells per well 
with 10μl of virus plus 8 μg/ml polybrene and the plates were centrifuged at 2,250 
rpm for 90 minutes. Infection medium was replaced with fresh complete medium. 
Puromycin was added at a final concentration of 5 μg/ml at day 2. Medium was 
replaced with exosome-depleted medium at day 4. Supernatants were collected 48 h 
later for OVA and exosome quantification, and the amount of live cells in each well 
was determined using the Cell titer blue reagent viability assay (Promega). Both 
OVA and exosome secretions were normalized to the number of viable cells present 
in the wells, and only wells with a minimal cell number of 75,000 cells/well were 
analysed. In each experiment, the basal level of exosome or OVA secretion (= 
control) was calculated as either A.U. of cells transduced with control scrambled 
shRNA, or mean of A.U. of one entire plate. A candidate gene was defined as a hit if 
two or more shRNAs modified A. U. of exosome secretion, in duplicate, by more than 
one standard deviation from the control. Results are presented as percent of A.U. of 
control. 
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Quantitative RT-PCR 
RNAs were isolated from each well at day 5 after lentiviral infection with the Qiagen 
RNeasy Mini Kit and 200 ng were reverse transcribed with SuperScript II (Invitrogen) 
according to the manufacturer’s directions. 1/10th of cDNA was used for each PCR 
reaction, performed in absolute QPCR ROX MIX (Abgene) on iCycler (BioRad). 
Primers used for GAPDH amplification were: GAPDH_F: GAG TCA ACG GAT TTG 
GTC GT and GAPDH_R: TTGATT TTG GAG GGA TCT CG. Primer sequences for 
each gene were either retrieved from Primer Bank 
(http://pga.mgh.harvard.edu/primerbank/) or designed using Primer3 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). Cycle thresholds (Ct) were 
normalized to Ct of GAPDH and fold enrichments were calculated as compared to 
the control shRNA-transduced cells values. 
 
Statistical analyses 
Student’s t-test was used for statistical analyses of the shRNA screen (exosome 
secretion, OVA secretion, mRNA level). Values are given as mean ± S.D.. *= p<0.05, 
**= p<0.01, ***=p<0.001 
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Concluding Remarks 
 
Macrophages are an important part of host defence, playing a critical role in innate 
immune responses against pathogens and in the initiation of adaptive immunity. One 
of the main characteristics of these cells is their ability to recognize and internalize 
invading microorganisms into a phagosome. The internalized microbe is rapidly 
delivered into a mature phagolysosome where it is killed and degraded. However, M. 
tuberculosis, have evolved complex mechanisms to manipulate these intracellular 
organelles to establish its survival niche. Vesicular traffic genes such as Rab 
GTPases and SNAREs have been associated with M. tuberculosis phagolysosome 
biogenesis inhibition. Micro RNAs by its turn have been associated with immune 
response to Tuberculosis. In the present thesis we aimed to study the effect of 
several human factors in phagocytosis and their effect in the survival/persistence of 
M. tuberculosis. To achieve this we developed and optimized several methodologies 
to quantify the role of several host factors in macrophage M. tuberculosis infection, 
macrophage uptake of mycobacteria and exosome secretion.  
To achieve this, we took advantage of the fluorescent proteins properties and used 
two different fluorescent reporters for assessment of macrophage and mycobacteria 
viability during infection. This methodology might be applied to test intracellular 
survival of mutant mycobacteria within macrophages and, can be used in other host-
pathogen studies. Additionally, the study of anti-mycobacterial effect of pyrazinoic 
acid esters in GFP expressing mycobacteria broth cultures highlighted the 
importance of intracellular environment in the assessment of the biological activity of 
candidate drugs against M. tuberculosis. To the best of our knowledge this is the first 
non-invasive, long-term and live methodology that can help to study both host and 
pathogen during infection. 
Subsequently, we applied the dual fluorescence reporter technic combined with 
lentivirus-delivered stable gene silencing by RNAi in human macrophage cell line 
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and made a genomic screen to knockdown 120 genes associated with human 
vesicular traffic (mainly Rab GTPases and SNAREs proteins). After infection with M. 
tuberculosis we found 10 candidate genes whose knockdown affected the 
survival/persistence of intracellular mycobacteria. From these candidates, 9 were 
recently described in phagosomes and 5 have been already associated with 
mycobacterium containing phagosomes. We further observe that the results of the 
dual fluorescence assay for the candidates could be corroborated by CFU for Rab7, 
Rab 34, Rab14 and Stx4 proteins either when testing virulent or avirulent M. 
tuberculosis. 
To further characterise the candidate genes, we optimized a macrophage uptake 
assay based in flow cytometry in order to define if the results obtained from the 
genomic screen could, in part, be justified by macrophage defects in M. tuberculosis 
uptake. We first compared several mycobacterial strains and macrophage types and 
observed that the internalization of mycobacteria by macrophages is a fast 
phenomenon and that virulent M. tuberculosis rate of uptake is slower than avirulent 
M. smegmatis and BCG independently of the macrophage type. Indeed this was 
observed even after knockdown of candidate genes: knockdown of candidate genes 
that led to a reduction in intracellular M. tuberculosis burden also induced a reduction 
in M. tuberculosis macrophage uptake. We couldn´t however dismiss a potential role 
of this genes in phagosome maturation. Indeed confirmation by alternative methods 
should be used to further confirm the role of identified candidates in M. tuberculosis 
infection and also identify the mechanisms underlying their interference in infection 
of both virulent and avirulent M. tuberculosis. 
In sum, the candidate genes identified were found to be specific of several different 
organelles suggesting that phagosome maturation and in particular the maintenance 
of mycobacteria containing phagosomes may be regulated by other pathways than 
the endosomal pathway alone. In particular, the possible association between the 
ER and the mycobacteria containing phagosome might explain the reduced antigen 
presentation of infected macrophages via MHCII. Additionally, the reduction in the 
rate of virulent M. tuberculosis uptake led us to conclude that this strain probably 
invades macrophages by a different route than that one of avirulent mycobacteria. 
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Undeniably, we were able to demonstrate a mechanism by which virulent M. 
tuberculosis controls its uptake by macrophages. We found that virulent M. 
tuberculosis, but not avirulent M. smegmatis or latex beads, induce the expression of 
macrophage miR-142-3p during the initial stages of infection. The miR-142-3p 
reduction leads to the reduction of N-Wasp, a miR-142-3p partner, involved in signal 
transduction of surface phagocytic receptors. Reduction of N-wasp by miR-142-3p 
expression or by RNAi of Wasl, the N-Wasp gene, leads to a reduction in M. 
tuberculosis macrophage uptake. We have shown a probable mechanism by which 
virulent M. tuberculosis modulate macrophage infection in order to maintain low 
levels of immune activation. 
In order to dissect the role of Rab GTPases in exosome secretion we performed a 
genomic screen to knockdown 57 Rab family members. In this screen we identified 5 
small GTPases of the Rab family that promote exosome secretion in HeLa cells, 
including Rab27a and Rab27b.  This approach led to the demonstration that 
exosomes are secreted from multivesicular bodies. However it was not possible to 
apply this methodology to our infection model in order to determine the role of 
vesicular traffic genes in exosome secretion in the context of M. tuberculosis 
macrophage infection.  
In conclusion, in this thesis we developed, optimized and applied several tools for 
the study of macrophage phagocytosis and its subversion by M. tuberculosis that 
can help future identification of new host and pathogen factors involved in 
tuberculosis infection. We highlighted the importance of drug screening using models 
with intracellular M. tuberculosis, the relevance of the of virulent strains other than 
surrogate strains to study M. tuberculosis-human interactions and the importance 
determination of viable intracellular mycobacteria when defining the importance of an 
host factor in M. tuberculosis infection. We unveil the impact of several host factors 
involved in macrophage phagocytosis and M. tuberculosis infection. Both Rab 
GTPases and microRNAs are targeted host factors for new treatment strategies and 
differentially expressed in M. tuberculosis infected individuals highlighting the 
importance of these host factors in tuberculosis. The study and identification of 
members from these groups of host factors implicated in M. tuberculosis infection will 
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allow identifying new targets for the development of new diagnosis markers and 
host-targeted drugs to control one of the most ancient diseases that still takes a big 
toll to mankind: tuberculosis. 
 
